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 i 
Abstract 
 
Synthesis of !-Hydroxy and Fluoro Phosphonates and  
Cyclic Ether-Containing Natural Products  
Nongnuch Sutivisedsak 
Doctor of Philosophy 
University of Missouri-St. Louis 
Prof. Christopher D. Spilling, Chairperson 
 
A number of important classes of natural product (eg. amphidinolide C, (-)-
centrolobine, etc) contain common structural features of tetrahydrofurans and 
tetrahydropyrans. This study involved the development of stereoselective mothods for the 
synthesis of tetrahydrofurans and tetrahydropyrans including the application of allylic 
hydroxy phosphonates and their derivatives as chiral, non racemic building blocks for the 
synthesis of biological active molecules.  
The enantiomeric excess of non racemic !-hydroxy phosphonates and carbonate 
derivatives prepared via the asymmetric Pudovik reaction can be improved by kinetic 
resolution. Both chemical and enzyme catalysts were utilized in the kinetic resolution of 
phosphonates. Enantioselective acylation of a variety of racemic !-hydroxy phosphonates 
using Birman catalysts (generation 0, I, II and III) was studied. Birman’s generation II 
catalyst acylated a representative non racemic benzylic !-hydroxy phosphonate with 
moderate 70 % e.e. and resulted in enhanced enantiomeric excess (97 % e.e.) in 
preparative scale. The enzyme catalyzed resolution via the asymmetric hydrolysis of 
 ii 
phosphono allylic carbonate using different lipases was explored. Among a variety of 
lipases (14 kinds) screened, CALB showed adequate selectivity (E = 3.3) at 40
o
C and was 
chosen for the hydrolysis of the phosphono allylic carbonate. By virtue of encapsulation, 
CALB can be reused up to 5 times and still provide satisfactory enantioselectivities. 
These two methods were found to be quite effective in producing enantiomerically 
enriched allylic phosphonates in high e.e. and reasonable yield. The methodology was 
also successfully applied to the formal synthesis of natural product (+)-centrolobine.  
 Reaction of hydroxy substituted phosphono allylic carbonate in the presence of 
Pd(PPh3)4 and Hunig’s base in THF at 40
o
C gave the corresponding tetrahydrofuran and 
tetrahydropyran (E) vinyl phosphonates. A cyclization performed on non racemic 
phosphonates resulted in formation of tetrahydrofuran vinyl phosphonates with complete 
chirality transfer according to the evidence provided by HPLC analysis. Further studies 
continued to investigate the scope of the palladium(0) catalyzed addition of alcohol and 
carboxylic acid to phosphono allylic carbonate. The longer chained alcohols (7 and 8 
carbon chain) were prone to give elimination products rather than 7 or 8 membered-
cyclic ether products. The carboxylic acid reacted with palladium(0) to give 
corresponding tetrahydrofuran lactone. Surprisingly, the homologous acid failed to 
cyclize and only the formation of a mixture of diene products was observed. 
 Oxidation of hydroxy substituted phosphono allylic carbonates provided the 
aldehyde substituted phosphonates in good yield. Stereospecific palladium(0) catalyzed 
cyclization in the presence of methanol or water gave acetal tetrahydrofuran and 
tetrahydropyran vinyl phosphonates, respectively, derived from hemiacetal trapping. The 
HPLC analysis showed complete chirality transfer in the palladium(0) catalyzed 
 iii 
cyclization  reaction. However, an effort to the synthesis of the southern part of the 
natural product amphidinolide C failed. The reaction sequence resulted in erosion 
(racemization) of stereochemistry due to the chiral center adjacent to aldehyde group of 
the compound. The tetrahydrofuran acetals undergo Lewis acid catalyzed addition of 
various nucleophiles to give a diastereomeric mixtures of substituted tetrahydrofurans. 
 Another part of this research involved the study of the stereochemistry of the 
substitution reaction of hydroxyl for fluorine in !-hydroxy phosphonates which has been 
the subject of some debate. The reaction of dimethylaminosulfur trifluoride (DAST) and 
[bis(2-methoxyethyl)amino]sulfur trifluoride (Deoxofluor) with enantiomerically pure 
benzylic hydroxy phosphonates were re-examined. A number of factors such as the 
substituent on the aromatic ring, the reaction temperature, and the solvent were 
investigated.  The study showed that changing parameters such as fluorinating agent, 
solvent and/or reaction temperature did not significantly alter the results. The most 
dramatic change occurred as a result of introduction of electron withdrawing substituents 
on the aryl group giving less racemization and slower rate of the reaction. 
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Chapter One 
 
 
 
 
 
 
 2 
1.1 General Objective 
!-Hydroxy phosphonates are versatile intermediates for the asymmetric synthesis 
of natural products and enzyme inhibitors.
1 
A variety of substituted hydroxy 
phosphonates and their carbonate derivatives can be prepared via cross metathesis of 
phosphonates 1.1 and 1.2 with substituted alkenes
2 
(Scheme 1.1). Thus, a large scale 
synthesis of enantiomerically pure phosphonates 1.1 and 1.2 was required. Hence, the 
aim of the work described in this chapter corresponds to the development of methods to 
provide optically pure hydroxy phosphonates and their carbonate derivatives 1.3 via 
chemical and enzymatic kinetic resolution. Ultimately, these enantiomerically pure 
phosphonate compounds 1.3 could be applied to the formal synthesis of the natural 
products, (+)-centrolobine 1.4 and amphidinolide C 1.5 via a novel palladium catalyzed 
intramolecular nucleophilic addition, which is discussed in greater detail in chapter 3 of 
this thesis (Scheme 1.1). 
 3 
 
Scheme 1.1 General objective 
 
1.2 Introduction 
Phosphonic acids (1.6, Figure 1.1) are an important group of compounds because 
of their biological properties which include examples that exhibit antibacterial, 
 4 
anticancer, antibiotic and pesticidal properties, and some that are enzyme inhibitors.
3
 For 
instance, the antibiotic phosphonomycin 1.7
4
 (Figure 1.2) is used in the treatment of 
urinary tract infections. !-Hydroxy phosphonates (1.8, Figure 1.2), which are derivatives 
of phosphonic acids 1.6 have attracted considerable attention as biologically active 
compounds, enzyme inhibitors and drugs as well.
5,6,7
 For example (Figure 1.2), 
phosphonopeptide 1.9 efficiently inhibits human renin which is the enzyme responsible 
for catalyzing the conversion of angiotensinogen to angiotensin.
8
 Cidofovir 1.12 is used 
as antivirus
9
 medication for the treatment of smallpox.
10 
 
 
Figure 1.1 Examples of biologically active hydroxy phosphonic acids 
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Figure 1.2 Examples of biologically active hydroxy phosphonates 
 
1.3 Asymmetric Synthesis of !-Hydroxy Phosphonates 
The chemistry and biology of !-hydroxy phosphonates 1.14 has developed rapidly 
over the last two decades accompanied by the development of highly effective methods 
for their preparation.
11,12,13
 Various methods such as kinetic resolution, chemoenzymatic 
synthesis, and asymmetric synthesis have been applied to the preparation of chiral 
hydroxy phosphonates. Early popular methods used for the synthesis of !-hydroxy 
phosphonates 1.14 are the Pudovik
14
 and the Abramov
15
 reactions (Scheme 1.2). The 
Pudovik reaction is the addition of a dialkyl phosphite 1.15 to an aldehyde or ketone 1.16, 
while the Abramov reaction uses a trialkyl phosphite 1.17. These two methods have been 
modified for the synthesis of non racemic !-hydroxy phosphonates 1.14. Some additional 
examples of the methods for the synthesis of hydroxy phosphonates are described in 
greater detail below.
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Scheme 1.2 The Pudovik and Abramov reaction 
 
a) The Use of Chiral, Non Racemic Phosphite Equivalents  
Spilling
16
 demonstrated that the addition of chiral phosphorous acid diamide 1.18 
to aldehydes 1.19 gave diastereomeric mixtures of !-hydroxy phosphonamides 1.20 in 
good yield and with good diastereoselectivity (54 – 93 % d.e.). Hydrolysis of the 
phosphonamides gave phosphonic acids 1.21, which were methylated to yield dimethyl 
phosphonates 1.22 without loss of stereochemical integrity (Scheme 1.3). 
 
Scheme 1.3 Preparation of hydroxy phosphonates employing the use of chiral, 
non racemic phosphite auxillaries  
 7 
b) Diastereoselective Addition to Chiral Aldehydes or Equivalents 
The additions of phosphites to both chiral !-amino and !-benzyloxyaldehydes led 
to the formation of non racemic hydroxy phosphonates. Hammerschmidt
17
 first reported 
the addition of dialkyl(trimethylsilyl)phosphite to (S)-2-(benzyloxy)propanal provided a 
moderate diastereomer ratio of 3 : 1 of product . Shibuya
18
 carried out the TiCl4 catalyzed 
hydrophosphonylation of chiral aldehyde 1.23 with diethyl tert–butyldimethylsilyl 
phosphite 1.24 to generate the enantiomerically pure "–amino-!-hydroxy phosphonates 
(1.25, 1.26) with excellent diastereoselectivity (98 : 2) (Eq. 1.1). 
 
 
 
c) Asymmetric Reduction 
Asymmetric reduction of !-ketophosphonates is one of the most convenient 
methods to the synthesis of hydroxy phosphonates. The reaction can proceed under the 
control of asymmetric catalysts or chiral reagents.
19 
In 1994, Gadja
20
 prepared non racemic hydroxy phosphonates by the asymmetric 
reduction of a series of acyl phosphonates 1.27 using borane BH3 and "-butyloxazo-
borolidine 1.28 in THF (Eq. 1.2). The reaction gave hydroxy phosphonates 1.29 in 
moderate yield (53-85 %) and moderate to good enantiomeric excess (53 - 83 %).  
 8 
 
 
A year later, Meier and coworkers
21,22
 examined the same reaction using the same 
catalyst at a higher loading (12 mol%) with catecholborane or Me2S
.
BH3 replacing pure 
borane as the hydride source. In most cases, phosphonates were formed in good yield 
with excellent enantiomeric excess (> 99 % e.e.). 
 
d) Asymmetric Hydroxylation 
Asymmetric oxidation of a carbon-hydrogen bond plays an important role in the 
synthesis of hydroxy phosphonates. Weimer
23
 reported the asymmetric hydroxylation of 
benzylic phosphonate 1.30 with enantiomerically pure (camphorsulfonyl)oxaziridine 
1.32. !-Hydroxy phosphonate 1.31 was formed in moderate yield with good enantiomeric 
excess (Eq. 1.3). As shown in Scheme 1.4, the enantiopurity of hydroxy phosphonate 
1.31 was improved up to 96 % e.e. when the methoxy group on phosphorous was 
replaced with a OCH2CH=CH2 group (1.33), and up to 98 % e.e. when m-substititution of 
the phenyl ring (1.34) was used.
27
 The hydroxy phosphonic acids 1.31 formed from 
enantiopure hydroxy phosphonates 1.35 still retained the high degree of stereochemical 
purity. 
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Scheme 1.4 Asymmetric oxidation of benzyl phosphonates with chiral oxaziridine 
 
Recently, the first proline-catalyzed asymmetric aldol reaction
24
 for the synthesis 
of tertiary (R)-hydroxy phosphonates was reported by Zhao and coworker
25
 (Eq. 1.4). 
Tertiary !-hydroxy phosphonates 1.39 were synthesized in good yields and high 
enantiomeric purity (up to 99 % e.e.) using 20 mol% of L-proline 1.38 as the catalyst via 
cross aldol reaction of !-ketophosphonate 1.36 and ketone 1.37. The enantiopurity was 
determined by HPLC analysis, but the absolute configuration was not determined. 
 10 
 
 
Moreover, in the same year, another catalyst, L-prolinamide 1.42 which is readily 
available, was also employed in the cross aldol reaction of ketone 1.41 and diethyl 
formylphosphonate hydrate 1.40
26 
(Eq. 1.5). Diethyl formylphosphonate hydrate 1.40 was 
used since it is more stable and is in equilibrium with its formyl form. Secondary !-
hydroxy phosphonates 1.43 have been synthesized in high enantioselectivity (up to > 97 
% e.e.). 
 
 
e) Asymmetric Dihydroxylation  
The oxidation of (E)-alkenylphosphonates with conjugated aromatic ring 
substituents with AD-mix-! 1.44 (Figure 1.3) or AD-mix-" 1.45 (Figure 1.4) is a well 
known preparative method providing the enantiomerically pure dihydroxy phosphonate.
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Figure 1.3 The structure of AD-mix-! 
 
 
Figure 1.4 The structure of AD-mix-" 
 
Shibuya and coworkers
28,29
 reported the use of the Sharpless asymmetric 
dihydroxylation of vinylphosphonates 1.46 as a route to chiral !-hydroxy phosphonates 
1.47. Using the commercially available AD-mix-! 1.44 or " reagents 1.45
30
 in the 
presence of potassium osmate (0.8 mol%), two stereogenic centers were successfully 
generated in one step from achiral aryl vinyl phosphonate 1.46 in good yield with very 
high enantioselectivity. Ultimately, the resulting chiral glycol 1.47 can be further 
converted into 1.48 or 1.49 (Scheme 1.5).  
 12 
 
 
Scheme 1.5 Sharpless asymmetric dihydroxylation of vinylphosphonates 
 
f) Asymmetric Aminohydroxylation 
In 1996, a new catalytic route for the syntheses of !-amino "-hydroxy compounds 
from the corresponding olefins was reported by Sharpless.
31a,b
 The use of osmium(VIII) 
and the chinchona alkaloid (DHQ)2PHAL (1.44, Figure 1.3) as a catalyst resulted in 
products of high enatiomeric excess. Sharpless
31c
 demonstrated the feasibility of 
asymmetric aminohydroxylation of vinyl phosphonates 1.51 as an approach to synthesize 
"-hydroxy-!-toluenesulfonamido phosphonates (R=Ts, 1.52a) and "-hydroxy-!-
ethylcarbamido phosphonates (R=EtO2C, 1.28b) with good to high e.e. (32 – 98 %) (Eq. 
1.6). 
 
  
 13 
Synthesis of aminohydroxy phosphonates via ring opening of epoxypropyl-
phosphonates was reported by Wroblewski
32
 (Scheme 1.6). The epoxide ring of two 
diastereomers of O-benzylated phosphonates 1.54a and 1.54b (obtained from 
cyclohexylidenepropylphosphonates 1.53 after purification) was regioselectively opened 
with dibenzylamine. The reaction, after acetylation, followed by the selective 
hydrogenolysis, gave the (1R,2R)- and (1S,2R)-!-hydroxy propyl-phosphonates 1.55a 
and 1.55b, respectively. 
 
Scheme 1.6 The aymmetric aminohydroxylation of epoxyphosphonate with 
dibenzylamine 
 14 
g) Asymmetric Hydrogenation 
The enantioselective hydrogenation of !,"-unsaturated substrates using rhodium 
complexes of chiral phosphine ligands (eg. DuPHOS) provides a convenient access to the 
synthesis of chiral !-hydroxy phosphonates. For instance, in 1999, the asymmetric 
hydrogenation of enolbenzoate phosphonate 1.58 with a cationic rhodium catalyst 
coordinated to the ligand DuPHOS 1.56 or BPE 1.57 (Figure 1.5) was reported by Burk.
33
 
The complex DuPHOS-Rh and BPE-Rh (1.61) provided good to excellent 
enantioselectivities in the hydrogenation of "-alkyl substituted phosphonates 1.58 
(Scheme 1.7).  
 
Figure 1.5 The DuPHOS and BPE ligands 
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Scheme 1.7 Asymmetric hydrogenation of !-alkyl phosphonates using a cationic 
rhodium catalyst with DuPHOS and BPE ligands 
 
 The enantioselective hydrogenation of various alkenephosphonates 1.58 with Rh-
BisP and Rh-MiniPHOS catalysts (1.64) was reported by Beletskaya
34
 in 2004 (Scheme 
1.8). The reaction with (S,S)-t-Bu-BisP 1.62 and (R,R)-t-Bu-MiniPHOS 1.63 (Figure 1.6) 
led to (R)-configuration of hydrogenated products 1.59. In most cases, the use of t-Bu-
MiniPHOS 1.63 as the chiral ligand gave higher enantioselectivities than t-Bu-BisP 1.62. 
 
 
 
Figure 1.6 The (S,S)-t-Bu-BisP and (R,R)-t-Bu-MiniPHOS ligands 
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Scheme 1.8 Asymmetric hydrogenation of !-alkyl and aryl phosphonates using 
rhodium catalyst based on chiral phosphine-phosphite 
 
Hydrogenation of !-aryl substrates was also studied later by Pizzano
35
 in 2005. !-
Aryl substituted phosphonates are an important class of compound. These compomds 
allow, for instance, the synthesis of phosphonic acid analogs of phenylalanine and 
tyrosine.
40a
 The efficient catalyst 1.67 based on chiral phosphine-phosphite 1.65 
(prepared from bisphenol 1.66, Scheme 1.9) hydrogenated both  !-aryl and !-alkyl 
substrates 1.58 with high enantioselectivities up to 98 %  (Scheme 1.10). 
 17 
 
Scheme 1.9 Preparation of ligand based on chiral phosphine-phosphite 
 
 
 
Scheme 1.10 Asymmetric hydrogenation of !-alkyl and aryl phosphonates using 
rhodium catalyst based on chiral phosphine-phosphite 
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h) Asymmetric Catalytic Hydrophosphonylation 
Another route to hydroxy phosphonates of moderate to high enantiomeric purity 
is the catalytic phosphonylation of aldehydes using metal complexes. In 1993, Shibuya
37c
 
first reported the use of a lanthanum based catalyst in the Pudovik reaction. Using the 
Shibasaki procedure,
38
 lanthanum catalyst (R)-LLB (1.68, Figure 1.7) was prepared by 
reaction of lithium (R)-binapthoxide with LaCl3.7H2O. The addition of several p-
substituted benzaldehydes 1.70 with diethyl phosphite 1.69 in the presence of 20 mol% of 
(R)-LLB 1.68 gave the resulting hydroxy phosphonates 1.71 in excellent yield with the 
enantiopurity ranging from 20 – 82 % (Scheme 1.11).  
 
Figure 1.7 The structure of (R)-lanthanum-lithium-BINOL catalyst 
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Scheme 1.11 Asymmetric preparation of hydroxy phosphonate using lanthanum-
lithium-BINOL based catalyst 
 
In 1994, Spilling et al.
39 
independently reported the application of asymmetric 
phosphonylation of unsaturated aldehydes 1.73 using this same catalyst system. 
However, the resulting enantiopurity was low (~ 33 % e.e.). A few years later, 
Shibasaki
40j
 reported an improvement in the catalyst preparation. The catalyst (R)-LLB 
1.68 was prepared using LaCl3.7H2O (1 mol eq), (R)-BINOL dilithium salt (2.7 mol eq) 
and NaOt-Bu (0.3 mol eq) in THF at 50
o
C. Using the catalyst prepared by this method, 
the phosphonaylation gave !-hydroxy phosphonates 1.74 in higher enantiomeric excess 
up to 95 % e.e. (Scheme 1.12).  
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Scheme 1.12 Asymmetric preparation of hydroxy phosphonate using lanthanum-
lithium-BINOL based catalyst 
 
The aluminum-lithium-BINOL complex (R)-ALB (1.75, Figure 1.8) was also 
developed by Shibasaki and coworkers.
40n 
The resulting hydroxy phosphonates 1.74 were 
obtained in moderate to good yield with enantiomeric excesses ranging from 55 – 90 % 
(Scheme 1.13). The primary disadvantage of this methodology is the need to maintain 
low temperature (-40
o
C) for 4 – 5 days. 
 
Figure 1.8 The structure of (R)-aluminum-lithium-BINOL catalyst 
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Scheme 1.13 Asymmetric preparation of allylic hydroxy phosphonate using 
aluminum-lithium-BINOL based catalyst 
 
The titanium based catalyst system was employed as an asymmetric catalyst for 
the enantioselective phosphonylation by Shibuya.
37c
 The Sharpless titanium alkoxide 
system 1.76 (generated in situ from diisopropyl tartrate and titanium isopropoxide) 
catalyzed the Pudovik reaction with aromatic aldehydes 1.70 and diethyl phosphite 1.69 
(Scheme 1.14).
41
 The enantioselectivity was dependent on the solvent used. Diethyl ether 
was the best among the solvents examined, giving the hydroxy phosphonate 1.71 in good 
yield (75 %), with enantiomeric excess of 53 % e.e. 
 22 
 
Scheme 1.14 Asymmetric Pudovik reaction using Sharpless titanium alkoxide-
diisopropyl tartrate system 
 
In addition, two titanium based catalyst systems were also developed in Spilling’s 
group.
37a,b
 A reaction between dimethylphosphite 1.72 and a diverse array of aldehydes 
1.73 was catalyzed by the chiral diol ligand, cyclohexanediol 1.77 and Ti(Oi-Pr)4. The 
titanium alkoxide was generated in situ from the mixture of 1.77 with Ti(Oi-Pr)4 in a 
1.1:1 ratio.. The reaction afforded !-hydroxy phosphonates 1.74 with enantiomeric 
excesses ranging from 60 – 70 % in 44 - 70 % chemical yield (Scheme 1.15). 
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Scheme 1.15 Asymmetric preparation of allylic hydroxy phosphonate using 
titanium alkoxide catalyst 
 
Upon further exploration, Spilling
42
 showed that replacing cyclohexanediol with 
dimethyl L-tartrate 1.78 provided increased yields and improved enantiomeric excesses 
of non racemic hydroxy phosphonates 1.80a. The reaction between dimethyl phosphite 
1.72 and cinnamaldehyde 1.79 using 20 mol% dimethyl L-tartrate 1.78 and 20 mol% 
Ti(Oi-Pr)4 at 0.13 M catalyst solution yielded solid cinnamyl hydroxy phosphonate 1.80a 
in 70 % e.e. (Eq. 1.7). After recrystallization, additional improvements were achieved 
resulting in more than 98 % e.e. 
 
Due to the advantage of air and water tolerance, an aluminum catalyst system was 
first introduced for use in the Pudovik reaction by Kee.
43
 As shown in Scheme 1.16, the 
 24 
reaction of benzaldehyde 1.70 with dimethylphosphite 1.72 in the presence of salcyen 
based aluminum catalyst 1.81 gave the (R)-hydroxy phosphonate 1.71 with enantiomeric 
excess of 43 %.
43a
 A year later, the original salcyen catalyst 1.82 was improved by 
reduction of the imine (C=N) bond. The newly developed salcyan based catalyst system 
1.82 showed an increase in the enantiopurity (59 % e.e.). However, the configuration of 
hydroxy phosphonates obtained was (S), which is opposite to that obtained when using 
salcyen catalyst 1.81.
43b 
 
Scheme 1.16 Asymmetric Pudovik reaction using Kee’s aluminum based  
catalyst system 
 
Spilling and He
44
 later discovered that a 1 to 5 mol% loading of the Schiff base 
ligand 1.83 (synthesized from !-amino alcohols and salicylaldehyde derivatives) with 
AlMe3 is effective at room temperature and yielded (S)-cinnamyl hydroxy phosphonate 
1.80b with modest stereoselectivity (~ 60 % e.e.) (Eq. 1.8). 
 25 
 
 
1.4 Resolution 
 There are many attractive routes toward the synthesis of !-hydroxy phosphonates, 
nevertheless, non racemic allylic hydroxy phosphonates are most conveniently generated 
by resolution. In the last two decades, the resolution of racemates has been the most 
common method in industry for the preparation of single enantiomers. A brief detail of 
three categories of resolution is described below. 
1. Crystallization
18,45 
Crystallization involves the addition of an enantiomerically pure seed crystal to a 
saturated solution of racemic material in order to preferentially crystallize only one 
enantiomer out over the other one. The disadvantage of this simple, easy process is that it 
is always accompanied with a yield decrease. Indeed, in order to be successful, the 
racemic mixture must form a conglomerate (a mechanical mixture of the two enantiomers 
in equal amounts) and the sample must be of moderate enantiomeric excess. 
2. Chromatography 
Modern instrumental chromatography methods for analysis, such as GC and 
HPLC, have been developed to separate enantiomers.
36
 These method are fast, simple to 
carry out and unaffected by a small amount of impurities. Although chiral HPLC is quite 
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expensive and specific, it is possible to find a stationary phase on which the enantiomers 
can be resolved. 
3. Kinetic resolution : will be described below. 
 
1.5 Kinetic Resolution 
Kinetic resolution has been widely used to achieve enantiomerically enriched 
compounds (eg. primary, secondary, tertiary alcohol, carboxylic acid, diol, etc.).
46
 
Secondary alcohols
47
 are among the most frequently targeted molecules due to their 
prominent role in synthetic organic chemistry and will be focused on this discussion
48
 as 
will the !-hydroxy phosphonates, since they both exhibit similar chemistry. The fact that 
two enantiomers react at different rates with a chiral entity makes it very useful (Scheme 
1.17). Theoretically, one enantiomer should react much faster than the other one in order 
to provide a route to a useful resolution. The chiral entity, which should be present in a 
catalytic amount in the resolution reaction, could be a biocatalyst (such as an enzyme) or 
a chemocatalyst (such as a chiral organic catalyst).  
 
 
Scheme 1.17 Kinetic resolution of racemates 
 
(R/S) Starting material 
(R)-Product 
(S)-Product 
kR >> kS  or  kR << kS 
kS 
kR 
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1.6 Asymmetric Amplification of Non Racemic Hydroxy Phosphonates by Kinetic 
Resolution  
As mentioned earlier, in Spilling’s group, the dimethyl tartrate/Ti(Oi-Pr)4 catalyst 
system has been employed for the preparation of non racemic hydroxy phosphonates. The 
method is general, inexpensive, high yielding and scalable, but compounds of only 
moderate enantiomeric excesses ranging from 74 to 80 % were generated. To improve the 
enantiomeric excess, the amplification of the moderate enantioenriched substance using a 
kinetic resolution is discussed. The coupling of two steps-reaction, asymmetric catalysis 
followed by kinetic resolution allowed stereoselectivity enhancement. 
 
1.7 Chemical Catalyzed Kinetic Resolution  
 1.7.1 Background 
 In 1996, Oriyama
49
 reported that the chiral SnBr2-diamine complex 1.87 catalyzed 
acylation of the racemic compound 1.84 with a selectivity factor of 160. The benzoyl 
chloride 1.88 acylated one enantiomer preferentially over the other and gave both the 
acetylated product 1.85 and unreacted starting material 1.86 with excellent enantiomeric 
excess (Eq. 1.9). 
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 In 1997, Fuji
50 
reported that the acylative kinetic resolution of racemic amino 
alcohol derivatives was catalyzed by DMAP based catalyst, 1.89 (Figure 1.9). Although 
this catalyst has no chiral element in the catalytic pyridine ring, the two enantiomers can 
be differentiated with selectivity factor of 54 due to the chirality transfer from the remote 
stereogenic center to the reactive site (Eq. 1.10).  
 
Figure 1.9 DMAP based catalyst structure 
 
 
 
 In 2000, Fu
51 
reported another asymmetric nucleophilic acyl transfer catalyst for 
kinetic resolution based on DMAP, an (Eq. 1.11). The use of 1 mol% catalyst 1.95 
improved the selectivity of acylation of alcohol 1.93 in the range from 32 to more than 
200. 
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In 2001, several important groups of asymmetric catalysts were developed for 
kinetic resolution. Enantioselective acylation of the secondary alcohol was reported by 
Spivey,
52 
using the atropisomeric !-methyl substituted analog of DMAP 1.100. The high 
barrier of rotation about the aryl-aryl bond of the catalyst 1.100 produced atropisomers 
which enantioselectively acetylated alcohol 1.97 with a selectivity of 24 (Eq. 1.12).  
 
 The kinetic resolution of allylic alcohols 1.102 with isobutyric anhydride 1.104 
using the chiral phosphine catalyst, t-Bu2PhPBO (phosphabicyclo[3.3.0]octane, 1.101) 
(Figure 1.10) was reported  by Vedejs.
53 
A selectivity of 4 - 82 was achieved for alcohols 
1.102 in the presence of 5 mol% of the catalyst (Eq. 1.13). 
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Figure 1.10 Phosphabicyclo[3.3.0]octane structure 
 
 
 
 Reported by Stoltz,
54
 (-)-sparteine 1.108 was an effective ligand in the 
asymmetric palladium catalyzed oxidative kinetic resolution of the secondary alcohol 
1.105 with molecular oxygen. In the presence of both 10 mol% of (-)-sparteine and Pd(II) 
1.109, the (S)-alcohol 1.106 was recovered with excellent e.e. as shown in Eq. 1.14. 
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 Miller
55 
reported that the enantioselective acylation of racemic compound 1.111, 
using only 2 mol% peptide based catalyst 1.110 (Figure 1.11), gave the non racemic 
alcohol 1.112 with an enantiomeric excess of 90 % (Eq. 1.15). 
 
Figure 1.11 Peptide based catalyst structure 
 
 
In 2003, another palladium catalyzed deracemization of carbonates was reported 
by Gais.
56
 The asymmetric kinetic resolution of 1.114 was carried out using 8 mol% of 
BPA 1.116 as an asymmetric catalyst and 2 mol% Pd2(dba)3 to afford enantiomerically 
pure alcohol 1.115 with 88 % e.e. in 89 % yield (Scheme 1.18).  
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Scheme 1.18 The Pd-catalyzed deracemization using BPA as an asymmetric catalyst 
 
Recently, Chen and coworkers
57
 reported a vanadium-catalyzed oxidative kinetic 
resolution for the highly enantioselective synthesis of secondary (R)-hydroxy 
phosphonates 1.118 (Scheme 1.19). The kinetic resolution using the vanadyl(V) 
methoxide complex 1.117 proceeded through the highly enantioselective aerobic 
oxidations of !-hydroxy phosphonates 1.118 at ambient temperature resulting in 
compound 1.119 with the selectivity factors ranging from 3 to > 99. The disadvantage of 
this method is the sacrifice of 50 % of the starting material. 
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Scheme 1.19 Asymmetric aerobic oxidation of hydroxy phosphonate with 
vanadium(V) catalyst 
 
 1.7.2 Kinetic Resolution of !-Hydroxy Phosphonates using Birman Catalysts 
Over the past few years, Birman et al.
58-62
 have developed a series of easily 
accessible and effective non-enzymatic asymmetric acylation catalysts (1.121 to 1.124, 
Figure 1.12). These catalysts provide a convenient method for the kinetic resolution of 
secondary alcohols 1.125 via enantioselective acyl transfer (Eq. 1.16). The catalysts are 
easily prepared from commercially available materials. They are inexpensive, available 
as either enantiomer, and are recoverable from the reaction mixture by acid extraction. 
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Figure 1.12 Birman catalysts 
 
 
 
In 2004, Birman
59,58
 showed that 2 mol% of Gen I (1.122), propionic anhydride 
(R
3
 = Et) and diisopropyl ethylamine at 0
o
C allowed the enantioselective acylation of 
benzylic alcohols 1.125 with selectivities up to 85 (when R
1
 = Ph and R
2 
= t-Bu, 48 % 
conversion within 52 h). A year later, a new class of “quinoline based catalyst” (Gen II, 
Cl-PIQ, 1.123)
60,58
 was developed. The addition of a !-system in the catalyst provided the 
solution for the cinnamyl alcohol series in which the benzyl (Ph) group of the substrate 
was positioned too far from the chiral center to interact with the pyridinium moiety of the 
catalyst.  Later in 2006, a 3
rd
 generation Birman catalyst
61,62
 (Gen III, BTM, 
benzotetramisole, 1.124) was synthesized and shown to possess markedly higher 
enantioselectivity than Gen II in the kinetic resolution of benzylic alcohol (S = 100 - 
350). Due to its relationship to the desired catalysts, tetramisole base (Gen 0, 1.121) 
became interesting for Birman
61
 due to its commercial availability in enantiomerially 
pure form (as the hydrochloride). The experimental results of Gen 0 (1.121) compared to 
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Gen III (BTM, 1.124) indicated the certain benefit of an extended !-system in the catalyst 
structure for the chiral recognition of the benzylic alcohol.    
 
1.8 Enzymatic Catalyzed Kinetic Resolution 
1.8.1 Background 
Today, kinetic resolution of racemic substrates by enzyme catalysis has become a 
standard reaction in organic syntheses.
63
 Enzymes are very unique proteins and can 
exhibit control over the stereochemistry in single step reactions. They catalyze a broad 
range of reactions and there is an enzyme equivalent for most organic transformations. 
The enzyme decreases the activation energy of an organic reaction which leads to an 
increase of the reaction rate. This is why in some cases, their efficiency is 10
12
 times 
faster than the uncatalyzed reaction. The fact that enzymes can show high selectivities for 
a particular enantiomer in many useful transformations also makes them very valuable 
chiral catalysts. The advantages include that they provide mild reaction conditions often 
at neutral pH and ambient temperature. However, the limitation of using an enzyme is 
that they reside in aqueous media and are not well-suited for water-insoluble substrates. 
Nevertheless, in this case, a two-phase organic/aqueous system may be used in order to 
get the substrate into the organic phase, diffuse into the water layer and react with the 
enzyme, then diffuse back to the organic phase.  
In the last two decades, lipases have attracted great attention as useful chiral 
catalysts for the preparation of enantiomerically pure compounds. Lipases are among the 
group of enzymes that show specificity for a broad range of substrates. They are 
relatively stable, inexpensive and available. Furthermore, in kinetic resolution using 
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lipases, a cofactor (for example, NAD, ATP, nicotinamide, etc.), which is usually used to 
drive the reaction to completion, is not needed. Alcohols, carboxylic acids and amides 
can be resolved by kinetic resolution with an enzyme via ester hydrolysis or 
transesterification. The drawback of the former method is that the reaction pH must be 
maintained neutral since the generation of acid from hydrolysis results in the loss of 
selectivity and reaction rate. 
In 1982, Sih
64
 reported a set of equations for describing the course of an 
enantioselective enzyme catalyzed hydrolysis. The substrate-enzyme combination 
reacting under a given set of conditions (Scheme 1.20) is characterized by the 
enantioselectivity ratio (E) (Eq. 1.17) where c is the extent of reaction conversion and 
ee(P) is the % enantiomeric excess of product. The E value is related to the ratio of the 
rates for the faster and slower reacting enantiomers. Normally, for the successful 
resolution, E > 100 is required which means that the rate of reaction of the faster reacting 
enantiomer with enzyme should be > 100 times greater than that of the other enantiomer.  
 
Scheme 1.20 The three steps kinetic mechanism of the enzyme catalyzed resolution 
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In 1993, Rabillier
65
 showed that the lipase from Pseudomonas proved to be the 
catalyst of choice for the transesterification reaction of N-benzyloxycarbonyl derivatives 
of the phosphonic analogs of amino acids isoserine 1.126 and serine 1.127 (Eq. 1.18). 
The product 1.128 was obtained in very high enantiomeric excess for isoserine (> 99 %) 
while the same lipase showed very poor selectivity for serine. The yield in the case of 
serine was sacrificed for the excellent enantiopurity and only about 30 % yield was 
realized. The reaction was slow with only 33 % conversion in 7 days. 
 
 
The initial substrate for the resolution of a racemic mixture is an equal mixture of 
enantiomers, therefore the maximum theoretical yield is limited to only 50 % (although 
30 % is more common). This low yield is the compromise for the higher enantiopurity. 
As one enantiomer is converted quickly, the other starts to dominate in the mixture and 
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reacts as a substrate as well (although at the slower rate) and this causes a decrease of the 
product enantiopurity. To overcome this problem, a combination of two techniques, e.g. 
the coupling of two asymmetric reactions
66
 or an asymmetric reaction and a resolution,
67
 
has been studied. Some literature examples are described below.  
In 1996, William
68 
reported the dynamic kinetic resolution of certain allyl acetates 
by enzymatic hydrolysis to the corresponding alcohol. In the presence of a palladium 
catalyst 1.132, the allyl acetate 1.130 underwent racemization, allowing a dynamic 
resolution to take place (Eq. 1.19). Although the kinetic resolution of the substituted 
cyclohexenyl acetates 1.130 took a long time to complete [19 days, Pseudomonas 
fluorescens lipase (PFL), 5 mol% PdCl2(MeCN)2], the alcohol 1.131 was formed with 96 
% e.e. and in 81 % yield. 
  
 
In 1999, Kim
69
 also reported the use of a lipase and a palladium catalyst in the 
dynamic kinetic resolution of acyclic allylic acetates 1.133. Lipase catalyzed 
transesterification was first performed in an organic solvent, then the palladium(0) 
catalyzed racemization. The palladium catalyzed racemization is believed to proceed via 
cis migration of the coordinated acetate. The resolution afforded the alcohol products 
1.133a in yields of 70 - 87 % and enantiomeric excesses of 86 - 99 % (Scheme 1.21). 
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Scheme 1.21 Dynamic kinetic resolution of acyclic allylic acetate using palladium 
catalyzed racemization and lipase catalyzed transesterification 
 
In 1999, Bäckvall
48a
 described the dynamic kinetic resolution of a racemic 
secondary alcohol 1.136 using an immobilized lipase from Candida Antarctica 
(commercially available under the trade name “Novozym 435”) in the presence of the 
ruthenium catalyst 1.135. A variety of secondary alcohols 1.136 were transformed to the 
corresponding enantiomerically pure acetates 1.137, making efficient use of all 
substrates. In most cases, the reaction proceeded with > 99 % e.e. and in good yield 
(Scheme 1.22). 
 
Scheme 1.22 Dynamic kinetic resolution of secondary alcohol using ruthenium 
catalyzed in situ racemization and Novozym 435 catalyzed transesterification 
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Another ruthenium catalyst was reported by Park and coworkers
70 
to be an 
effective racemization catalyst with application in the dynamic kinetic resolution of 
secondary alcohols. The ruthenium catalyzed racemization using catalyst 1.141 occurred 
via transfer hydrogenation, while at the same time, one enantiomer 1.138a was 
selectively transesterified using the Pseudomonas cepacia lipase (PCL) (Scheme 1.23). 
The yield and enantiomeric excess of 1.139 were in the range of 60 - 98 % and 82 - 99 %, 
respectively. 
 
Scheme 1.23 Dynamic kinetic resolution of alcohol using ruthenium catalyzed 
racemization via transfer hydrogenation and lipase catalyzed transesterification 
 
Later in 2004, Kim and Park
47c
 reported the dynamic kinetic resolution of alcohol 
1.142 using a ruthenium complex 1.144 as a racemization catalyst and Novozym 435 as a 
transesterification catalyst. The aminocyclopentadienyl ruthenium complex 1.144 can be 
used at room temperature. The acetate 1.143 was given in excellent yield (> 99 %) and 
excellent enantiomeric excess (95 % e.e)(Scheme 1.24). 
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Scheme 1.24 Dynamic kinetic resolution of alcohol using ruthenium catalyzed 
racemization and Novozym 435 catalyzed transesterification 
 
1.8.2 Enzymatic Catalyzed Kinetic Resolution of Phosphonates 
The dynamic kinetic resolution methods mentioned above seem to be very useful, 
but appear to not work very well with hydroxy phosphonates. The problem is that 
hydroxy phosphonates are very resistant to isomerization at the 1-hydroxy position
1
 and 
other functionalities in the phosphonate molecule may react with the metal reagent used 
in the racemization catalyst. Hence enzyme catalyzed hydrolysis of the enantiomerically 
enriched substrates proved to be the best route to achieve hydroxy phosphonates of high 
enantiopurity. Many optically active hydroxy phosphonates have been prepared from 
chemoenzymatic synthesis.
40,71
 For example, Hammerschmidt et al.
72
 extensively 
investigated enzymatic methods for resolving hydroxy phosphonates. The most common 
used enzymatically catalyzed resolution is the asymmetric acylation or deacylation 
catalyzed by lipases
1,72,73,74
 such as CALB (Novozyme 435), Pseudomonas, Lipase AY, 
etc. Hammerschmidt reported that lipase F-AP 15 selectively hydrolyzed (S)-acetoxy 
phosphonate 1.146 to afford (S)-allylic hydroxy phosphonate 1.148a in 82 % 
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enantiomeric excess. The (R)-allylic acetoxy phosphonate 1.147 was hydrolyzed to give 
chemically (R)-hydroxy phosphonate 1.148b in 81 % e.e (Scheme 1.25). 
 
 
Scheme 1.25 Enzyme catalyzed kinetic resolution using F-AP 15 
 
The kinetic resolution of hydroxy alkane phosphonates catalyzed by Candida 
antarctica lipase B (CALB) in organic media was reported by Yuan
75
 in 2003. A series of 
hydroxy alkane phosphonates 1.149 were studied as substrates for CALB catalyzed 
acetylation (Eq. 1.20). Some hydroxy alkane phosphonates 1.149 could be resolved 
successfully to give both (R) and (S)-isomers of 1.149 with high enantiomeric excess (up 
to 95 %) and yield between 40 and 50 %. 
 
 In 2003, Backvall
74
 applied the ruthenium catalyst 1.135 for the dynamic kinetic 
resolution of !- and "-hydroxy phosphonates 1.151 (Eq. 1.21). The application of enzyme 
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kinetic resolution in combination with ruthenium catalyzed alcohol isomerization 
efficiently transformed a variety of !- and "-hydroxy phosphonates 1.151 to the 
corresponding enantiomerically pure acetates 1.152 with enantiomeric excesses up to 99 
% in the yields up to 87 %. 
 
 
Spilling and Rowe
76
 utilized the (R)-selective lipase catalyzed hydrolytic kinetic 
resolution of acetates to enhance the enantiomeric excess of hydroxy phosphonates 
formed by asymmetric catalysis (Scheme 1.26). The hydrolysis of predominantly (R)-non 
racemic acetoxy phosphonate 1.153a gave alcohol (R)-1.154 with improved enantiomeric 
excess. 
 
Scheme 1.26 Sequential asymmetric catalysis and enzyme catalyzed hydrolysis 
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Here we proposed to study the kinetic resolution of phosphonates using a variety 
of lipases. Phosphonate 1.155 (Figure 1.13) is a particular interesting substrate for us 
since it reacts quickly with the other alkenes in the Grubbs metathesis reaction to provide 
other derived phosphonates. Furthermore, the carbonate functional group can lead to the 
other functionalized phosphonates (as mentioned earlier in this chapter) by palladium 
catalyzed substitution.  
 
Figure 1.13 Structure of phosphono acrolyl carbonate 
 
1.9 Result and Discussion 
1.9.1 Cross Metathesis 
Olefin metathesis
77
 is a type of carbon-carbon bond forming reaction and is 
therefore significant in the syntheses of organic compounds. The transformation is 
catalyzed by a transition metal. One of the more prominent catalyst systems is the 
ruthenium carbene complex developed by Grubbs and coworkers.
78
  
Allylic hydroxy phosphonates can be formed via the Pudovik
14
 reaction. When 
the Pudovik reaction and the cross metathesis are combined, a wide range of allylic 
hydroxy phosphonates can be synthesized from a single phosphonate precursor. The 
interconversion of allylic hydroxy phosphonates via alkene metathesis using Grubbs’s 
catalyst (2
nd
 generation) (1.156, Figure 1.14) has been investigated by Spilling et al.
2
 It 
was shown that acrolein derived hydroxy phosphonate 1.157 underwent cross metathesis 
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with several terminal alkenes 1.158, but the reaction was complicated by formation of 
homodimer (1.160, 1.161) (Eq. 1.22). These results prompted the investigation of the 
effect of the substituent on the allylic carbon double bond (eg. phenyl) of the allylic 
hydroxy phosphonate 1.159.  
 
 
Figure 1.14 The structure of Grubbs 2
nd
 generation catalyst  
 
 
 
 In general, it was shown that cinnamyl derived phosphonate 1.80 was less reactive 
than acrolein derived phosphonate 1.157. However, from previous results,
79
 cinnamyl 
hydroxy phosphonate 1.80 did not undergo a self metathesis reaction to form the 
phosphonate dimer 1.160. Indeed, as mentioned earlier in this chapter, this hydroxy 
phosphonate is a solid and can be recrystallized to more than 95 % e.e. These facts made 
the cinnnamyl hydroxy phosphonate 1.80 a promising precursor for the synthesis of other 
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hydroxy phosphonates with high enantiomeric excess. The Grubbs’ cross metathesis 
reaction was further investigated using the racemic cinnamyl hydroxy phosphonate 1.80 
with some of the terminal alkenes 1.158 employing 5 mol% loading of Grubbs’ catalyst 
(2
nd
 generation, 1.156) and 10 mol% CuI as a co-catalyst. The results are listed in Table 
1.1. 
 
Table 1.1 Cross Metathesis with Cinnamyl Hydroxy Phosphonate 
 
 
Entry R Alkene Equivalent Adduct % Yield 
1 1.158a (CH2)3OH 5 1.159a 0 
2 1.158b (CH2)4OH 5 1.159b 0 
3 1.158c (CH2)3OBn 5 1.159c 62 
4 1.158d (CH2)4OTBS 10 1.159d 39 
5 1.158e (CH2)7CH3 10 1.159e 45 
 
Dimethyl cinnamyl hydroxy phosphonate 1.80 failed to react with the terminal 
hydroxy alkenes, 4-pentenol and 5-hexenol (1.158a and 1.158b) (Entry 1 and 2). In both 
cases, there were no observed products after a normal reaction time of 3 h as indicated by 
31
P NMR spectroscopy. Neither an increase of the reaction time nor adding 10 mol% CuI, 
co-catalyst, was useful for the stimulation of the reaction. However, the cinnamyl 
hydroxy phosphonate 1.80 reacted successfully with protected hydroxy alkene (1.158c 
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and 1.158d, Entry 3 and 4) and a simple terminal alkene (1.158e, Entry 5). The reaction 
with benzyl protected hydroxy alkene 1.158c gave cross metathesis adduct 1.159c in 
reasonable chemical yield (62 % yield). The silyl protected hydroxy alkene 1.158d also 
reacted, albeit in somewhat lower yield (39 %). The reaction with decene 1.158e, 
(phosphonate : decene, 1:10) was optimized to give the adduct 1.159e in 45 % yield. 
Since the carbonate group at the !-position of the hydroxy phosphonate is more 
likely to be an excellent leaving group for any reaction, phosphonate 1.159d was 
converted to the corresponding methyl carbonate derivative 1.160d (Eq. 1.23). The 
protection of the !-hydroxy group was accomplished by reaction with 2.2 eq 
methylchloroformate 1.161 in the presence of 1.5 eq pyridine and 0.2 eq DMAP to give 
the carbonate protected phosphonate 1.60d in 64 % chemical yield. 
 
 
Phosphono carbonate 1.160d was further employed as a starting material for the 
palladium catalyzed addition of a nucleophile (Eq. 1.24). In the presence of 3 mol% of 
Pd(PPh3)4 and an excess amount of diisopropyl ethylamine, allylic phosphono carbonate 
1.160d readily reacted with 10 eq of p-methoxyphenol 1.163 to afford vinylic 
phosphonate 1.162d in 61 % yield.  
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1.9.2 Chemical Catalyzed Kinetic Resolution 
In 2005, the kinetic resolution of hydroxy phosphonates by enantioselective 
acylation using the 1
st
 generation Birman’s catalyst was investigated by Spilling and 
He.
44
 The results showed that the 1
st
 generation-catalyst (Gen I, CF3-PIP, 1.84) will 
acylate some hydroxy phosphonates with useful selectivity factors.  
The other three “Birman” catalysts (1.83, 1.85 and 1.86) have not yet been used in 
the kinetic resolution of !-hydroxy phosphonates. Here the resolution of a series of !-
hydroxy phosphonates was investigated utilizing the three Birman catalysts, Gen 0, Gen 
II and Gen III. In addition, the enantiomeric excess of the non racemic hydroxy 
phosphonate synthesized via asymmetric catalysis was then enhanced by a sequential 
kinetic resolution to afford the !-hydroxy phosphonate in higher enantiomeric excess on 
the preparative scale. 
An extensive comparison of all of Birman’s catalysts will be later explained in the 
discussion section. Some previous results by He
44
 are shown in Table 1.2.  
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Table 1.2 (Previous Result)
44
  
Screening of Chemical Catalyzed Kinetic Resolution of !–Hydroxy Phosphonates by 
1
st
 Generation Birman Catalyst; CF3-PIP 
Entry R
1
 R
2
 R' Time C% 
Alcohol 
Configuration 
Ester 
Configuration 
S 
1 Me PhCH=CH Me 30 min 70 S R 1.6 
2 Me PhCH=CH Et 30 min 55 S R 1.4 
3 Me CH2=CH Et 3 h 52 R S 2.5 
4 Ph CH2=CH Et 11.5 h 56 R S 4.7 
5 Me Ph Et 5 h 50 S R 9.2 
6 Me PhCH2 Et 66 h 48 S R 3.2 
7 Me PhCH2CH2 Et 5 h 25 R S 5.2 
 
a) Catalyst Preparation 
The Gen II catalyst 1.123 can be synthesized easily in 2 steps from commercially 
available 2,6-dichloroquinoline 1.164 and (S)-(+)-phenylglycinol 1.165 according to the 
literature procedure as shown in Scheme 1.27.
59
 
 
Scheme 1.27 Preparation of 2
nd
 generation-Birman catalyst 
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The Gen III catalyst 1.124 can also be synthesized in 2 steps from commercially 
available 2-chlorobenzotriazole 1.167 and (S)-(+)-phenylglycinol 1.165 according to the 
literature procedure as shown in Scheme 1.28.
62
  
 
Scheme 1.28 Preparation of 3
rd
 generation-Birman catalyst 
 
b) Absolute Configuration Assignment 
 The absolute configurations of a series of phosphonates used in the study were 
determined using HPLC analysis under the conditions described below (Table 1.3). The 
absolute configuration was, otherwise, determined using the direction and magnitude of 
the quinine induced chemical shifts in the 
31
P NMR spectra and as reported in a previous 
study.
44
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Table 1.3 HPLC Conditions used to Determine the Enantiopurity of Some Hydroxy 
Phosphonates 
 
Hydroxy Phosphonate HPLC Condition 
 
Whelko-S,S column, eluting solvent : hexane/ethanol = 
80/20, pump rate = 1 mL/min, wavelength = 254 nm 
 
Silicon-Chiralpak column, eluting solvent : 
hexane/ethanol = 80/20, pump rate = 1 mL/min, 
wavelength = 210 nm 
 
Whelko-S,S column, eluting solvent : hexane/ethanol = 
90/10, pump rate = 1 mL/min, wavelength = 210 nm 
 
 
c) The Screening of !-Hydroxy Phosphonates 
 Three different Birman catalysts (Gen 0, Gen II, Gen III) were investigated for the 
resolution of a series of !-hydroxy phosphonates. The acylating agent has some influence 
on the enantioselectivity and Birman reported that the selectivity can be improved by 
using a bulkier acyl donor. Hence, among all acylating agents available, propionic 
anhydride (R’CO)2O (1.170, R’ = Et) was mainly used in our work. The reaction was 
performed at low temperature 0
o
C for better selectivity, hence the presence of i-Pr2NEt is 
necessary to dramatically increase the reaction rate. For the reaction media, CHCl3 was 
shown to be the best solvent. The significance of i-Pr2NEt as an auxillary base and CHCl3 
as the solvent was supported by experimental evidence
44
 as well as the literature 
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precedence.
59
 The reactions were performed according to the standard procedure 
described by Birman
58
 and the result for each catalyst is shown below.  
 
1) Gen II, Cl-PIQ 
In the presence of 2 mol% of Birman’s generation II catalyst 1.123, the racemic 
dimethyl (R
1
 = Me) hydroxy phosphonate (R/S) 1.169 can be selectively acylated 
providing (R)-alcohol 1.171 and leaving (S)-ester 1.172 as shown in Table 1.4.  
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Table 1.4 Screening of Chemical Catalyzed Kinetic Resolution of !–Hydroxy Phos-
phonates by 2
nd
 Generation Birman Catalyst 
 
Entry R
1
 R
2
 R' Time C% 
Alcohol 
Configuration 
Ester 
Configuration 
S 
1 Me PhCH=CH Me 30 min 75 R S 4.3 
2 Me PhCH=CH Et 30 min 74 R S 7.0 
3 Me CH2=CH Et 1 h 63 R S 1.3 
4 Me Ph Et 1 h 65 R S 17.2 
5 Me PhCH2 Et 2 h 46 R S 1.2 
6 Me PhCH2CH2 Et 2 h 42 R S 2.6 
 
The acylation of cinnamyl hydroxy phosphonate (R
2
 = PhCH=CH, Entry 1 and 2) 
with Gen II catalyst 1.123 and propionic anhydride (R’ = Et), gave better selectivity (S = 
7.0) when compared to acetic anhydride (R’ = Me) (S = 4.3).  
The carbon substituent (R
2
) was extremely important in determining the 
selectivity of acylation. Not suprisingly, among all substrates studied, the benzylic 
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hydroxy phosphonates (R
2
 = Ph, Entry 4) proved to be the best substrates providing the 
highest selectivity (S = 17.2). The addition of one extra methylene (phenylethyl, R
2
 = 
PhCH2, Entry 5) caused a dramatic drop in selectivity to 1.2. With two additional 
methylene groups (dihydrocinnamyl, R
2
 = PhCH2CH2, Entry 6), the selectivity was a 
minimally restored to S = 2.6. The acrolyl phosphonate (Entry 3) showed almost no 
selectivity (S = 1.3).  
 
 2) Gen 0, (-)-tetramisole 
 Using 2 mol% of Birman’s generation 0 catalyst 1.121, all racemic dimethyl (R
1
 = 
Me) and diphenyl (R
1
 = Ph) hydroxy phosphonates (R/S) 1.169 can be selectively 
acylated providing (R)-alcohol 1.171 and leaving (S)-ester 1.172 as well as the result 
shown in Table 1.5. 
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Table 1.5 Screening of Chemical Catalyzed Kinetic Resolution of !–Hydroxy Phos-
phonates by (-)-Tetramisole 
 
Entry R
1
 R
2
 R' Time C% 
Alcohol 
Configuration 
Ester 
Configuration 
S 
1 Me PhCH=CH Et 5 min 47 R S 1.1 
2 Me CH2=CH Et 5 min 23 R S 1.5 
3 Ph CH2=CH Et 10 min 74 R S 1.2 
4 Me Ph Et 20 min 60 R S 9.9 
5 Me PhCH2 Et 30 min 41 R S 5.3 
6 Me PhCH2CH2 Et 20 min 26 R S 12.7 
  
Changing the catalyst from Gen II to Gen 0 resulted in a decrease in the 
selectivity of the acylation of the benzylic phosphonate (R
2
 = Ph, Entry 4) and cinnamyl 
phosphonate (R
2
 = PhCH=CH, Entry 1) from S = 17.2 to S = 9.9 and S = 7.0 to S = 1.1, 
respectively. On the other hand, Gen 0 Birman catalyst improved the selectivity on 
phenylethyl phosphonate (R
2
 = PhCH2, Entry 5, S = 1.2 to S = 5.3) and dihydrocinnamyl 
phosphonate (R
2
 = PhCH2CH2, Entry 6, S = 2.6 to S = 12.7). The acrolyl hydroxy 
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phosphonate (R
2
 = CH2=CH, Entry 2) was still a poor substrate with the selectivity factor 
of 1.5. The attempt to obtain better selectivity in acrolyl phosphonate by replacing 
methoxy groups (R
1
 = Me) with phenoxy groups (R
1
 = Ph) was unsuccessful since the 
selectivity in acylation of diphenyl acrolyl phosphonates (R
1
 = Ph, R
2
 = CH2=CH, Entry 
3, S = 1.2) was not improved over the dimethyl acrolyl phosphonate  (R
1
 = Me, R
2
 = 
CH2=CH, Entry 2, S = 1.5). 
 
 3) Gen III, BTM, benzotetramisole 
Using 2 mol% of Birman’s generation III catalyst 1.124, the racemic dimethyl (R
1
 = Me) 
hydroxy phosphonates (R/S) 1.169 can be selectively acylated providing (R)-alcohol 
1.171 and leaving (S)-ester 1.172 as the result shown in Table 1.6. 
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Table 1.6 Screening of Chemical Catalyzed Kinetic Resolution of !–Hydroxy Phos-
phonates by 3
rd
 Generation Birman Catalyst 
 
Entry R
1
 R
2
 R' Time C% Alcohol 
Configuration 
Ester 
Configuration 
S 
1 Me PhCH=CH Et 5 min 48 R S 2.5 
2 Me CH2=CH Et 5 min 5 R S 1.1 
3 Me Ph Et 6 min 56 R S 10.8 
4 Me PhCH2CH2 Et 20 min 36 R S 22.6 
 
 The result from using Gen III Birman catalyst provided a similar outcome as the 
result when using the Gen 0 catalyst. The only extraordinary change was given for the 
resolution of dihydrocinnamyl phosphonates (R
2
 = PhCH2CH2, Entry 4) where the 
selectivity went up to 22. 
 To be able to assess and easily compare the effect of all four Birman catalysts, the 
summary of all results combined of Table 1.2, 1.4, 1.5 and 1.6 is shown below.  
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Table 1.7 (The Summary of the Result of Table 1.2, 1.4, 1.5 and 1.6) 
Screening of Chemical Catalyzed Kinetic Resolution of !–Hydroxy Phosphonates by 
Birman Catalysts 
 
S 
Entry R
1
 R
2
 R' 
Gen II Gen 0 Gen III Gen I
44 
1 Me PhCH=CH Me 4.3 - - 1.6 
2 Me PhCH=CH Et 7.0 1.1 2.5 1.4 
3 Me CH2=CH Et 1.3 1.5 1.1 2.5 
4 Me Ph Et 17.2 9.9 10.8 9.2 
5 Me PhCH2 Et 1.2 5.3 - 3.2 
6 Me PhCH2CH2 Et 2.6 12.7 22.6 5.2 
 
In general, using all of the Birman catalysts, the results were similar to Birman’s 
observations in that benzylic phosphonates (R
2
 = Ph, Entry 4) were good substrates, 
particularly with the Gen II catalyst (S factor ranging from 9.2 to 17.2). Cinnamyl 
phosphonate (R
2
 = PhCH=CH, Entry 2) works very well with only the Gen II catalyst 
with a selectivity = 7.0, while with the other catalysts showed unsatisfactory results. The 
Gen 0 and Gen III catalysts improved the selectivity of the acylation of phenylethyl (R
2
 = 
PhCH2, Entry 5) and were particularly effective for the acylation of dihydrocinnamyl 
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phosphonates (R
2
 = PhCH2CH2, Entry 6) which is either reluctant or entirely 
unsuccessful with the Gen II catalyst, hence, these two catalysts complement each other. 
Acylation of the benzylic and cinnamyl alcohol substrate (R
2
 = Ph and PhCH=CH, Entry 
1, 2 and 4) catalyzed by Gen II proceeded with selectivity factors 1.9 to 5 times higher 
than those obtained with Gen I. 
The acrolyl hydroxy phosphonate (R
2
 = CH2=CH, Entry 3) is always a poor 
substrate due to the low chiral recognition in the !-! and cation-! interaction between the 
relative acylated intermediate and the carbon-carbon double bond in the transition state 
model proposed by Birman
60
 (1.173, scheme 1.29). It was found that unlike the benzylic 
hydroxy phosphonates (R
2
 = Ph) (1.174, scheme 1.29) or cinnamyl hydroxy 
phosphonates (R
2
 = PhCH=CH) (1.175, scheme 1.29), the acrolyl hydroxy phosphonates 
(R
2
 = CH2=CH) are less capable of !-stacking with the acylated intermediate, resulting in 
a !-interaction too weak to give good kinetic resolution. 
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Scheme 1.29 !-Stacking shown in the transition state of resolution of hydroxy 
phosphonates using 2
nd
 generation Birman catalyst 
 
d) The Preparative Scale 
 The dimethyl cinnamyl hydroxy phosphonate 1.80a is an important synthetic 
precursor for cross metathesis with a variety of alkenes to synthesize functionalized !-
hydroxy phosphonates.
2 
For this reason, optimized resolution conditions were applied to 
the preparative scale acylation of (R)-cinnamyl hydroxy phosphonate 1.80a (Scheme 
1.30). The hydroxy phosphonate 1.80a from the asymmetric catalysis (74 % e.e.) was 
acylated in the presence of 2 mol% of Gen II catalyst 1.123 and diisopropyl ethylamine to 
~ 30 % conversion. The minor enantiomer was acylated to give the (S)-propionate 1.176 
and leaving the major (R)-hydroxy phosphonate 1.80ah in 97 % enantiomeric excess. 
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Scheme 1.30 Preparative scale of chemically catalyzed kinetic resolution of non 
racemic !–hydroxy phosphonates 
 
1.9.3 Enzyme Catalyzed Kinetic Resolution  
a) The Screening of !-Hydroxy Phosphonates 
An initial screening was used to identify an optimal enzyme system which gave 
high conversion and good selectivity for resolution of carbonate acrolyl phosphonate 
1.155. The reaction condition must be finally optimized using the best choice of enzyme 
chosen from the screening.  
In an initial screening, racemic (R/S)-carbonate substituted hydroxy phosphonate 
1.155 was screened with a variety of lipases (14 different enzymes) for enantioselective 
hydrolysis at two different temperatures, room temperature and 40
o
C (Table 1.8).  
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Table 1.8 Lipase Screening for Kinetic Resolution of Methoxycarbonyloxy Phospho-
nates 
 
Activity Amount at room temperature 
(units/g) used 16 h 1 day Lipase 
 (g) 
Config. 
% Conv. % e.e.A % Conv. % e.e.A 
E 
AK N/A 0.0025 S very slow N/A 4.5 59 3.9 
AY N/A 0.0025 R 4.1 57 10 60 4.3 
PS N/A 0.0025 S 4 75 8.9 50 5.1 
CALB 10,000 0.0160 S very slow N/A very slow N/A N/A 
Cand Cy 2,400 0.0025 R 16 84 12 82 11 
 at 40
o
C 
AK N/A 0.0025 S 10 18 16 19 1.5 
AY N/A 0.0025 R 10 18 19 45 2.9 
PS N/A 0.0025 S 14 44 21 43 2.8 
CALB 10,000 0.0160 S 15 51 25 46 3.3 
Cand Cy 2,400 0.0025 R 9.4 19 14 11 1.5 
 
 The screening of 0.1 mmol of racemic phosphonate 1.155 was performed in 7 mL 
vials with ~10 % weight of enzyme. The value of the selectivity ratio (E) was obtained 
from % conversion and % e.e. of alcohol 1.157b derived directly from 
31
P NMR analysis 
using quinine as a shift reagent. The configuration in which each different enzymes 
selectively hydrolysed the substrate was identified using 
31
P NMR as well. Three samples 
 63 
of each reaction were taken over a 16 and 24 h period of time. Five (out of 14) of the 
enzymes screened worked moderately to extremely well for this particular phosphonate 
as shown. Among these 5 enzymes, AK Amano, PS Amano and CALB (Candida 
antarctica lipase B) are (S)-configured selective enzymes while AY Amano and Candida 
cylindracea are (R)-configured selective enzymes for the asymmetric hydrolysis of the 
phosphonate 1.155.  
At ambient temperature, Candida cylindracea is the (R)-configured selective 
enzyme which gave better enantioselectivity than lipase AY. Among (S)-configured 
selective enzymes, lipase PS gave the best result. 
To accelerate the reaction rate, the screening was done at a higher temperature of 
40
o
C. As expected, all of the enzymes gave the decrease of selectivity. Surprisingly, 
CALB gave better selectivity than when the reaction was performed at ambient 
temperature. In addition, CALB provided the highest selectivity among (S)-selective 
enzymes. 
Due to the modest enantiomeric excess obtained (~ 70 % e.e.) from asymmetric 
catalysis, a second asymmetric process was applied to try to obtain the phosphonates in 
high yield and high enantiomeric excess. It was proposed that asymmetric hydrolysis of 
(R)-non racemic phosphonate 1.155a (from asymmetry catalysis and carbonylation) with 
any highly (S)-selective enzyme would provide us the recovered enantiomerically pure 
(R)-non racemic phosphonate 1.155ah. 
Of the specifically considered (S)-selective enzymes, PS seemed to be a good 
candidate for the resolution performed at room temperature. However, by virtue of being 
immobilized, the (S)-selective encapsulated enzyme CALB appeared to be the better 
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choice. CALB is an interesting lipase with potential application in a number of industrial 
processes.
80 
Immobilization of an enzyme offers several benefits such as greater stability 
of the enzyme to various denaturants, ease in product separation, facile recovery, and re-
use. These, in turn, would help in reducing the enzyme cost per unit of final product. In 
addition, the low E value of CALB could still be useful by cycling the phosphonate 
substrate through multiple enzymatic hydrolysis reactions where each cycle leads to an 
increase in enantiomeric excess. Selected from this point of view, we decided to perform 
the asymmetric hydrolysis of (R)-1.155a on the preparative scale using CALB at 40
o
C.  
 
b) The Preparative Scale 
Hydrolysis of (R)-non racemic phosphonate 1.155a (72 % e.e. from asymmetric 
catalysis) with (S)-selective CALB to approximately ~ 25 % conversion left the enriched 
(R)-configured phosphonate 1.155ah with improved enantiomeric excess. The efficiency 
of the encapsulated enzyme CALB was decreased resulting in a longer reaction times 
upon recycling as shown in Table 1.9. 
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Table 1.9 Preparative  Scale  of  Enzymatical Catalyzed   Kinetic  Resolution  of  
Non Racemic !–Hydroxy Phosphonates 
 
 
# Times recycled CALB % Conversion Reaction Time 
1 23.5 2 days 22 h 
2 23.2 3 days  
3 25.8 2 days 19 h 
4 23.3 3 days 19 h 
5 23.5 5 days 
 
The enantiometric excess of (R)-1.155ah from the fifth enzyme catalyzed kinetic 
resolution was determined by coupling the product with styrene 1.177 via the Grubbs 
metathesis reaction as shown in Eq. 1.25 using 2
nd
 generation Grubbs catalyst 1.156 in 
CH2Cl2 at 40
0
C. The enantiomers of metathesis adduct (R)-1.178ah were separated on 
chiral stationary phase using the HPLC technique.
78
 In this case after being reused up to 5 
times, CALB still provided satisfactory enantioselectivities (95 % e.e.) in 68 % yield 
based on 24 % conversion. 
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1.10 Summary 
A high enantiomeric excess of !-hydroxy phosphonates can be achieved using 
sequential asymmetric catalysis and kinetic resolution. The application of Birman’s 
enantioselective acylation catalyst and enzymatic catalyzed kinetic resolution provided a 
general, reproducible, high yielding method for the resolution of phosphonates with high 
selectivities. 
 
1.11 Experimental Section 
General Experimental 
1
H, 
13
C{
1
H} and 
31
P{
1
H} NMR spectra were recorded on a Bruker Avance 300 MHz 
NMR spectrometer in CDCl3 at room temperature. 
1
H NMR spectra were referenced to 
CDCl3 (7.27 ppm), 
13
C{
1
H} NMR spectra were referenced to the center line of CDCl3 
(77.23 ppm) and 
31
P{
1
H} NMR spectra were referenced to external 85 % H3PO4 (0 ppm). 
Coupling constants, J, are reported in Hz. Infrared spectra were recorded on a Thermo 
Nicolet Avatar 360 FT-IR spectrometer. Analytical thin layer chromatography (TLC) 
analyses were performed on silica gel plates, 60PF254. Visualization was accomplished 
with UV light, KMnO4 solution or Iodine. Silica gel 60 Merck (0.040-0.063 mm) was 
used for chromatography. Enantiomer ratios were measured by chiral stationary phase 
HPLC, or by 
31
P NMR spectroscopy using quinine as the shift reagent.
37a,81
 Mass spectral 
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analyses were performed using a JEOL MStation (JMS-700) mass spectrometer; electron 
impact (EI) direct insertion at 70 eV, or fast atom bombardment-FAB [MH
+
 or MNa
+
]. 
All reactions were conducted under argon atmosphere using oven-dried glassware. All of 
the commercially available chemicals were purchased from Sigma-Aldrich, Strem or 
Acros. Methylene chloride was distilled from CaH2 and THF was dried, then distilled 
from sodium benzophenone ketyl under argon atmosphere. Dimethyl phosphite, titanium 
isopropoxide and propionic anhydride were distilled under reduced pressure. Chloroform 
was distilled at atmosphere.Other reagents were obtained from commercial sources and 
used without purification. The enzymes were purchased from Fluka Chemical Co. Most 
of the enzymes were generously donated by Amano Co., Ltd. USA. 
 
1.11.1 General Procedure for Grubbs Metathesis Adduct and Palladium 
Nucleophilic Reaction 
 
(E)-Dimethyl 1-hydroxyundec-2-enylphosphonate (1.159e) 
(E)-Dimethyl 1-hydroxy-3-phenylpropenylphosphonate 1.80 (1eq, 0.200 g, 0.83 mmol), 
1-decene 1.158e (10 eq, 0.1.5 mL, 8.3 mmol), CuI (10 mol%, 0.016 g, 82.6 !mol) and 2
nd
 
generation Grubbs catalyst 1.156 (5 mol%, 0.035 g, 41.3 !mol) were dissolved in CH2Cl2 
(1 mL) and the resulting solution was heated at 40
o
C for 3 h to give, after 
chromatography (SiO2, hexane : EtOAc), the product as a dark yellow oil (0.104 g, 45 % 
yield). 
1
H NMR (CDCl3) " 5.80 (1H, m), 5.51 (1H, m), 4.38 (1H, m), 3.72 (6H, d,  JHP = 
10.4 Hz), 1.99 (2H, m), 1.28 (12H, m), 0.80 (3H, t, JHH = 6.4 Hz); 
13
C NMR (CDCl3) " 
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135.4 (d, JCP = 13.3 Hz), 124.2 (d, JCP = 3.3 Hz), 32.5 (d, JCP = 0.9 Hz), 31.9, 29.5, 29.3, 
29.2, 29.0 (d, JCP = 2.8 Hz), 69.1 (d, JCP = 161.9 Hz), 53.8 (d, JCP = 7.0 Hz), 53.6 (d, JCP 
= 7.4 Hz), 22.7, 14.1; 
31
P NMR (CDCl3) ! 25.35. 
 
(E)-Dimethyl 6-(benzyloxy)-1-hydroxyhex-2-enylphosphonate (1.159c) 
(E)-Dimethyl 1-hydroxy-3-phenylpropenylphosphonate 1.80 (1eq, 0.200 g, 0.83 mmol), 
[(pent-4-enyloxy)methyl]benzene 1.158c (5 eq, 0.728 g, 4.13 mmol), CuI (10 mol%, 
0.016 g, 82.6 "mol) and 2
nd
 generation Grubbs catalyst 1.156 (5 mol%, 0.035 g, 41.3 
"mol) were dissolved in CH2Cl2 (1 mL) and the resulting solution was heated at 40
o
C for 
3 h to give, after chromatography (SiO2, hexane : EtOAc), the product as a dark yellow 
oil (0.161 g, 62 % yield). 
1
H NMR (CDCl3) ! 7.31 (5H, m), 5.87 (1H, m), 5.59 (1H, m), 
4.47 (2H, m), 4.45 (1H, m), 3.78 (3H, d,  JHP = 10.4 Hz), 3.77 (3H, d,  JHP = 10.4 Hz), 
3.46 (2H, t, JHH = 6.4 Hz), 2.19 (2H, m), 1.71 (2H, m); 
13
C NMR (CDCl3) ! 138.7, 135.1 
(d, JCP = 13.1 Hz), 128.6, 127.9, 127.8, 124.6 (d, JCP = 3.9 Hz), 73.1, 69.7, 69.4 (d, JCP = 
161.6 Hz), 53.9 (d, JCP = 7.1 Hz), 53.8 (d, JCP = 7.1 Hz), 29.2, 26.4 (d, JCP = 15.3 Hz); 
31
P 
NMR (CDCl3) ! 25.02. 
 
(E)-Dimethyl 7-(t-butyldimethylsiloxy)-1-hydroxyhept-2-enylphosphonate (1.159d) 
(E)-Dimethyl 1-hydroxy-3-phenylpropenylphosphonate 1.80 (1eq, 0.100 g, 0.41 mmol), 
t-butyl(hex-5-enyloxy)dimethylsilane 1.158d (10 eq, 0.885 g, 4.13 mmol), CuI (10 
mol%, 0.008 g, 41.3 "mol) and 2
nd
 generation Grubbs catalyst 1.156 (5 mol%, 0.018 g, 
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20.6 !mol) were dissolved in CH2Cl2 (0.8 mL) and the resulting solution was heated at 
40
o
C for 3 h to give, after chromatography (SiO2, hexane : EtOAc), the product as a dark 
yellow oil (0.057 g, 39 % yield). 
1
H NMR (CDCl3) " 5.85 (1H, m), 5.56 (1H, m), 4.40 
(1H, m), 3.77 (3H, d,  JHP = 10.4 Hz), 3.76 (3H, d,  JHP = 10.4 Hz), 3.56 (2H, t, JHH = 6.0 
Hz), 2.08 (2H, m), 1.44 (4H, m), 0.84 (9H, s), 0.01 (6H, s); 
13
C NMR (CDCl3) " 135.9 (d, 
JCP = 13.1 Hz), 124.2 (d, JCP = 3.8 Hz), 69.4 (d, JCP = 161.5 Hz), 63.2, 53.9 (d, JCP = 7.0 
Hz), 53.8 (d, JCP = 6.9 Hz), 32.4, 32.3 (d, JCP = 1.7 Hz), 26.2, 25.4 (d, JCP = 2.8 Hz), 18.6, 
-5.1; 
31
P NMR (CDCl3) " 24.88. 
 
(E)-Dimethyl 7-(t-butyldimethylsiloxy)-1-(methylcarbonyloxy)hept-2-enylphospho-
nate (1.160d) 
Hydroxy phosphonate (1.159d) (1.0 eq, 0.056 g, 0.16 mmol) was dissolved in dry CH2Cl2 
(1 mL) and the solution was cooled to 0
o
C. Pyridine (1.5 eq, 0.02 mL, 0.24 mmol) and 
DMAP (0.2 eq, 0.004 g, 31.8 !mol) were added, followed by the slow addition of methyl 
chloroformate 1.161 (2.2 eq, 0.03 mL, 0.35 mmol). After the addition was completed, the 
reaction mixture was allowed to warm to room temperature and then stirred until the 
reaction was completed (TLC). The reaction mixture was washed with H2O and saturated 
CuSO4 (2 x each), then the organic layer was dried over anhydrous Na2SO4. The solvent 
was removed in vacuo and the crude product was purified by column chromatography 
(SiO2, hexane : EtOAc) to give the product as a light yellow oil. (0.042 g, 64 % yield). 
1
H 
NMR (CDCl3) " 5.94 (1H, m), 5.54 (1H, m), 5.42 (1H, dd,  JHH = 7.8 Hz, JHP = 12.3 Hz), 
3.794 (3H, s), 3.790 (3H, d,  JHP = 10.6 Hz), 3.78 (3H, d,  JHP = 10.6 Hz), 3.57 (2H, t, JHH 
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= 6.0 Hz), 2.11 (2H, m), 1.46 (4H, m), 0.86 (9H, s), 0.01 (6H, s); 
13
C NMR (CDCl3) ! 
154.9 (d, JCP = 9.8 Hz), 138.9 (d, JCP = 12.4 Hz), 120.6 (d, JCP = 3.8 Hz), 73.2 (d, JCP = 
171.0 Hz), 63.1, 55.5, 54.0 (d, JCP = 7.2 Hz), 53.9 (d, JCP = 7.6 Hz), 32.44, 32.40, 26.2, 
25.1 (d, JCP = 2.3 Hz), 18.6, -5.1; 
31
P NMR (CDCl3) ! 20.22 
 
(E)-Dimethyl 7-(tert-butyldimethylsiloxy)-3-(4-methoxyphenoxy)hept-1-enylphos-
phonate (1.162d) 
Phosphonate 1.160d (1 eq, 0.040 g, 97.4 "mol), p-methoxyphenol 1.163 (10 eq, 0.121 g, 
0.97 mmol) and Pd(PPh3)4 (3 mol%, 0.003 g, 2.92 "mol) were dissolved in dry THF (1 
mL). After diisopropyl ethylamine (4 eq, 0.06 mL, 0.39 mmol) was added, the reaction 
mixture was heated at reflux for 3 h. The solvent was evaporated in vacuo and the crude 
product was purified by column chromatography (SiO2, hexane : EtOAc) to give a pale 
yellow oil (0.028 g, 61 % yield). 
1
H NMR (CDCl3) ! 6.80 (1H, ddd, JHH = 4.4 Hz, JHH = 
17.2 Hz, JHP = 22.5 Hz), 6.76 (4H, s), 5.83 (1H, ddd, JHH = 1.6 Hz, JHH = 17.3 Hz, JHP = 
20.2 Hz), 4.60 (1H, m), 3.72 (3H, s), 3.65 (3H, d,  JHP = 11.1 Hz), 3.63 (3H, d,  JHP = 
11.1 Hz), 3.57 (2H, t, JHH = 6.1 Hz), 1.74 (2H, m), 1.54 (4H, m), 0.85 (9H, s), 0.00 (6H, 
s); 
13
C NMR (CDCl3) ! 154.5, 153.0 (d, JCP = 5.1 Hz), 152.2, 117.2, 116.3 (d, JCP = 188.1 
Hz), 114.9, 78.9 (d, JCP = 21.4 Hz), 63.1, 55.9, 52.6 (d, JCP = 5.5 Hz), 52.5 (d, JCP = 5.5 
Hz), 34.8 (d, JHP = 2.3 Hz), 32.8, 26.2, 21.8, 18.6, -5.1; 
31
P NMR (CDCl3) ! 21.56. 
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1.11.2 General Procedure for Preparation of Dialkyl 1-Hydroxy Phosphonates  
 The racemic dialkyl 1-hydroxy phosphonates were synthesized by the Pudovik
14
 
reaction by the addition of dialkyl (methyl or phenyl) phosphite to the corresponding 
aldehyde in the presence of triethylamine. The non racemic (R)-hydroxy phosphonates 
were prepared by catalytic asymmetric phosphonylation using dimethyl D-tartrate and 
Ti(Oi-Pr)4 as the catalyst in THF solvent.
42
 Both racemic and non racemic (R)-carbonate 
protected acrolein phosphonates can be synthesized by the reaction with 
methylchloroformate in the presence of pyridine as a base and DMAP as a catalyst.
42
 
 Preparation and characterization of dialkyl 1-hydroxy phosphonates and their 
derivatives can be found in the literatures.
37,40,42,42,72 
 
1.11.3 Chemical Catalyzed Kinetic Resolution of Dialkyl 1-Hydroxy Phosphonates 
The selectivity (S) was calculated by the following equation
64
 : 
S = ln[(1-C)*(1-eeA)]/ ln[(1-C)*(1+eeA)]          Eq. 1.26 
where C = the extent of conversion = eeA/(eeA+eeE) or determined by integration 
of the peaks in the 
31
P NMR spectrum 
eeA = the enantiomeric excess of unreacted alcohol determined by integration of 
the peaks in the 
31
P NMR spectrum using quinine as a shift reagent, 
eeE = the enantiomeric excess of the ester formed in the reaction. 
 
 
The stock solution of catalyst and the exact procedure for kinetic resolution using 
Birman’s catalysts can be found in the literature.
44
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a) The Preparation of Stock Solution of the Birman Catalysts 
The Birman catalyst (0.100 mmol) and diisopropyl ethylamine (3.75 mmol) was 
dissolved in distilled CHCl3 in a 5 mL volumetric flask and the volume was adjusted to 
the mark. 
b) The Screening Procedure using Medium Throughput 
A 7 mL glass vial was charged with 0.5 mmol (1 eq) of the dialkyl 1-hydroxy 
phosphonate 1.169 and 0.5 mL (0.02 eq catalyst + 0.75 eq base) of the stock solution of 
the catalyst. The vial containing the solution was placed into the medium throughput 
reaction block which was set to a temperature of 0
o
C and the solution was swirled for 15 
min at that temperature until the mixture became homogeneous. After 0.375 mmol of the 
anhydride 1.170 was injected, the mixture was swirled at 0
o
C for a specified period of 
time. A small portion of the solution sample was taken and quenched with ethanol. The 
% conversion was determined by the integration of the peaks using 
31
P NMR analysis. To 
determine the enantiomeric excess using HPLC, the sample was injected directly. To 
determine the enantiomeric excess using 
31
P NMR, the sample was evaporated in vacuo, 
then dissolved in CDCl3. For each reaction, at least 3 samples were taken to give an 
average S value and the experiment was repeated twice. 
c) The Preparative Scale Procedure 
To a solution of (R)-non racemic cinnamyl hydroxy phosphonate 1.80a (74 % 
e.e., 1 g) in CHCl3 (5 mL), was added Birman’s 2
nd
 generation catalyst 1.123 (0.02 eq, 
0.023 g, 82.6 !mol), followed by propionic anhydride (1.170, R’ = Et) (0.3 eq, 0.16 mL, 
1.24 mmol) and the solution was stirred for a few minutes. To the mixture was added 
diisopropyl ethylamine (0.3 eq, 0.2 mL, 1.24 mmol) and after stirring for a while, it was 
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moved to a refrigerator and stored at 0
o
C. After leaving the reaction for 4 - 5 h (30 % 
conversion), the mixture was quenched with ethanol and was evaporated in vacuo. The 
crude mixture was partitioned between 0.2 M HCl and CH2Cl2. The layers were separated 
and the organic layer was again extracted with CH2Cl2. The organic layers were 
concentrated in vacuo and the crude product was purified by column chromatography 
(SiO2, hexane : EtOAc) to give a pale yellow oil 1.80ah (0.511 g, 73 % yield based on % 
conversion, 51 % yield recovered, 97 % e.e.). The % enantiomeric excess was determined 
using HPLC (Whelko-S,S column, hexane/EtOH = 80/20, eluting rate 1 mL/min, 
wavelength 254 nm). 
 
1.11.4 General Procedure for Enzymatic Catalyzed Kinetic Resolution of Carbonate 
Protected Acrolein Phosphonates 
The Enantioselectivity Ratio (E) was calculated by the following equation
64
 : 
E = ln[1-C(1+eeA)]/ ln[1-C(1-eeA)]                    Eq. 1.27          
where C = the extent of conversion determined by integration peaks of the 
31
P 
NMR peaks 
eeA = the enantiomeric excess of alcohol 1.157b formed in the reaction 
determined by integration peaks of the 
31
P NMR peaks using quinine as a shift reagent 
 
a) The Screening Procedure using Medium Throughput 
The lipase enzymes were weighed into 7 mL vials in pH 7.0 phosphate buffer (1.8 
mL). A stock solution of the racemic carbonate 1.155 was prepared by dissolution in t-
BuOMe (0.25 M). To each vial was added a sample of the carbonate solution (0.4 mL). 
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The vials were put in the medium throughput reaction block which was set at the required 
temperature (two different temperatures; room temperature and 40
o
C). The vials were 
shaken and small amounts of aliquots were removed and condensed in vacuo to 
determine the % reaction conversion and % e.e. of alcohol 1.157b formed in the reaction 
(
31
P NMR analysis using integration of the peaks and addition of quinine as a shift 
reagent, respectively). 
b) The Preparative Scale Procedure 
A solution of the (R)-non racemic carbonate 1.155a (72 % e.e., 0.5 g) in t-BuOMe 
(5 mL) was added to a solution of CALB (0.6 g) in pH 7.0 phosphate buffer (5 mL). The 
flask containing the mixture was put in the oil bath set to 40
o
C and stirred. The progress 
of the reaction was monitored by taking an aliquot from the organic and aqueous layers 
(0.1 mL each layer). The aliquot was drawn out from the mixture by syringe and 
evaporated in vacuo before checking by 
31
P NMR spectroscopy. The reaction was 
stopped at 24 % conversion and the CALB was removed by filtration The CALB was 
washed several times with t-BuOMe to rinse off the reaction mixture which was coated 
on the enzyme-polymer surface. The CALB was dried in air and kept in the freezer for 
subsequent reuse. The reaction mixture was extracted with more CH2Cl2 and the organic 
layer. The aqueous phase was reextracted with CH2Cl2. The combined organic layer was 
dried over Na2SO4 and concentrated in vacuo to afford the recovered/unreacted (R)-
enantiomerically pure carbonate 1.155ah (0.26 g, 68 % yield based on % conversion 
from 5
th
 reaction).  
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c) Recycling of Encapsulated CALB 
The same batch of CALB used in this first reaction was reused 4 more times in 
the hydrolysis of (R)-non racemic carbonate 1.155a (72 % e.e) under the same reaction 
condition. The recovered (R)-enantiomerically pure carbonate 1.155ah from the 5
th
 
reaction (0.26 g, 68 % yield based on % conversion from 5
th
 reaction) was then subjected 
to Grubbs cross metathesis (the procedure described below) to examine % enantiomeric 
excess obtained. 
d) Enantiomeric Excess Determination of (R)-Non Racemic Carbonate from 
Enzymatic Kinetic Resolution 
The (R)-enantiomerically pure carbonate 1.155ah recovered from the 5
th
 reaction 
was subjected to Grubbs metathesis with styrene 1.177 to provide the (R)-non racemic 
carbonate protected cinnamyl phosphonates 1.178ah. The enantiomeric excess of 
1.178ah was determined using HPLC (Whelko-S,S column, hexane/EtOH = 80/20, 
eluting rate 1 mL/min, wavelength 210 nm). The enantiomeric excess of this coupling 
product was assumed to be the same as the starting (R)-non racemic carbonate 1.155ah  
from enzymatic catalyzed kinetic resolution. 
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Appendix 
HPLC Condition : Whelko-S,S column, hexane/EtOH = 80/20, eluting rate 1 mL/min, 
wavelength 254 nm 
HPLC spectrum of (R)-1.80a (74 % e.e. from asymmetric catalysis)
a 
 
Component Retention time (min) Area (%) 
1 6.36 12.81 
2 7.60 87.19 
 
HPLC spectrum of (R)-1.80ah (97 % e.e. from chemical catalyzed kinetic 
resolution)
a 
 
Component Retention time (min) Area (%) 
1 6.93 1.41 
2 8.73 98.59 
a  
see ref
44 
(p 96) for absolute configuration   
 
 
(S) 
(R) 
(S) 
(R) 
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(S) 
(R) 
31
P NMR spectrum of precursor used for preparation of 1.155a (after adding 
quinine, 72 % e.e. from asymmetric catalysis, % e.e. is assumed to be same as those 
of 1.155ah)
b
 
 
 
HPLC spectrum of (R)-1.178ah (95 % e.e. from enzyme catalyzed kinetic resolution, 
% e.e. is assumed to be same as those of 1.155ah)
b
 
HPLC condition : Whelko-S,S column, hexane/EtOH = 80/20, eluting rate 1 mL/min, 
wavelength 210 nm 
 
 
Component Retention time (min) Area (%) 
1 12.20 97.39 
2 13.78 2.61 
b 
see ref
79 
(p 205) for absolute configuration 
 
 
 
(S) 
(R) 
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2.1 General Objective 
The stereochemistry of the substitution of hydroxyl for fluorine in !-hydroxy 
phosphonates has been the subject of some debate.
1,2
  We have re-examined the 
fluorination of enantiomerically pure benzylic hydroxy phosphonates 2.3 using 
dimethylaminosulfur trifluoride (DAST) and Deoxofluor to determine the effect of the p-
substitutent on the aromatic ring on the stereochemical course of the reaction.  The 
benzylic phosphonates 2.3 used in the fluorination were prepared in > 95 % enantiomeric 
excess using a 2 step procedure consisting of sequential asymmetric catalysis and 
chemical catalyzed kinetic resolution.  A number of factors, such as the substituent on the 
aromatic ring, the reaction temperature, and the solvent, were investigated (Scheme 2.1).   
 
 
Scheme 2.1 General objective 
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2.2 Introduction  
 Fluorine is the most electronegative of all the elements, and it has one of the 
highest ionization potentials. When substituted for one or more hydrogen atoms, the 
presence of fluorine in a molecule can have a profound effect on the molecule’s physical 
properties, reactivity, biological activity, solvency and stability of the molecule. 
Examples of the various applications are explained below. 
Pharmaceuticals  
Fluorine substitution can dramatically change the properties of biologically active 
compounds, affect the hydrophobicity and lipophilicity of the compounds,
3 
and influence 
the metabolism and distribution of drug molecules in the body. This has been the 
rationale behind synthesis of various fluorinated drugs in the pharmaceutical industry. 
Some of the applications of fluorinated pharmaceuticals have been as anticancer, antiviral 
and central nervous system agents. Other applications include uses as antibacterial and 
antifungals, !-lactam antibiotics, anesthetics, and artificial blood substitutes.
4
 
 
Agricultural Chemicals  
Fluorinated compounds used as fungicides, herbicides and insecticides often exhibit more 
potency than their non-fluorinated analogs.
5 
Many fluoro agricultural chemicals have 
structures based on the presence of at least a fluorinated aromatic ring, which imparts the 
activity of the compound. Generally, the active principles are stable and effective due to 
the inherent characteristics of the carbon-fluorine bond which is present in the structure. 
Such a bond, in fact is more stable and iso-geometrical compared with the corresponding 
carbon-hydrogen bond. 
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Advanced Photoresists 
Fluorinated compounds are used in semiconductor lithography. Photoresist polymers 
incorporating fluorine, exhibit the best combination of optical transparency at shorter 
wavelengths, etch resistance and solubility.
6 
Liquid Crystals   
Fluorinated compounds have been employed for use in display devices. A fluorine 
containing molecule plays an important role in these devices due to the changes in 
viscosity, miscibility, electrical properties, steric characteristics and other qualities.
7 
Fluorinated Surfactants 
Based on ability of fluorine to change surface-energy properties, fluorinated compounds 
are utilized as emulsifying and dispersing agents, repellant finishes and soil-release 
finishes for textiles.
8 
Dyes  
The addition of fluorine or fluorinated substituents, such as the CF3 group, has been 
found to improve the fixation yield, lightfastness and chemical resistance of dyes.
9 
Fluoroplastics and Fluoroelastomers 
By the virtue of chemical and thermal stability, fluorinated compounds have been applied 
in uses such as coatings, vessel liners, films, wiring insulation, gaskets, seals, lab 
equipment and hoses.
10 
Ion-Exchange Membranes  
Fluoropolymer membranes are used for enhanced chemical and thermal stability in harsh 
environments.
11 
 
 93 
2.3 Application of Fluoro Chemistry 
 As mentioned, a compound possessing a carbon-fluorine bond has both academic 
and industrial appeal. It is well known that the use of fluorine can affect the chemical and 
physical properties of an organic compound.  The introduction of fluorine can modify a 
number of properties of organic compounds such as thermal stability, oxidative stability 
and lipophilicity. Fluorophosphonates are also well explored bioactive molecules.
12-14
 
Some examples are shown below. 
In 1984 Blackburn
15
 reported that difluoromethylene- and fluoromethylene-
diphosphonic acids are novel, isopolar and isosteric phosphonate analogs of the 
phosphate group found in nucleotides such as ATP and GTP. He showed that the 
replacement of the methylene (CH2) group in 2.8 by either CHF or CF2 in the analog 
provides 2.9 and 2.10 improves the physical analogy of the compound in the series: CH2 
< CHF < CF2 < O as shown by 
31
P NMR spectroscopy and pKa
2
data (Scheme 2.2). 
 
Scheme 2.2 Phosphate, phosphonate and fluoro derivatives and their pKa
2 
 
Berkowitz
16
 reported the use of the monofluorinated phosphonate 2.11 (Figure 
2.1) as a phospholipase C inhibitor. Monofluorinated phosphonate 2.11, which is 
isoacidic with the phosphate, is used for the inhibition of cellular differentiation and the 
treatment of inflammatory disorders. 
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Figure 2.1 Phospholipase C inhibitor 
 
Indeed, several reports have shown that !-monofluorinated phosphonates and !,!-
difluorinated phosphonates are especially effective phosphate isosteres and behave as 
excellent pyrophosphate
17
 or phosphate ester mimics.
18
 For example, the phosphoenol 
pyruvate analog (2.12, Figure 2.2) was found to irreversibly inactivate EPSP synthase
18d
 
and the difluorinated analogs of phosphotyrosine 2.13b (Figure 2.3) incorporated into the 
hexapeptide was able to increase the PTP1B-binding affinity to 2000 fold compared to 
CH2-phosphonate 2.13a.
18b 
 
Figure 2.2 Irreversible inhibitor of EPSP synthase 
 
Figure 2.3 Reversible inhibitor of PTP1B 
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In 2005, Blackburn
19
 reported !-fluoro and !,!-difluoro benzenemethane-
sulfonamides as new inhibitors of carbonic anhydrase. These fluorinated compounds 
have been used in the development of a glaucoma therapy.
20
 The !-fluorination of the 
arenemethanesulfonamide anion of 2.14a and 2.14b using N-fluorodibenzenesulfonimide 
(NSFI) under mild condition provided the corresponding fluoro derivatives (2.15a, 2.15b, 
2.16a and 2.16b) (Scheme 2.3). The fluoro derivatives had IC50 and pKa values which 
showed an increase of all sulfonamide acidity, lipophilicity and carbonic anhydrase 
inhibition.  
 
Scheme 2.3 The synthesis of new inhibitors of carbonic anhydrase 
 
Although organofluorine compounds have widespread uses (for examples, dyes, 
cooking utensils, drugs, textile chemicals solvents, fire extinguisher agents, surfactants, 
etc.), they are difficult to prepare due to the high reactivity of molecular fluorine itself. 
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The regio- and stereoselective introduction of fluorine into a molecule requires specific 
and controlling conditions. 
 
2.4 Source of Fluorine 
There are both nucleophilic and electrophilic fluorinating agents available for 
fluorine introduction.21 Examples of these two categories of fluorinating agents are 
described in the details below. 
 
2.4.1 Nucleophilic Fluorinating Agents 
 Although fluorine is the most electronegative element, nucleophilic substitution 
with F- remains difficult due to its small size (1.36 Å radius), the low polarizability of F- 
(more likely to function as a base rather than a nucleophile), poor solubility in the 
reaction mixture, competing elimination in a nucleophilic displacement reaction, the 
toxicity, stability and price of F-, etc. Below are examples of some nucleophilic 
fluorinating agents. 
 
a) Alkali Metal Fluoride 
 Fluorinating agents such as KF and CsF are used to substitute fluorine for other 
halogens in alkyl halides, aromatic halides, !-halo esters, nitriles and amides, etc. The 
formation of the C-F bond is thermodynamically driven. A high boiling point or 
anhydrous solvent is usually employed in this kind of fluorination. A high boiling point 
solvent diminishes the high hydration energy of F- (123 kcal/mol) which causes the 
formation of an undesired hydrogen bond, and increases the solubility of F- which 
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encourages the formation of unsolvated F
-
, called “naked fluoride”. Liotta
22
 concluded 
that solubilized naked fluoride dependent fluorination of halo compounds takes place in 
the presence of a crown ether.
23
 A crown ether, e.g. 18-crown-6, is used to solvate and 
complex with the fluoride ion. The reaction gave either fluoride, alkene, or mixture of 
both indicating that the fluoride ion can act both as a nucleophile and a base in a 
competition between displacement and elimination, respectively. However, in the case of 
benzyl bromide 2.17, fluorination with KF provided only substitution 2.18 in quantitative 
yield since elimination is not possible (Eq. 2.1).  
 
 
Harpp
24
 also reported that when using CsF, 18-crown-6 and dibenzo-24-crown-8 
helped increase the rate of the nucleophilic reaction of the fluorination of the halo 
compound  by factors of 5 and 7, respectively, compared to when using CsF alone. 
Clark
25
 reported that surprisingly, a small amount of water increased the reactivity 
of KF or CsF supported on CaF2. Moderate drying conditions (dried briefly at 80
o
C under 
vacuum) for preparing a supported reagent appeared to give more efficient KF-CsF2 
resulting in better reactivity, compared to more forcing conditions (280
o
C for 16 h) which 
caused a loss of KF-CsF2 reagent reactivity.
 
 
b) AgF 
 Due to its high selectivity and low basicity compared to alkali metal fluoride, 
silver (I) fluoride is a more popular fluorinating agent. Its low basicity yields a cleaner 
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reaction product from substitution over competing elimination. Although there are 
disadvantages due to its high cost and 2 moles of the reagent required (per 1 mol of 
substrate), AgF is still mainly used in selective halogen exchange reaction as shown in 
Eq. 2.2. 
 
 As mentioned earlier, the addition of water, which normally results in hydrogen 
bonding, was thought to inhibit the reaction. Instead it served to enhance the 
nucleophilicity of F
-
. Using “wet” AgF provided 2-fluorostearic acid 2.21 from the 
bromide 2.19 in 84 % yield (Scheme 2.4)
26
 compared to a reduced yield of 10 - 15 % 
under anhydrous conditions.  
 
Scheme 2.4 The use of “wet” AgF in the fluorination of the bromide derivative 
 
 Unlike the sticky, light sensitive and highly hygroscopic natural AgF salt, AgF 
supported on CaF2 is more easily handled. This AgF-CaF2 mixture gave an improved 
yield of fluoro-substituted compound 2.23 as shown in Scheme 2.5.
27
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Scheme 2.5 The modification of using AgF-CaF2 to achieve the fluorination 
 
Replacing KF or CsF on supported CaF2 with AgF resulted in the modified 
mixture reported by Ando.
27
 Compared to the KF-CaF2 system, with the same bromo 
compound 2.17, the result clearly showed almost quantitative yield of fluoride 2.18 in 10 
min as shown in Scheme 2.6. 
 
Scheme 2.6 The fluorination using KF-CaF2 system and the modification by using 
AgF-CaF2 
 
c) Tetraalkylammonium Fluorides 
Tetraalkylammonium fluorides are used to solve the problem that occurs when 
using an alkali metal fluoride. Replacing the M
+
 ion with a bulky organic cation results in 
a reduction of ion pairing and an increase in the nucleophilicity of F
-
. Among 
tetrabutylammonium fluoride (TBAF), tetramethylammonium fluoride (TMAF), tetra-
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ethylammonium fluoride (TEAF), and benzyltrimethylammonium fluoride (BTMAF), 
TBAF is the most popularly used.  
Shimizu and co-workers
28
 described the chemoselective monofluorination of a 
primary alcohol in the presence of a secondary or tertiary hydroxy group using TBAF and 
TsF. The conversion of diol 2.24 into corresponding fluoride 2.25 was performed in THF 
solvent for 17 h and provided a good yield (80 %) (Eq. 2.3). 
 
 
 
  Anhydrous TBAF is very hygroscopic. A trace amount of water in the TBAF 
produces varying results. The use of wet TBAF was reported by Kabat.
29 
As shown in 
Scheme 2.7, a range of !-fluoromethyl ketones 2.29 were prepared via reaction of allene 
epoxides 2.28 using hydrated TBAF. 
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Scheme 2.7 The use of hydrated TBAF in the fluorination 
 
d) Polypyridinium Hydrogen Fluoride (PPHF) 
 Polypyridinium hydrogen fluoride, known as “Olah’s reagent” has been used to 
replace anhydrous hydrogen fluoride (AHF) which is corrosive and has a low boiling 
point (19
o
C).
30
 It is a stable, commercially available liquid composed of pyridine and HF 
(PPHF) in a ratio of 1 : 9 (30 % pyridine : 70 % HF w/w). PPHF has been mostly used in 
the fluorination of secondary alcohols, tertiary alcohols, alkenes, alkynes
31 
and in the 
halogen exchange reaction.
32 
In addition, the fluorine insertion into shikimic acid 
derivatives via ring opening of the allylic epoxide 2.30 has also been achieved using 
PPHF as shown in Scheme 2.8.
33
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Scheme 2.8 Fluorine insertion via ring opening of the allylic epoxide 
 
2.4.2 Electrophilic Fluorinating Agents 
 Electrophilic fluorinating agents have been used in fluorination reactions in which 
a source of nucleophilic fluorine failed. Fluorine can be used as an electrophile when 
either coupled with the electron withdrawing effect of an additional fluorine atom (F2) or 
when there is another excellent leaving group attached adjacent to a fluorine atom. 
Examples of electrophilic sources of fluorine are described below. 
 In 1984 and 1987, Rozen
34
 reported that F2 itself can act as an electrophile. The 
use of F2 diluted with N2 was employed for the fluorination of a compound containing an 
electronegative substitutent. It was proposed that the reaction between F2 and the C-H 
bond proceeded via a pentacoordinated carbonium ion. Both fluorination of 2.34 and 2.36 
provided fluoro compound 2.35 and 2.37, respectively with complete retention of 
configuration and no byproduct formation from elimination, rearrangement or inversion 
of configuration was observed as shown in Eq. 2.4 and 2.5. 
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 Silyl enol ether and enol acetate also responded well to treatment with F2.
35
 
Ignoring the low yield obtained, estrones 2.38 were fluorinated in 5 min with excellent 
stereoselectivity (Scheme 2.9). The ! configuration was obtained exclusively in 44 % 
yield, specifically when XeF2 was used as a fluorinating agent [R = OSi(Me)3].  
 
Scheme 2.9 The fluorination of enol using fluorine as a source of F
+ 
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 Acyl hypofluorite, CF3COOF 2.41, is a useful sources of electrophilic fluorine. 
CF3COOF 2.41 was synthesized from a suspension of sodium trifluoroacetate 2.40 in 
Freon at -75
o
C through which was passed fluorine gas (Eq. 2.6).  
 
 
CF3COOF 2.41 was used in the preparation of !-fluorohydrins 2.43.
36
 The substantial 
destabilizing inductive effect of the vicinal fluorine on the resulting carbocation resulted 
in a “tight ion pair” 2.42a which is in equilibrium with the “phenonium ion” 2.42b 
leading to syn addition as shown in Scheme 2.10. 
 
 
Scheme 2.10 The fluorination using CF3COOF 
 
 Fluoroxy compounds CF3(CF2)7OF, and CF3(CF2)6CF(OF)2 are also excellent 
sources of fluorine. Treatment of enol acetates 2.44, 2.46 and 2.48 with the oxidative 
solution of CF3(CF2)7OF and CF3(CF2)6CF(OF)2
37
 yielded !-fluoro ketones 2.45, 2.47 
and 2.49 in 85, 60, and 85 % yield, respectively (Scheme 2.11). Indeed, these yields are 
comparable with those obtained when using CF3COOF 2.41.
36b 
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Scheme 2.11 The fluorination of enol acetate using the solution of CF3(CF2)7OF or 
CF3(CF2)6CF(OF)2 
 
 In 1988, a solid electrophilic fluorinating agent, CsSO4F was used by Zefirov
38
 
for the fluorination of alkenes. The reaction between CsSO4F and alkenes 2.50 and 2.55 
preferred the anti Markonikov adduct from syn addition (2.52 and 2.56, respectively) 
(Scheme 2.12). 
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Scheme 2.12 The fluorination of alkenes using CsSO4F as the fluorinating agent 
 
2.5 Diethylaminosulfur trifluoride (DAST) 
 
Among the many fluorinating agents containing nitrogen and sulfur, 
dialkylaminosulfur trifluorides (R2NSF3, 2.59) and bis(dialkylamino)sulfur difluorides 
(R2NSF2NR’2, 2.60) have become very useful nucleophilic fluorinating agents for 
replacing hydroxyl and carbonyl oxygens with fluoride since they are easy to handle and 
the reaction can be carried out under mild conditions.  
Dimethylaminosulfur trifluoride (Me2NSF3, 2.59a) was prepared in 1964,
39
 but 
diethyllaminosulfur trifluoride (Et2NSF3, 2.59b, DAST) has become more popular since 
1970.
40
 SF4 itself is a fluoride source for replacing oxygen in organic compounds, but 
substituting one or two of the fluorine atoms with dialkylamino groups also results in the 
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other two fluorinating agents mentioned above. The reaction of 
dialkylaminotrialkylsilane 2.58 with SF4
41
 gives trifluoride 2.59 which is able to be 
converted into difluoride 2.60 when re-reacting with dialkylaminotrialkylsilane 2.58 as 
shown in Scheme 2.13. 
 
Scheme 2.13 Preparation of dialkylaminosulfur trifluorides and 
bis(dialkylamino)sulfur difluorides 
 
Sulfur tetrafluoride
41
 (SF4) is a useful fluorinating agent for the conversion of 
ketones,  aldehydes, carboxylic acids and alcohols to the  gem-difluoro compounds, the 
trifluoro methyl group and alkyl fluoride.
41a,42
 However, the main problem with SF4 is the 
high pressure and the toxicity of the products generated during the reaction. 
Diethylaminosulfur trifluoride (DAST, 2.59b) is one of the most important fluorinating 
agents and has been used to replace sulfur tetrafluoride. DAST 2.59b and 
bis(dialkylamino)sulfur difluorides 2.60 are particularly useful in fluorinating sensitive 
alcohols as reported by Middleton.
43a
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2.6 Fluorination with DAST 
The reaction of DAST with secondary alcohols to produce secondary alkyl 
fluorides is known.
43
 In most cases, the reaction proceeds with inversion of 
configuration
43b-e
 by an SN2-like mechanism wherein the fluoride displaces an 
intermediate DAST-derived S
IV
 ester. 
In principle, the replacement of a hydroxyl group with fluorine can occur via one 
of several mechanisms depending mainly on the structure of the hydroxy compound.
45
 
The conversion of an alcohol to a fluoro compound with DAST normally involves a two-
step reaction. The first step is the nucleophilic displacement of fluorine on the sulfur of 
the fluorinating agent 2.63 by the oxygen atom on the hydroxy compound 2.61, 
accompanied by elimination of hydrogen fluoride (fluoride anion source for next step) to 
form the intermediate 2.63 (Eq. 2.7). The existence of intermediate 2.63 can be inferred 
from 
19
F NMR spectroscopy of a mixture of the equivalent amount of DAST and the 
intermediate itself which showed a 5 line-signal  further down field than DAST’s 
chemical shift (
19
F ! = 40). 
 
The 2
nd
 step is the reaction of intermediate 2.63 with a fluoride ion in which alcohol 2.63 
is converted into the alkyl fluoride 2.64 (Eq. 2.8).  
 
This 2
nd
 step depends mainly on the structure of intermediate 2.63. The simple alcohol 
tends to proceed through this pathway to give the unrearranged fluorinated product 2.64, 
otherwise, there are two main competing reactions. 
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1) Carbonium ion type rearrangement 
Conversion of some alcohols occurs via SN1 pathway. This pathway is less likely 
to occur when DAST is used than when other known fluorinating agents are used. For 
example, as reported in 1975 by Middleton,
43a 
the fluorination of i-butyl alcohol with 
DAST afforded i-butyl fluoride as the main product in 49 % yield and t-butyl fluoride 
from rearrangement in 21 % yield,
 
whereas the fluorination with SeF4.pyridine
44 
provided 
only the rearranged t-butyl fluoride. However, the reaction of the more easily rearranged 
both exo- and endo-borneols 2.65 with DAST gave only fluoride 2.66 (Eq. 2.9). 
 
2) Dehydration or elimination  
The evidence for the occurrence of dehydration was shown by the fluorination of  
cyclooctanol 2.67 with DAST.
43a
 Although there is less of this competing reaction with 
DAST than with other fluorinating agents, the reaction gave fluorinated product 2.68 
accompanied by dehydrated product 2.69 in a ratio of 7 to 3 (Eq. 2.10). 
 
Dehydration appeared to be the main competing reaction in the fluorination of 
crotyl alcohol (2-buten-1-ol, 2.70a) when using SeF4.
44
 As shown in Scheme 2.14, 
alcohol 2.70a is known to be sensitive to dehydration as well as double bond 
rearrangement, therefore the reaction afforded butadiene 2.71 as a major product (90 % 
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yield), the double bond rearranged fluorinated product 2.72 as the minor product (9 % 
yield), and only a trace amount of unrearranged fluorinated product 2.73. On the other 
hand, the reaction with DAST was cleaner, giving no dehydrated product 2.71 and 
provided only both monofluorinated products (2.72 and 2.73), mainly from 
rearrangement (72 % and 28 %, respectively).
43a
 The solvent had little effect on the ratio 
of each monofluorinated product obtained. The result on the isomer of 2.70a (3-buten-2-
ol, 2.70b) showed that the same two products were obtained in a ratio of 78 to 22. After 
changing the solvent from dimethoxyethane to the less polar solvent, isooctane, the 
reaction of alcohol 2.70a with DAST still gave two fluorinated products, but with a 
greater % of unrearranged product. Conversely, the smaller amount of unrearranged 
product was observed in the reaction of the other isomer 2.70b. 
 
Scheme 2.14 Competing rearrangement and dehydration with fluorination of 2 
isomers of alcohol using SeF4 and DAST in solvent dimethoxyethane and isooctane 
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DAST, unlike SF4, has great utility in the conversion of !-keto esters to !,!-
difluoro esters.
46
 The synthesis of the gem-difluoromethylene compound 2.75 which was 
normally inaccessible by a CF2-synthon approach based on the Reformastky-Claisen 
rearrangement
47
 was achieved using DAST in 92 % yield (Eq. 2.11). 
 
 
Owing to thermal in stability, DAST presents major problems in large-scale 
synthesis.
48
 DAST undergoes catastrophic decomposition (explosion or detonation) with 
gas evolution at > 90
o
C. In 1999, Lal
49
 utilized bis(2-methoxyethyl)-aminosulfur 
trifluoride (Deoxofluor
TM
, 2.76, Figure 2.4) in the conversion of a variety of alcohols to 
alkyl fluorides. Deoxofluor is one of the more efficient nucleophilic fluorinating agents.
45 
It is a less thermally sensitive and a very effective alternative to DAST.
50
 The ring 
structure in (b) (Figure 2.5) is calculated to be more stable in electronic energy terms than 
the open molecule (a) (Figure 2.5). This results in the increase in the thermal stability by 
the conformational rigidity brought about by coordination of the alkoxy group with the 
electron-deficient trifluoride substituted S atom in (b). 
 
Figure 2.4 Deoxofluor
TM
 structure 
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Figure 2.5 The conformational structure of Deoxofluor
TM
  
 
In 2002, Schreeve
51
 synthesized fluorinated chiral compounds using Deoxofluor 
as a nucleophilic fluorinating agent. The fluorination of a number of amino alcohols and 
diols (2.77 – 2.83, Figure 2.6) under mild conditions (CH2Cl2 as a solvent and at between 
0 and 25
o
C) gave the corresponding chiral mono- and difluoro compounds in good yields 
(72 – 91 % yield). 
 
Figure 2.6 Amino alcohols and diols used in the synthesis of  
chiral fluoro compounds 
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2.7 Fluorination of Phosphonates 
!-Halogenated chloro, bromo, and iodo derivatives of tetraalkyl methanediphos-
phonates have been known
52
 since 1968. However, it was not until in the early 1980s that 
the corresponding fluoro derivative of a diphosphonate was synthesized. 
 In 1981, Mckenna
53
 investigated the route to both monofluoromethane-
diphosphonate 2.87 and difluoromethanediphosphonates 2.88 via the reaction of 
methanediphosphonate ester 2.84 and the electrophilic reagent, perchloryl fluoride 
(FClO3) as shown in Scheme 2.15. The perchloryl fluorination of ester 2.84 provides 2.85 
and 2.86 which can be easily converted to the corresponding fluoromethane-
diphosphonic acids 2.87 and 2.88, respectively. Fluoromethanediphosphonic acids 2.87 
and 2.88 are believed to have biochemical applications such as synthons for new fluorine-
containing oligophosphonate analogs of compounds such as ATP.
54,55 
 
Scheme 2.15 Fluorination of methanediphosphonate ester using perchloryl fluoride 
 
Using FClO3 as a fluorinating agent, like highly stabilized methylene 
bisphosphonates 2.84, phosphonoacetate 2.89 (Eq. 2.12)
56
 and [!-(phenylsulfonyl)-
methyl]phosphonates 2.91 (Eq. 2.13)
57
 gave good to excellent yields of the corresponding 
fluorinated compound 2.90 and 2.92, respectively. 
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The difluorination of !-keto esters, particularly benzylic !-oxophosphonates  with 
DAST, provides a pathway to hydrolytically stable phosphate mimics.
2,58,59
 The !,!-
difluoro phosphonic acid 2.95, a hydrolytically stable analog of O-phosphotyrosine which 
was prepared from 2.93
59
 followed by N-Boc protection using 2.94 (Eq. 2.14) has 
enabled its incorporation into peptides.
60 
 
 
 N-F fluorinating agents which are safe and easy to handle have been developed 
for use in fluorination. gem-Difluorination in the !-position of less acidic carbonyl 
compounds was achieved using N-fluoroimide 2.99 via enolates and enol ethers. The 
two-step fluorination starting from phosphonate 2.96 using the fluorinating agent 2.99 
with excess potassium diisopropylamide (KDA) (Scheme 2.16) yielded 2.98.
61
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Scheme 2.16 Two step synthesis of the gem-difluorination 
 
Other N-F fluorinating agents, such as N-fluoro-O-benzenedisulfonimide 2.102 
and N-fluorobis[(trifluoro-methyl)-sufonyl]imide 2.103 were successfully used in the 
fluorination of phosphonoacetate 2.100 (Eq. 2.15) and the anion of diethyl(cyano-
methyl)phosphonate 2.101 (Eq. 2.16), respectively. The former reaction provided !-
phosphono-!-fluoroacetate 2.104 in 78 % yield
62
 and the latter gave 
(cyanofluoromethyl)phosphonate 2.105 in good yield (51 %).
63
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!-Fluorophosphonates have been obtained by fluorination of !-hydroxy-
phosphonates with DAST. Blackburn
64a
 prepared (!-fluorobenzyl)phosphonates 2.107 by 
the reaction of !-hydroxy-!-(phenylmethyl)phosphonates 2.106 with DAST (Eq. 2.17) 
The hydroxy substitution by fluorine proceeded smoothly with a small amount of DAST 
in CH2Cl2 at 0
o
C. However, the reaction failed with a methoxy substitutent (X = OMe).  
 
 
In addition, the reaction of (!-hydroxyallyl)phosphonates 2.108 turned out to 
proceed via a cyclic SN2’ or SNi’ pathway resulting in !-fluoro-!,"-unsaturated 
phosphonates 2.109 rather than the !-fluorophosphonates as shown in Scheme 2.17.
64b
 
 
Scheme 2.17 The fluorination of hydroxyallyl phosphonate with DAST proceeded 
via SN2’ or a cyclic SNi’ pathway 
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However, with (!-hydroxypropargyl)phosphonates 2.110, DAST fluorination led 
to the regiospecific fluorine substitution at the hydroxy group producing product 2.111 
exclusively (Eq. 2.18).
65
 
 
 
In 1993, the first investigation of the stereochemical course of the DAST-
mediated transformation of !-hydroxy phosphonates to !-fluorophosphonates was 
performed by Burke.
2
 He reported that fluorination of N-Cbz-protected hydroxy 
phosphonate 2.112 with DAST provided only the monofluoro derivative 2.113 with net 
inversion or proceeded via an SN2 pathway (Eq. 2.19) and no other diastereomers were 
observed from 
1
H NMR analysis. He suggested that this result is consistent with the 
ability of DAST to stereospecifically deliver fluoride.  
 
 
However, this mechanism was corrected in 1996 by Shibuya.
1
 Conversion of 
hydroxymethylene phosphonate analogs 2.115a of the phosphorylated tyrosine 2.114 to 
the fluoromethylene phosphonate analogs 2.115b and 2.115c (Figure 2.7) was performed 
using DAST. Careful analysis of the 
19
F NMR data showed that the fluorination of 
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2.115a with DAST gave the two diastereomers of the fluoro derivative (2.117a, 2.117b) 
produced in the ratio of 60 : 40 (Eq. 2.20). The other diastereomer of hydroxymethylene 
phosphonate 2.116b also gave the two diastereomers of product 2.117a and 2.117b in a 
ratio of 44 : 56 (Eq. 2.21), hence, he showed that the reaction proceeded primarily in an 
SN1 manner.  
 
Figure 2.7 Phosphorylated tyrosine and hydroxy and fluoromethylenephosphonate 
analogs 
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In 2000, Berkowitz
66
 reported an approach to diastereomeric !-mono-fluorinated 
phosphonates (Scheme 2.18). The reaction started from sugar homologation through 
coupling of triflate 2.118 with lithiodithiane.
67 
Selective S,S-acetal cleavage in the 
presence of O,O-acetal generated the aldehyde 2.120. The Pudovik reaction
68
 with diethyl 
phosphite at -78
o
C produced a C-P bond in diastereomeric !-hydroxy phosphonates 
(2.121a, 2.121b). A slight preference for (R)-alcohol 2.121a was obtained in a ratio of 
1.4:1 relative to (S)-alcohol 2.121b. The stereochemistry was assigned by X-ray crystal 
structure analysis of the p-bromobenzoate ester of alcohol 2.121b. The mixture of 
diastereomers was subjected to fluorination using DAST and provided the diastereomeric 
monofluorinated phosphonates (2.121a, 2.121b) in a selectivity ratio of 10:1. The X-ray 
crystal structure of the predominant diastereomer 2.122b showed the (S)-configuration at 
the center ! to phosphorous. Treatment of the (R)-alcohol diastereomer 2.121a with 
DAST gave 2.122a in a yield comparable to those observed with the diastereomeric 
mixture, while 2.121b decomposed under the same reaction conditions. With this 
information, Berkowitz concluded that the fluorination reaction proceeded with inversion 
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of configuration consistent with a more SN2 manner. In this paper, he also studied and 
showed that !-fluorinated phosphonates behave as substrate mimics for glucose-6-
phosphate dehydrogenase due to their CHF stereochemistry.  
 
Scheme 2.18 Installation of the !-fluorophosphono functionality 
 
As mentioned earlier in this chapter, DAST is a convenient reagent for replacing 
the hydroxy group in hydroxy phosphonates with one fluorine atom. The reaction occurs 
under mild conditions even at -78
o
C. For the preparation of fluoro substituted hydroxy 
phosphonates which have moderate to high boiling points and can be distilled out of the 
reaction mixture, diglyme is normally used as a solvent due to its capability to form a 
complex with the HF formed in the fluorination step. Otherwise, lower boiling solvents 
such as CH2Cl2, or pentane are employed. Based on the easy handling, mainly DAST was 
chosen as a fluorinating agent for the studies in this chapter.  
Based on our knowledge of the synthesis of benzylic hydroxy phosphonates with 
a variety of p-substituents on the aromatic ring and the option for enhancement of the 
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enantiopurity by chemical catalyzed kinetic resolution using Birman’s 2
nd
 generation 
catalyst (based on the result of Chapter 1), benzylic hydroxy phosphonate was selected as 
the substrate for fluorination. Our purpose was to determine the effect of p-substituents 
on the aromatic ring in the stereochemical course of substitution of the hydroxy group in 
hydroxy phosphonates in comparison to Deoxofluor. Most experiments were carried out 
in CH2Cl2 at two temperatures ranging from -78
o
C to room temperature. 
 
2.8 Results and Discussion 
2.8.1 Preparation of Enantiomerically Pure Substrates 
To re-examine the stereochemistry of the DAST-fluorination reaction of benzylic 
hydroxy phosphonates, enantiomerically pure substrates 2.3 were prepared using a two 
stage reaction sequence; a sequential asymmetric catalyzed-Pudovik reaction (as 
mentioned in Chapter 1) and a chemical catalyzed kinetic resolution. The % enantiomeric 
excess and % yield of benzylic hydroxy phosphonates 2.2 and 2.3 prepared from the 
asymmetric Pudovik catalysis and kinetic resolution, respectively are shown in Table 2.1. 
 
 
 
 
 
 
 
 
 122 
Table 2.1 The Enantiomeric Excess and Yield of Benzylic Hydroxy Phosphonates ; 
the Substrates used for the Fluorination 
 
 
% Enantiomeric Excess (% Yield) 
X =  
2.2 (Pre-resolution) 2.3 (Post-resolution) 
OMe 71
a 
100 (63) 
Me 71
a 
100 (73) 
H 68
a 
100 (78) 
F 76
a 
100 (75) 
NO2 44-52
b 
             95 (71) 
CO2Me 70 (72) 100 (72) 
CN 67 (95)   91 (76) 
                  
a
 known compound (previously synthesized)
69a
 
                  
b 
off shelf 
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2.8.2 Fluorination of Enantiomerically Pure Benzylic Hydroxy Phosphonates 
 Typically, the alcohol can be slowly added to a solution of DAST in an inert 
solvent cooled to -50 to -78
o
C. For many alcohols, the reaction can occur rapidly at this 
low temperature. In our study, the dropwise addition of the fluorinating agent, DAST into 
a solution of the non racemic benzylic hydroxy phosphonates 2.3 in CH2Cl2 was done 
initially at -78
o
C. The fluorination of the p-nitro and p-cyano substituted hydroxy-
phosphonate was too slow to be observed. The elevation of temperature to -20
o
C to 
accelerate the reaction was done not only for this particular hydroxy phosphonate, but 
also for all substrates used, in order to compare the effect of temperature toward the 
stereochemical course. Below is the result of the study of the fluorination (Table 2.2). 
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Table 2.2 Fluorination of Enantiomerically Pure Benzylic Hydroxy Phosphonates  
 
X % e.e. of 2.3 ([!]D)* Temp. (
°
C) % e.e. (% Yield) of 2.4 
-78 1.2 (69) 2.4(a1) 
-20 0.1 (60) 2.4(a2)  
OMe 100 (44.16) 2.3(a) 
-78 (toluene) 2.2 (58) 2.4(a3)  
-78 6.6 (84) 2.4(b1) Me 100 (57.52) 2.3(b) 
 -20 2.7 (84) 2.4(b2)  
-78 32.9 (80) 2.4(c1) H 100 (43.60) 2.3(c) 
-20 20.7 (76) 2.4(c2) 
-78  17.0 (78) 2.4 (d1) F 100 (38.40) 2.3(d) 
-20 11.4 (70) 2.4(d2) 
NO2  94.88 (63.70) 2.3(e) -20 30.1 (53) 2.4(e1) 
rt 50.5 (78) 2.4(f1) CO2Me 100 (47.20) 2.3(f) 
 rt (toluene) 51.7 (71) 2.4(f2) 
rt 50.6 (74) 2.4(g1) 
rt (toluene) 51.4 (61) 2.4(g2) 
rt (deoxoflour) 59.1 (67) 2.4(g3) 
CN 90.54 (54.22) 2.3(g) 
-20 (deoxoflour) 64.0 (62) 2.4(g4) 
* (c = 1, MeOH, 25
o
C) 
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After the fluorination, (the results shown in Table 2.2), the results were as 
expected. The inductive effect at the p-substituent influences the stability of the 
carbocation intermediate. The more the carbocation was stabilized, the more SN1-like 
behavior was observed. With a strong electron donor such as the p-methoxy substituent, 
the reaction proceeded at an even lower temperature of -78
o
C and the products were 
racemic mixtures, i.e. the reaction was more SN1-like. In the case of a group with a less 
electron donating effect such as the methyl group, the fluorination still proceeded at -
78
o
C with less racemization.  
 Conversely, when an electron withdrawing substituent on the p-position is 
present, such as an NO2 group, no reaction was observed at -78
o
C. The reaction 
temperature was raised to -20
o
C and the reaction proceeded. An increase of a reasonable 
rate in SN2 pathway was also observed. With the CO2Me and the CN group, the reaction 
needed to be conducted at ambient temperature to achieve an adequate rate. The reaction 
proved to be more SN2 like. 
 With another fluorinating agent, Deoxofluor, which is a little more reactive, the 
reaction of the substrate with a CN group could be carried out at -20
o
C and provided 
slight increase in the enantiomeric excess of the product. Upon switching the solvent to 
toluene, the result on each substitutent was not significantly altered compared to when 
CH2Cl2 was used. 
  
2.9 Summary 
In general, the electron donating substituents on the p-position of the aromatic 
ring stabilized the carbocation intermediate. This resulted in an increase of the reaction 
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rate and more racemization (more SN1-like reaction) compared to electron withdrawing 
substituents. Changing parameters such as the fluorinating agent (Deoxofluor) and the 
solvent (toluene) did not significantly vary the result. 
 
2.10 Experimental Section 
General Experimental 
1
H, 
13
C{
1
H} and 
31
P{
1
H} NMR spectra were recorded on a Bruker Advance 300 MHz 
NMR spectrometer in CDCl3 at room temperature. 
1
H NMR spectra were referenced to 
CDCl3 (7.27 ppm), 
13
C{
1
H} NMR spectra were referenced to the center line of CDCl3 
(77.23 ppm) and 
31
P{
1
H} NMMR spectra were referenced to external 85% H3PO4 (0 
ppm). Coupling constants, J, are reported in Hz. Infrared spectra were recorded on a 
Thermo Nicolet Avatar 360 FT-IR spectrometer. Analytical thin layer chromatography 
(TLC) analyses were performed on silica gel plates, 60PF254. Visualization was 
accomplished with UV light, KMnO4 solution or iodine. Silica gel 60 Merck (0.040-0.063 
mm) was used for chromatography. Enantiomers ratios were measured by chiral 
stationary-phase HPLC on a Regis (S, S)-Whelko-O column using 210 nm of wavelength 
and eluting with 20 % ethanol in hexane at 1 mL/min. Mass spectral analyses were 
performed using a JEOL MStation (JMS-700) mass spectrometer; electron impact (EI) 
direct insertion at 70 eV, or fast atom bombardment-FAB [MH
+
]. All reactions were 
conducted under argon atmosphere using oven-dried glassware. All of the commercially 
available chemicals were purchased from Sigma-Aldrich, Strem or Acros. Methylene 
chloride and toluene were distilled from CaH2 and THF was dried, then distilled from 
sodium benzophenone ketyl under argon atmosphere. Dimethyl phosphite, titanium 
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isopropxide and propionic anhydride were distilled under reduced pressure. Chloroform 
was distilled at atmosphere. Other reagents were obtained from commercial sources and 
used without purification. 
 
 
 
2.10.1 General Procedure for Synthesis of Racemic Hydroxy Phosphonates  
(+/-)-2.2(a-g)  
To a mixture of dimethyl phosphite (1.2 eq) and the corresponding aldehyde 
(1.0 eq) (p-anisaldehyde, p-tolualdehyde, benzaldehyde, 4-fluorobenzaldehyde, 4-
nitrobenzaldehyde, methyl-4-formylbenzoate and 4-cyano-benzaldehyde for racemic 
2.2(a-g) respectively) was added triethylamine (0.7 eq) under argon atmosphere. The 
reaction was followed by 
1
H
 
NMR until the aldehyde peak disappeared. The triethylamine 
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was evaporated in vacuo and the crude product was purified by column chromatography 
(silica, hexane/EtOAc). 
 
2.10.2 General Procedure for Synthesis of Non Racemic Hydroxy Phospho-
nates 2.2(a-g) 
2.2(a-e) (known compound)  
The non racemic (R)-hydroxy phosphonates were prepared by catalytic 
asymmetric phosphonylation using dimethyl D-tartrate and Ti(Oi-Pr)4 as catalyst in THF 
solvent.
69b
  
Methyl 4-((dimethoxyphosphoryl)hydroxy)methyl)benzoate 2.2(f) and  
dimethyl-(4-cyanophenyl)hydroxy)methylphosphonate 2.2(g)  
Aldehyde (methyl-4-formylbenzoate for 2.2(f) and 4-cyano-benzaldehyde for 
2.2(g)) (2.0 eq, 0.03 mol) and dimethyl-L-tartrate (0.24 eq, 6.55 mmol) was dissolved in 
50 mL dry THF and the solution was cooled to -15
°
C under argon atmosphere. 
Titanium isopropoxide (0.2 eq, 5.5 mmol) was added and the solution was 
stirred for 30 min, then dimethyl phosphite (2.0 eq, 0.05 mol) was added. After 15 
min, the reaction mixture was placed in a freezer at -15
°
C overnight (12 h). The celite 
was added to the solution and it was quenched with water. The celite was filtered 
and the organic layer was diluted with CH2Cl2 and washed with brine solution. The 
organic layer was dried over Na2SO4 and the solvent was evaporated in vacuo. The crude 
product was purified by column chromatography (silica, hexane/EtOAc). The % 
enantiomeric excess was determined by HPLC using S, S-Whelko, det. 210 nm, 
hexane/ethanol 80:20.  
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2.10.3 General Procedure for Synthesis of Enantiomerically Pure Non 
Racemic Hydroxy Phosphonates 2.3(a-g) using Chemical Catalyzed Kinetic 
Resolution 
To a solution mixture of the non racemic phosphonate 2.2(a-g) (1.0 eq, 4 mmol) 
and Birman’s 2
nd
 generation catalyst (Gen II, 20 mol%, 0.08 mmol) in 5 mL dry 
chloroform was added propionic anhydride (0.3 eq, 1.0 mmol) and diisopropyl ethylamine 
(0.3 eq, 1.0 mmol). The mixture was maintained at -25
°
C until 
31
P
 
NMR indicated the 
consumption of substrate. The reaction mixture was quenched with ethanol and the 
solvent was evaporated in vacuo. The mixture was partitioned between 0.2 M HCl and 
CH2Cl2. The organic layer was evaporated in vacuo and the crude mixture was purified 
by column chromatography (silica, hexane/EtOAc). % Enantiomeric excess was 
determined by HPLC using S, S-Whelko, det. 210 nm, hexane/ethanol 80:20. 
 
2.10.4 General Procedure for Synthesis of Fluoro Phosphonates 2.4(a-g)  
To a precooled (-78
°
C) solution of racemic hydroxy phosphonate (+/-)-2.2(a-g) 
(1.0 eq, 0.4 mmol) in 1 mL dry CH2Cl2 under argon atmosphere was added a precooled 
(-78
°
C) solution of diethylaminosulfur triflouride (DAST) (1.45 eq, 0.6 mmol) in 0.5 mL 
dry CH2Cl2. For compound 2.4(a-d), the solution was maintained at -78
°
C and stirred for 
10-15 min before the reaction completion (
31
P
 
NMR). For compound  2.4(e-g), after stirring 
at -78
°
C for 2-3 min, the solution was raised immediately to room temperature and 
stirred for 2-3 h. or more until reaction was completed (
31
P NMR). The mixture was 
quenched with saturated aqueous NaHC03, followed by extraction with CH2Cl2. 
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The combined organics were dried over Na2SO4, filtrated and evaporated in vacuo. The 
pure produce was given after purifying by column chromatography (silica, hexane/EtOAc). 
Substitution of DAST with bis(2-methoxyethyl)amino]sulfur trifluoride 
(Deoxofluor) and/or CH2Cl2 with toluene was also followed the same procedure as 
mentioned above. HPLC was used to determine % enantiomeric excess of compound 
(S, S-Whelko, det. 210 nm, hexane/ethanol 80:20). 
 
 
Methyl 4-((dimethoxyphosphoryl)hydroxy)methyl)benzoate (+/-)-2.2(f)  
(72 %); IR (neat, NaCl) 3213, 1713 cm
-1
; m.p.: 152
o
C;
 1
H NMR (CDCl3) ! 8.08 (2H, d, 
JHH = 8.3 Hz), 7.60 (2H, d, JHH = 8.2 Hz),  5.17 (1H, d, JHP = 11.9 Hz), 3.95 (3H, s), 
3.743 (3H, d, JHH = 10.6 Hz), 3.740 (3H, d, JHH = 10.4 Hz); 
13
C NMR (CDCl3) ! 167.2, 
141.9 (d, JCP = 2.5 Hz), 130.3 (d, JCP = 3.3 Hz), 130.0 (d, JCP = 2.6 Hz), 127.3 (d, JCP = 
5.5 Hz), 70.8 (d, JCP = 158 Hz), 54.6 (d, JCP = 7.1 Hz), 54.2 (d, JCP = 7.4 Hz), 52.6; 
31
P 
NMR (CDCl3) ! 23.21; HRMS (EI, M
+
) calcd. for C11H15O6P: 274.0606, found 
274.0609. 
 
Dimethyl-(4-cyanophenyl)hydroxy)methylphosphonate  (+/-)-2.2(g)  
(95 %);  IR (neat, NaCl) 3216, 2228 cm
-1
; m.p.: 221
o
C; 
1
H NMR (CDCl3) ! 7.69 (2H, d, 
JHH = 8.3 Hz), 7.62 (2H, d, JHH = 8.6 Hz),  5.15 (1H, d, JHP = 12.1 Hz), 3.76 (3H, d, JHH = 
10.5 Hz), 3.74 (3H, d, JHH = 10.5 Hz); 
13
C NMR (CDCl3) ! 142.1, 132.5 (d, JCP = 2.7 
 131 
Hz), 127.9 (d, JCP = 5.3 Hz), 119.0, 112.4, 70.5 (d, JCP = 158 Hz), 54.6 (d, JCP = 7.0 Hz), 
54.3 (d, JCP = 7.5 Hz); 
31
P NMR (CDCl3) ! 22.60; HRMS (EI, M
+
) calcd for 
C10H12NO4P: 241.0504, found 241.0505. 
 
Dimethyl fluoro(4-methoxypheny)methylphosphonate (+/-)-2.4(a) 
(63 %); IR (neat, NaCl) 1617 cm
-1
; m.p.: 87
o
C; 
1
H NMR (CDCl3) ! 7.44 (2H, d, JHH = 
8.5 Hz), 6.95 (2H, d, JHH = 8.3 Hz),  5.65 (1H, dd, JHP = 7.0 Hz, JHF = 44.5 Hz), 3.84 
(3H, s), 3.78 (3H, d, JHH = 10.6 Hz), 3.72 (3H, d, JHH = 10.6 Hz); 
13
C NMR (CDCl3) ! 
160.9 (m), 129.2 (dd, JCP = JCF = 6.0 Hz), 124.9 (dd, JCP = very small, JCF = 19.8 Hz), 
114.5 (d, JCP = 1.5 Hz), 89.5 (dd, JCP = 173 Hz, JCF = 183 Hz), 55.7, 54.5 (d, JCP = 6.6 
Hz), 54.1 (d, JCP = 6.8 Hz); 
31
P NMR (CDCl3) ! 18.36 (d, JPF = 89.8 Hz); HRMS (EI, 
M
+
) calcd. for C10H14FO4P: 248.0614, found 248.0613. 
 
Dimethyl fluoro(p-tolyl)methylphosphonate (+/-)-2.4(b) 
(73 %); IR (neat, NaCl) 1613 cm
-1
; 
1
H NMR (CDCl3) ! 7.37 (2H, d, JHH = 8.0 Hz), 7.21 
(2H, d, JHH = 7.9 Hz), 5.67 (1H, dd, JHP = 7.3 Hz, JHF = 44.7 Hz), 3.73 (3H, d, JHH = 10.6 
Hz), 3.71 (3H, d, JHH = 10.6 Hz), 2.36 (3H, s); 
13
C NMR (CDCl3) ! 139.8 (dd, JCP = JCF = 
2.6 Hz), 130.0 (dd, JCP = 1.1 Hz, JCF = 19.0 Hz), 129.7 (d, JCP = 1.9 Hz), 127.3 (dd, JCP = 
JCF = 6.1 Hz), 89.6 (dd, JCP = 171 Hz, JCF = 183 Hz), 54.5 (d, JCP = 6.7 Hz), 54.1 (d, JCP = 
6.9 Hz), 21.7; 
31
P NMR (CDCl3) ! 18.17 (d, JPF = 86.8 Hz); HRMS (EI, M
+
) calcd. for 
C10H14FO3P: 232.0665, found 232.0662. 
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Dimethyl fluoro(phenyl)methylphosphonate (+/-)-2.4(c) 
(78 %); IR (neat, NaCl) 1636 cm
-1
; 
1
H NMR (CDCl3) ! 7.49 – 7.40 (5H, m),  5.72 (1H, 
dd, JHP = 7.7 Hz, JHF = 44.8 Hz), 3.73 (3H, d, JHH = 10.6 Hz), 3.72 (3H, d, JHH = 10.6 
Hz); 
13
C NMR (CDCl3) ! 139.8 (dd, JCP = very small, JCF = 18.6 Hz), 129.7 (dd, JCP = JCF 
= 2.4 Hz), 129.0 (d, JCP = 2.2 Hz), 127.1 (dd, JCP = JCF = 6.0 Hz), 89.6 (dd, JCP = 170 Hz, 
JCF = 184 Hz), 54.6 (d, JCP = 6.8 Hz), 54.2 (d, JCP = 6.9 Hz); 
31
P NMR (CDCl3) ! 17.92 
(d, JPF = 85.1 Hz); HRMS (EI, M
+
) calcd. for C9H12FO3P: 218.0508, found 218.0513. 
 
Dimethyl fluoro(4-fluorophenyl)methylphosphonate (+/-)-2.4(d) 
(75 %); IR (neat, NaCl) 1606 cm
-1
; 
1
H NMR (CDCl3) ! 7.48 – 7.44 (2H, m), 7.12 – 7.06 
(2H, m),  5.67 (1H, dd, JHP = 7.5 Hz, JHF = 44.6 Hz), 3.74 (3H, d, JHH = 10.6 Hz), 3.72 
(3H, d, JHH = 10.6 Hz); 
13
C NMR (CDCl3) ! 163.7 (ddd, JCP = JCF = 2.8 Hz, JCF = 248 
Hz), 129.3 (ddd, JCP = JCF = 6.2 Hz, JCF = 12.4 Hz), 128.9 (ddd, JCP = 1.1 Hz, JCF = 3.2 
Hz, JCF = 19.2 Hz), 116.1(dd, JCP = 2.0 Hz, JCF = 21.9 Hz), 89.0 (dd, JCP = 172 Hz, JCF = 
184 Hz), 54.6 (d, JCP = 6.9 Hz), 54.1 (d, JCP = 6.8 Hz); 
31
P NMR (CDCl3) ! 17.65 (dd, JPF  
= 4.3 Hz, JPF  = 86.0 Hz); HRMS (EI, M
+
) calcd. for C9H11F2O3P: 236.0414, found 
236.0416. 
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Dimethyl fluoro(4-nitrophenyl)methylphosphonate (+/-)-2.4(e) 
(71 %); IR (neat, NaCl) 1521, 1346 cm
-1
; m.p.: 109.5
o
C; 
1
H NMR (CDCl3) ! 8.30 (2H, d, 
JHH = 8.6 Hz), 7.68 (2H, d, JHH = 8.7 Hz), 5.86 (1H, dd, JHP = 9.6 Hz, JHF = 44.9 Hz), 
3.84 (3H, d, JHH = 10.8 Hz), 3.77 (3H, d, JHH = 10.7 Hz); 
13
C NMR (CDCl3) ! 148.7 (m), 
140.3 (dd, JCP = very small, JCF = 18.7 Hz), 127.5 (dd, JCP = 5.3 Hz, JCF = 7.5 Hz), 124.2 
(d, JCP = 2.3 Hz), 88.7 (dd, JCP = 168 Hz, JCF = 187 Hz), 54.9 (d, JCP = 6.9 Hz), 54.4 (d, 
JCP = 6.8 Hz); 
31
P NMR (CDCl3) ! 16.17 (d, JPF = 79.3 Hz); HRMS (EI, M
+
) calcd. for 
C9H11FNO5P: 263.0359, found 263.0357. 
 
Methyl 4-((dimethoxyphosphoryl)(hydroxy)methyl)benzoate (+/-)-2.4(f) 
(72 %); IR (neat, NaCl) 1709, 1003 cm
-1
; m.p.: 93
o
C; 
1
H NMR (CDCl3) ! 8.10 (2H, d, 
JHH = 8.4 Hz), 7.60 (2H, d, JHH = 9.6 Hz), 5.81 (1H, dd, JHP = 8.8 Hz, JHF = 44.9 Hz), 
3.94 (3H, s), 3.79 (3H, d, JHH = 10.7 Hz), 3.73 (3H, d, JHH = 10.6 Hz); 
13
C NMR (CDCl3) 
! 166.9, 138.0 (dd, JCP = very small, JCF = 18.9 Hz), 131.3 (m), 130.2 (d, JCP = 2.3 Hz), 
126.7 (dd, JCP = 5.4 Hz, JCF = 6.9 Hz), 89.2 (dd, JCP = 168 Hz, JCF = 185 Hz), 54.8 (d, JCP 
= 6.8 Hz), 54.3 (d, JCP = 6.9 Hz), 52.7; 
31
P NMR (CDCl3) ! 17.01 (d, JPF  = 81.5 Hz); 
HRMS (EI, M
+
) calcd. for C11H14FO5P: 276.0563, found 276.0562. 
 
Dimethyl (4-cyanophenyl)fluoromethylphosphonate (+/-)-2.4(g) 
(76 %); IR (neat, NaCl) 2225 cm
-1
; m.p.: 110
o
C; 
1
H NMR (CDCl3) ! 7.74 (2H, d, JHH = 
7.9 Hz), 7.62 (2H, d, JHH = 8.1 Hz), 5.85 (1H, dd, JHP = 9.4 Hz, JHF = 44.9 Hz), 3.84 (3H, 
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d, JHH = 10.8 Hz), 3.77 (3H, d, JHH = 10.7 Hz); 
13
C NMR (CDCl3) ! 138.4 (dd, JCP = 2.3 
Hz, JCF = 19.0 Hz), 132.8 (d, JCP = 2.3 Hz), 127.3 (dd, JCP = 5.3 Hz, JCF = 7.6 Hz), 118.7, 
113.5 (m), 88.8 (dd, JCP = 168 Hz, JCF = 187 Hz), 54.9 (d, JCP = 6.9 Hz), 54.4 (d, JCP = 
7.3 Hz); 
31
P NMR (CDCl3) ! 16.37 (d, JPF  = 79.6 Hz); HRMS (EI, M
+
) calcd. for 
C10H11FNO3P: 243.0461, found 243.0460. 
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Appendix 
HPLC Spectrum 
HPLC condition : S,S-Whelko-O column, det. 210 nm, hexane/ethanol 80:20, 1 
mL/min. 
 
                                                     
 
 
 
 
Retention time 
(min) 
% Area  
Retention time 
(min) 
% Area 
16.15 49.79  - - 
20.85 50.21  19.75 100.00 
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HPLC Spectrum 
 
 
 
                                                          
 
 
 
 
Retention time 
(min) 
% Area  
Retention time 
(min) 
% Area 
9.85 52.27  - - 
11.37 47.73  11.35 100.00 
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HPLC Spectrum 
 
 
 
                                                              
 
 
 
 
Retention time 
(min) 
% Area  
Retention time 
(min) 
% Area 
10.22 49.53  - - 
11.63 50.47  11.67 100.00 
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HPLC Spectrum 
 
 
                                                          
 
 
 
 
Retention time 
(min) 
% Area  
Retention time 
(min) 
% Area 
9.78 49.87  - - 
11.37 50.13  10.88 100.00 
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HPLC Spectrum 
 
 
                                                     
 
 
 
 
Retention time 
(min) 
% Area  
Retention time 
(min) 
% Area 
17.55 49.68  19.13 2.56 
20.37 50.32  21.77 97.44 
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HPLC Spectrum 
 
 
                                                          
 
 
 
 
 
Retention time 
(min) 
% Area  
Retention time 
(min) 
% Area 
19.68 48.63  - - 
24.72 51.33  25.85 100.00 
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HPLC Spectrum 
 
 
                                                      
 
 
 
 
Retention time 
(min) 
% Area  
Retention time 
(min) 
% Area 
21.80 49.66  20.45 4.73 
25.48 50.34  23.20 95.27 
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HPLC Spectrum 
 
                                                     
 
 
 
 
Retention time 
(min) 
% Area  
Retention time 
(min) 
% Area 
15.88 49.06  15.77 49.40 
21.37 50.94  21.05 50.60 
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HPLC Spectrum 
 
                                                     
 
 
 
 
Retention time 
(min) 
% Area  
Retention time 
(min) 
% Area 
15.88 49.06  15.90 49.96 
21.37 50.94  21.33 50.04 
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HPLC Spectrum 
 
                                                     
 
 
 
 
Retention time 
(min) 
% Area  
Retention time 
(min) 
% Area 
15.88 49.06  15.10 48.91 
21.37 50.94  19.93 51.09 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 145 
HPLC Spectrum 
 
 
                                                     
 
 
 
 
Retention time 
(min) 
% Area  
Retention time 
(min) 
% Area 
9.98 49.91  10.08 53.31 
12.08 50.09  12.28 46.69 
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HPLC Spectrum 
 
 
                                                     
 
 
 
 
                                                                                         
Retention time 
(min) 
% Area  
Retention time 
(min) 
% Area 
9.98 49.91  10.15 51.36 
12.08 50.09  12.38 48.64 
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HPLC Spectrum 
 
 
                                                              
 
 
 
 
Retention time 
(min) 
% Area  
Retention time 
(min) 
% Area 
10.62 49.90  10.78 66.46 
12.43 50.10  12.68 33.54 
           
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 148 
HPLC Spectrum 
 
 
                                                              
 
 
 
                                                                               
Retention time 
(min) 
% Area  
Retention time 
(min) 
% Area 
10.62 49.90  10.72 60.33 
12.43 50.10  12.58 39.67 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 149 
HPLC Spectrum 
 
 
                                                     
 
 
 
 
Retention time 
(min) 
% Area  
Retention time 
(min) 
% Area 
10.22 49.22  10.38 58.50 
11.95 50.78  12.23 41.50 
 
                                                                                         
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
-78
°
C  
 150 
HPLC Spectrum 
 
 
                                                     
 
 
 
 
Retention time 
(min) 
% Area  
Retention time 
(min) 
% Area 
10.22 49.22  10.35 55.70 
11.95 50.78  12.15 44.30 
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HPLC Spectrum 
 
 
                                                   
 
 
 
 
Retention time 
(min) 
% Area  
Retention time 
(min) 
% Area 
20.47 50.52  21.37 65.05 
23.52 49.48  24.65 34.95 
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HPLC Spectrum 
 
 
                                               
 
 
 
 
Retention time 
(min) 
% Area  
Retention time 
(min) 
% Area 
20.30 49.91  20.32 75.25 
26.53 50.09  27.40 24.75 
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HPLC Spectrum 
 
 
                                               
 
 
                                                                               
 
 
Retention time 
(min) 
% Area  
Retention time 
(min) 
% Area 
20.30 49.91  21.67 75.84 
26.53 50.09  28.93 24.16 
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HPLC Spectrum 
 
 
                                                      
 
 
 
 
Retention time 
(min) 
% Area  
Retention time 
(min) 
% Area 
25.90 49.93  23.13 75.30 
29.72 50.07  26.83 24.70 
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HPLC Spectrum 
 
 
                                                      
                          
 
 
 
 
Retention time 
(min) 
% Area  
Retention time 
(min) 
% Area 
25.90 49.93  25.95 75.71 
29.72 50.07  30.48 24.29 
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HPLC Spectrum 
 
 
                                                      
 
 
 
 
 
Retention time 
(min) 
% Area  
Retention time 
(min) 
% Area 
25.90 49.93  27.40 79.54 
29.72 50.07  31.78 20.46 
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HPLC Spectrum 
 
 
                                                      
                   
 
 
 
Retention time 
(min) 
% Area  
Retention time 
(min) 
% Area 
25.90 49.93  26.52 82.00 
29.72 50.07  31.33 18.00 
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3.1 General Objective 
 As shown in Scheme 3.1, the cross metathesis of enantiomerically pure allylic 
phosphonate 3.1a with either of the enantiomerically pure hydroxy alkenes (3.2a and 
3.2b) followed by intramolecular palladium-catalyzed nucleophilic addition of the 
hydroxy group to the phosphono allylic carbonates results in a stereospecific formation of 
the oxygen heterocycles (3.3a and 3.3b). This means that cross metathesis and 
cyclization with either the (R) or (S)-alcohol (3.2a and 3.2b) will provide either the cis or 
trans-furan or pyran (3.4a and 3.4b) from common phosphonate intermediate 3.1a. The 
vinyl phosphonate products (3.4a and 3.4b) can be transformed into several useful 
functional groups leading to the syntheses of biologically active natural products. For this 
thesis (Scheme 3.2), the synthesis of amphidinolide C 3.5 and the formal synthesis of (+)-
centrolobine (3.6a, the enantiomer of natural (-)-centrolobine) will be presented.  
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Scheme 3.1 The syntheses of cis- and trans-tetrahydrofurans and tetrahydropyrans 
  
Scheme 3.2 General Objective 
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3.2 General Palladium ! Allyl Chemistry 
As part of the development of organopalladium chemistry, many interesting 
organopalladium complexes have been prepared. Among these, an allylic palladium 
complex is one of the most often used organopalladium complexes.
1
 Allylic palladium 
complexes have been applied to the preparation of several chiral building blocks. It is 
well known that organopalladium !-allyl complexes 3.11 (Scheme 3.3) are very reactive 
species due to the positive charge on palladium. The reaction starts with the oxidative 
addition of the Pd(0) catalyst 3.7 to the allylic substrate 3.8 with an inversion of 
configuration. Another inversion of configuration occurs when the nucleophile attacks 
from the less hindered side of the !-allylcomplex 3.11 Therefore, most reactions proceed 
regioselectively with retention of configuration, thus leading to the predictability of the 
reaction pathway.
2 
 
 
Scheme 3.3 Mechanism in Pd(0) catalyzed !-allyl reaction 
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 A variety of palladium(0) catalysts have been used in the !-allyl reaction. 
Tetrakis(triphenylphosphine)palladium(0), Pd(PPh3)4 is one of the most commonly used 
commercially available palladium catalysts. However, the major concern with this 
catalyst that arises during some experiments is the generation of triphenylphosphine 
oxide, P(O)Ph3 which is sometimes hard to separate from the desired product. Other 
palladium catalysts become more attractive in some cases. The palladium(0) complex can 
be generated in situ by the reaction of a palladium salt such as Pd(OAc)2 or PdCl2 with a 
neutral ligand such as PPh3, dppe (1,2-bis(diphenyl)phosphinoethane) and dppb (1,2-
bis(diphenyl)phosphinobutane).  
 Allylic palladium complexes have been used in the asymmetric synthesis of a 
diverse array of carbocyclic and heterocyclic rings with a variety of different functional 
groups. The inter- and intramolecular nucleophilic additions are the key processes for the 
formation of a new bond (eg, C-C, C-N, C-O, etc). Based on the most common types of 
nucleophile used, palladium-catalyzed !-allyl reactions can be divided into three groups 
as detailed below: allylic alkylation (carbon nucleophile), allylic amination (nitrogen 
nucleophile) and alkoxylation (oxygen nucleophile).  
 
3.2.1 Allylic Alkylation (Carbon Nucleophile) 
 The formation of the carbon-carbon bond typically involves a carbanion which is 
a soft nucleophile. The nucleophile is usually stabilized by the electron withdrawing 
group. The typical stereochemical outcome is retention from the result of two inversion 
steps.   
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 In 2001, Trost
3 
demonstrated the use of (R,R)-BPA 3.14a as a chiral chelating 
ligand (Figure 3.1) for palladium-catalyzed enantioselective malonate addition to allylic 
gem-dicarboxylate 3.15 (Scheme 3.4). The first reaction provided product 3.17 as the 
only regioisomer in 98 % yield with 90 % e.e. Compound 3.17 was then subsequently 
subjected to a second malonate addition to give the bis-malonate substituted product 3.18 
with a complete transfer of chirality in 91 % e.e.  
 
 
Figure 3.1 (R,R)-BPA, chiral chelating ligand 
 
 
Scheme 3.4 Palladium-catalyzed malonate addition 
 
 172 
In the palladium-catalyzed reaction of symmetrical !-allyl intermediates, the 
nucleophile can attack at either side of the !-allyl intermediate 3.11. In 2003, Carretero
4
 
demonstrated the use of 1-phosphina-2-sulfenylferrocenes 3.20 as planar chiral ligands 
for the enantioselective palladium-catalyzed reaction of symmetric allyl substrate 3.19 as 
shown in Eq 3.1. Using this chiral ligand, compound 3.21 was formed with 93 % e.e.  
 
 
In 2004, the utility of the palladium-catalyzed malonate addition was established 
for the synthesis of the bis(lactone) analogs of acetomycin 3.26 by Uenishi
5
 (Scheme 
3.5). The addition of acetoacetate 3.22 to the allylic substrate 3.23 using Pd(OAc)2 and 
PPh3 produced a mixture of diastereomers 3.24. Protection of the acetyl group allowed 
the separation of both diastereomers, which were then subjected to ozonolysis and the in 
situ lactonization to provide the exo- and endo-bis(lactone) (3.25a and 3.25b, 
respectively). 
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Scheme 3.5 The synthesis of bis(lactone) analogs of acetomycin 
 
The intermolecular palladium-catalyzed nucleophilic additions of allylic 
phosphonates 3.38 with a variety of nucleophiles have been performed by many groups, 
including Spilling and coworkers. 
6,7,8,9
 The formal synthesis of 3.37 and 3.30 (Scheme 
3.6) will be further described below. 
 
Scheme 3.6 (S)-(+)-ar-Turmerone and (-)-enterolactone  
derived from allylic phosphonates 
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A palladium-catalyzed reaction and lactonization concept was employed by 
Spilling
9
 (Scheme 3.7) for the synthesis of (-)-enterolactone. The palladium-catalyzed 
reaction of allylic hydroxy phosphonate 3.27 (95 % e.e.) with malonate using Pd(PPh3)4 
resulted in complete chirality transfer from the !- to !-position giving compound 3.28 in 
85 % yield with 92 % e.e. as shown in Scheme 3.7. The vinyl phosphonate was converted 
in two steps (ozonolysis followed by in situ reduction with NaBH4, then cleavage of the t-
butylester) to butyrolactone 3.29 which had been previously reported by Sibi,
10i
 therefore, 
resulting in the formal synthesis of (-)-enterolactone 3.30.
10
 
 
Scheme 3.7 Formal synthesis of (-)-enterolactone 
 
Spilling
6
 also reported that the arylation of (S)-allylic hydroxy phosphonate 3.32 
with Pd2(dba)3 using p-tolyl tributylstannane 3.33 (Scheme 3.8) which provided the (E)- 
and (Z)-vinyl phosphonates (3.34a and 3.34b) in the ratio of 85 : 15. The synthesis of 
aldehyde (S)-3.36 represented the formal synthesis of (S)-(+)-ar-turmerone 3.37.
11
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Scheme 3.8 Formal synthesis of (S)-(+)-ar-turmerone 
 
Peiffer
1c 
reported the preparation of phosphono amino acid precursors 3.41 by the 
reaction of 3.39 and 3.40 using a combination of Pd(OAc)2 and dppe as the catalyst (Eq. 
3.2). 
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 Genêt
12
 demonstrated the use of the palladium(0) catalyst system, Pd(OAc)2 and 
dppe, for the intramolecular alkylation of compound 3.42. The palladium-catalyzed ring 
closure in the presence of NaH afforded the new fused bicyclic compound 3.43 in 
quantitative yield (Eq. 3.3). 
 
 
3.2.2 Allylic Amination (Nitrogen Nucleophile) 
 The reactions of nitrogen nucleophiles with allylic substrates are among the most 
useful reactions for organic synthesis for the controlled syntheses of allylic amines. The 
presence of the base is not required for the palladium-catalyzed reaction due to the 
property of the amine. Both primary and secondary amines work well in either inter- or 
intramolecular reactions and gave similar stereoselectivity and regioselectivity to those of  
allylic alkylation. 
 In 1987, Lu
13,14 
first investigated the effect of the steric and electronic properties 
of the phosphorous moiety on allylic phosphonates. It was reported that the phosphorous 
moiety can control the regioselectivity. The intermolecular addition of a soft nucleophile 
(such as malonate
13
 or amine
14
) on the !-position of the phosphonate 3.44 (Eq. 3.4) 
proceeded regioselectively to afford exclusively !-substituted vinyl phosphonate 3.45 in 
high yield. 
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 Ohler
15
 used the use of this strategy for the !-addition of BocNHOBoc 3.45 to a 
series of phosphono carbonates 3.44. The reaction regioselectively resulted in the 
corresponding vinyl phosphonate 3.46 (Scheme 3.9). 
 
Scheme 3.9 The !-addition of phosphono carbonate with BocNHBoc 
 
Spilling
8
 has also shown that the intermolecular amination of allylic hydroxy 
phosphonate 3.48 (99 % e.e.) with secondary amine 3.35 in the presence of Pd(OAc)2 and 
PPh3  proceeded with the complete transfer of chirality. The reaction resulted in vinyl 
phosphonate 3.49 (97 % e.e) with retention of the stereochemistry (Eq. 3.5). 
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Carretero
4 
employed the chiral ligand (R)-3.20 for the reaction of the palladium !-
allyl with benzyl amine 3.51. The reaction of 3.50 gave compound 3.52 in good yield (80 
%) with excellent enantiopurity (97 % e.e.) as shown in Eq. 3.6. 
 
 
 The imide anion has been used as a nucleophile in palladium-catalyzed reactions. 
The nucleophilic imide anion, potassium phthalimide 3.53 reacted with the allyl substrate 
3.50 in the presence of Pd and ligand (R)-3.55 to yield the aminated product 3.54 in 90 % 
yield with 81 % e.e. as shown in Eq. 3.7.
16 
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Intramolecular amination of the palladium !-allyls was utilized for the preparation 
of nitrogen heterocyclic compounds. The ring size and geometry dictate the 
regioselectivity. Trost
17
 reported the amination of epoxide 3.56 with Pd(dba)3 and the 
phosphite ligand 3.58. The new 6-membered ring compound was formed in 73 % yield 
(Eq. 3.8) Later the endo-macroheterocycle 3.60 was made in 89 % yield by the 
intramolecular amination of the allylic acetate 3.59 using 10 mol% of Pd(PPh3)4 and 8 
mol% of dppb as shown in Eq. 3.9.
18
  
 
 
 Spilling and He
19
 reported that reaction of the amine 3.61 in THF at different 
temperatures provided the different ratios of the (E) and (Z)-products (3.61a and 3.61b) 
(Scheme 3.10). As the reaction temperature decreased, the amount of the (Z)-isomer 
3.61b increased. Thus, it was shown that (Z)-isomer 3.61b is a kinetically controlled 
product (temperature dependent) and the (E)-isomer 3.61a is the thermodynamically 
controlled product. 
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Scheme 3.10 Intramolecular amine addition 
 
3.2.3 Alkoxylation (Oxygen Nucleophile) 
A number of different oxygen nucleophiles have been employed in intermolecular 
palladium-catalyzed allylic etherifications and esterifications. 
 The alkoxylation using a variety of oxygen nucleophiles has been performed by 
Trost.
20
 Triphenylsilanol (Ph3SiOH) acted as a nucleophile to open the epoxide ring of 
compound 3.62 (Eq. 3.10). The triphenylsilyl ether product 3.63 was obtained in 67 % 
yield. 
 
  Using the ligand (S,S)-BPA 3.14b, the substitution reaction of carboxylate 
nucleophile 3.65 with the allylic carbonate 3.64 resulted in the formation of ester 
compound 3.66 in high e.e. (98 % e.e.) (Eq. 3.11).
21
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Phenol and its derivatives are efficient oxygen nucleophiles. The O-alkylation of 
methyl carbon 3.68 with phenol using (R,R)-BPA 3.14a provided ether 3.69 with 98 % 
e.e. (Eq. 3.12).
22
 
 
 
Sinou
23
 also reported on the use of a phenol as a nucleophile in palladium-
catalyzed alkoxylation. The reaction between phenol 3.71 and allylic carbonate 3.70 gave 
ether compound 3.72 in 89% yield (Eq. 3.13). 
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Nucleophilic substitution of allylic acetate 3.73 with trialkyl borate B(OMe)3 3.74 
as a source of methoxy nucleophile using chiral ligand 3.76 provided ether 3.75 in 92 % 
yield and 94 % e.e. (Eq. 3.14).
24
 
 
  
3.3 Asymmetric Synthesis of Tetrahydrofuran and Tetrahydropyran 
Tetrahydrofurans (thf) and tetrahydropyrans (thp) are structures frequently found 
in several important classes of biologically active natural products
25
 such as polyether 
antibiotics, acetogenins, and C-glycosides. Scheme 3.11 shows examples of compounds 
containing the thf and thp ring systems. Mucocin (3.77) is an annanoceous acetogenin, 
which is shown to possess selective activity against A-549 lung and PACA-2 pancreatic 
solid tumor cell lines.
26
 Amphidinolides are biologically active macrocyclic natural 
products. All of the members of the amphidinolide family are cytotoxic.
27
 Lipid 
dihydroxytetrahydrofurans
28
 (3.78, 3.79) which have similar structures are shown to 
inhibit the larval development in parasitic nematodes.
29
 Some cytotoxic compounds such 
as vernolide-A (3.81)
30
 and the methoxylated protolimonoid (3.82)
31
 have shown 
inhibitory activity against trypomastigote forms of Trypanosoma cruzi. Bryostatin 1
32 
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(3.83) is a macrolactone isolated from the marine bryozoan, Bugula neritina, that 
modulates protein kinase C (PKC) activity. Bryostatin 1 sensitizes cancer cells to the 
cytotoxic effects of anti-cancer agents. It was also shown to exhibit selective activity 
against leukemia. The complex macrolide (+)-acutiphycin
 
(3.84), which was first isolated 
in 1984, is known to possess potent in vivo antineoplastic activity against murine Lewis 
lung carcinoma, as well as significant cytotoxicity against KB and NIH/3T3 cell lines.
33
 
The natural source of (+)-acutiphycin (the blue-green alga Oscillatoria acutissima), 
however, no longer produces this metabolite. 
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Scheme 3.11 Tetrahydrofuran and tetrahydropyran containing natural products 
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Due to wide distributions of thf and thp structures and their common occurrence 
in nature,
34
 O-heterocycles are frequent and important targets for synthesis either as final 
products or as useful synthetic intermediates.
35
 The stereoselective construction of thf and 
thp core structures has been achieved by many types of reactions,
36
 for instance, the 
Prins-cyclization,
37,38
 reductive etherification.
39
 However, these methods are sometimes 
specific for either single substrates or unique target molecules due to their particular 
advantages and disadvantages. A number of methods have issues with diastereoselctivity, 
which puts limitations on their applicability. The basic routes (such as oxidative 
cyclization, electrophilic cyclization, etc.) toward the syntheses of thf and thp compounds 
are discussed below. 
  
3.3.1 Oxidative Cyclization 
The oxidation of an olefin 3.85 by potassium permanganate (KMnO4) in aqueous 
media proceeds via a hypomanganate or manganate ester intermediate 3.85b
40
 and results 
in a !-glycol 3.86
41
 (Scheme 3.12). Klein and Rojahn’s
 
oxidation
42
 of 1,5-diene 3.88 with 
KMnO4 under mild condition was used in the synthesis by Wolfe
43
 (Eq. 3.15). The 
reaction formed the thf glycol 3.89 in 20 % yield and ketol 3.90 in 8 % yield (46 % yield 
of 3.89 and unreported % yield of 3.90 as reported by Klein and Rojahn).
42
 Wolfe 
implied that the ketol 3.90
40
 is the normal product of permanganate oxidation of the 
terminal olefin generated from manganate ester intermediate 3.85d in the reaction 
mixture. The oxidative hydrolysis to !-ketol 3.87 formed with dependence on the 
reaction pH resulting in the consequently lower yield of thf ring 3.89. 
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Scheme 3.12 Mechanism of permanganate oxidation of 1,5-diene 
 
 
Substrates other than dienes are also susceptible to oxidative cyclization. 
Dihydroxyalkene 3.91 (Eq. 3.16) was successfully converted into the cis-2,5-
disubstituted thf ring 3.92 using Collin’s reagent (CrO3 and pyridine) and PCC.
44 
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 Epoxidation-cylization reactions are known to yield thf rings.
45,46,47
 The diene 
3.93 underwent a Sharpless epoxidation followed by hydroxy protection (using TsCl) to 
give the bis-epoxide 3.94.
48
 Deprotection of the isopropylidene (using Amberlyst 15) 
resulted in the exo-attack of the bis-hydroxy group on the bis-epoxide in intermediate 
3.95 giving the bis-thf compound 3.96 in 30 - 40 % yield (Scheme 3.13). 
 
Scheme 3.13 The epoxidation-cyclization of diene 
 
The treatment of the !,"-unsaturated alcohol 3.97 with t-BuOOH and 
VO(acac)2
49,50
 in toluene yielded the mixture of trans-thf 3.99a as the major product and 
cis-thf 3.99b as the minor product (Scheme 3.14). The stereochemistry favored 
intermediate 3.98a in which the epoxide ring is inclined away from sterically bulky group 
R’ and R”’.  
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Scheme 3.14 The epoxidation-cyclization of ! ,"-unsaturated alcohol 
 
In 2006, Krause
51
 demonstrated the tandem cycloisomerization-hydroalkoxylation 
of homopropargylic alcohols 3.100 using a dual catalyst system consisting of gold 
precatalyst, such as AuCl, AuCl3 or Au(OH)3 and a Brønsted acid p-TsOH (Eq. 3.17). 
The homopropargyl alcohol 3.100 was treated with catalytic amounts of a gold salt and 
10 mol% of p-TsOH in alcohol 3.101 as solvent at room temperature for 3 – 6 h. The 
transition metal catalyzed reaction led to the formation of the tetrahydrofuranyl ethers 
3.102 in 53 – 76 % yield. The proposed mechanism
51
 is shown below in Scheme 3.15 
where the acetal 3.102 was formed by gold-catalyzed cycloisomerization
52
 of the alcohol 
3.100 to the corresponding 2,3-dihydrofuran 3.103, followed by an acid-catalyzed 
hydroalkoxylation
53
 of the dihydrofuran 3.103. 
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Scheme 3.15 The mechanism of tandem gold catalyzed cycloisomerization-acid 
catalyzed hydroalkoxylation of homopropargylic alcohol
 
 
Yang et al.
54
 developed an efficient and regioselective Yb(OTf)3-promoted 
palladium-catalyzed oxidative cyclization of alkenyl !-keto amides 3.104 (Eq. 3.18). The 
reaction was carried out using PdCl2(MeCN)2 (10 mol%), and Yb(OTf)3 (1 eq) as 
catalysts in dry THF under 1 atm pressure of O2 at ambient temperature. Under simple 
aerobic conditions for 4 -5 h, various six-membered-O-heterocycles 3.105 could be 
obtained in 54 – 98 % yield through oxidative formation of the C-C bond.  
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The mechanism that was proposed for the reaction is as follows: Yb(OTf)3 acted as a 
Lewis acid to promote the enol formation of 3.106 followed by intramolecular attack of 
the nucleophilic enol toward Pd(II)-activated olefin
55
 (Scheme 3.16). The next step was 
!-H elimination followed by Pd-migration which led to the formation of the intermediate 
3.108. Selective !-H elimination of 3.108 resulted in the final product 3.105. The 
completion of the catalytic cycle occurred by the reoxidation of Pd(0) to active Pd(II) 
species using molecular oxygen as the terminal oxidant.
56 
Scheme 3.16 The mechanism of palladium-catalyzed oxidative cyclization of 
alkenyl keto amides in the presence of Yb(OTf)3 
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Chamberlin
57a
 demonstrated that the carbonyl group was a viable nucleophile for 
the intramolecular ring opening addition of the activated epoxide 3.109 (Scheme 3.17). 
The treatment of the !,"-substituted epoxy ketone 3.109 with a Lewis acid such as BH3 
and BF3 resulted in intermediate cyclic oxacarbenium ions (3.110a and 3.110b) which 
were then stereoselctively reduced in situ. The sterochemical control in the reaction 
depends on whether the reduction is intra- or intermolecular. In the presence of BH3, 
which acted as both a Lewis acid and a reducing agent. Delivery of the hydride 
intramolecularly was favored and trans-2,5-disubstituted thf 3.111a resulted in the ratio 
of cis : trans 1 : 24 in 77 % yield. On the other hand, when BF3 was used as a Lewis acid 
and triphenylsilane was used as the hydride source, the intermolecular reduction was 
favored and cis-2,5-disubstituted thf 3.111b resulted in the ratio of trans : cis 1 : 5 in 43 
% yield. 
 
 
Scheme 3.17 Intramolecular ring opening addition of activated epoxide with 
carbonyl group 
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In the reaction of 3.109 with TMSOTf, the resulting oxocarbenium ion 3.112 can 
also be trapped with various other nucleophiles
57b
 to afford the cis-substituted thf 
compound 3.113 (Scheme 3.18). 
 
Scheme 3.18 Stereochemical control in the nuleophilic reaction of oxocarbenium ion 
formed by intramolecular ring opening of epoxide by neighboring carbonyl groups 
 
The electronic influence on the stereoselectivity of the nucleophilic addition of 
allyl trimethylsilane 3.116 to the thp oxocarbenium ion 3.115 was explored by Woerpel
58
 
(Scheme 3.19). It was reported that the presence of an electropositive substitutent such as 
an alkyl group (example: Me; Entry 1 and CH2Bn; Entry 2) on the oxocarbenium ion 
3.115 led to the formation of product 3.117 with opposite diastereoselectivities as 
compared to the product obtained due to the presence of alkoxy group substituent such as 
OBn (Entry 3). An alkyl group preferred the pseudoequatorial position in the transition 
state giving the 2,5-cis stereoselectivity (Scheme 3.20). On the other hand, the alkoxy 
group preferred the pseudoaxial position leading to the 2,5-trans stereoselectivity. 
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Scheme 3.19 The addition of cyclic oxocarbenium ion with allyl trimethylsilane 
 
 
Scheme 3.20 The different transition states of cyclic oxocarbenium ion with allyl 
trimethylsilane leading to different diastereoselectivity 
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The loss of the stereoselectivity of the same reaction was later demonstrated in 
2006 by Woerpel.
60
 It was observed that addition of a highly reactive nucleophile like 
Me3SiCN 3.118 (as compared to the weak nucleophile allyl trimethylsilane 3.116, Entry 
4), to the substituted cyclic oxocarbenium ion 3.115 in the presence of BF3.OEt2 resulted 
in the erosion of stereochemistry as shown in Scheme 3.21 (Entry 5). 
 
 
Scheme 3.21 The nucleophilic addition of cyclic oxocarbenium ion 
 
The study showed that (Scheme 3.22) the selectivity for the reaction using the 
highly reactive nucleophile 3.118 was based on the rate of formation of the initially 
formed ion pair 3.119, k1, rather than the rate of nucleophilic capture, kNu. The ion pair 
3.119 was more stable than its dissociated ions 3.118 and 3.115. The faster rate of the 
nucleophilic capture, compared to the slower dissociation rate (kNu > k-1) resulted in the 
uncontrolled stereoselectivity outcome. 
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Scheme 3.22 The nucleophilic addition of cyclic oxocarbenium 
 
3.3.2 The Electrophilic Cyclization  
 The treatment of the !,"-unsaturated alcohol (Scheme 3.23), with electrophilic 
reagents such as I2
 
(Eq. 3.19), PhSeCl (Eq. 3.20), or Hg(OAc)2/NaBH4 (Eq. 3.21 and 
3.22) results in the electrophilic cyclization. As shown in Eq. 3.19, the reaction of !,"-
unsaturated alcohol 3.120 (R = H) with iodine gave a mixture of the cis- and trans-iodo 
thf compounds 3.121a and 3.121b.
47
 The trans-3.121b was favored in the iodocyclization 
(trans/cis = 2 : 1). However, cis-3.121a became preferable over trans-3.121b (trans/cis = 
1 : 2 and 1 : 28) when changing to ether derivative (R = Bn and t-Bu, respectively).  
 The reaction between benzyl alcohol 3.122 and PhSeCl gave product 3.123a and 
3.123b in the ratio of trans/cis = 3 : 2 via the selenocyclization (Eq. 3.20).
61 
Surprisingly, 
in the presence of K2CO3, the stereochemistry changed to favor cis-3.123a (ratio of 
trans/cis = 3 : 17). 
 A 2,5-disubstituted thf product can be prepared via mercuricyclization,
62
 for 
example, in the reaction of 3.124 and 3.126 (Eq. 3.21 and 3.22)
 
with a mercury salt such 
as Hg(OAc)2. After the removal of the mercury group via reduction with NaBH4, the 
reaction gave good stereoselectivity in favor of the trans-cyclized products 3.125b and 
3.127b (in the ratio of trans/cis = 84 : 16 and 81 : 19 for the Eq. 3.21 and 3.22, 
respectively).   
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Scheme 3.23 The electrophilic cyclization of ! ,"-unsaturated alcohol 
 
In 2005, intramolecular hydro-O-alkylation of aldehyde substrates 3.128 leading 
to spiroketals 3.129 was reported by Sames et al.
63
 (Scheme 3.24). The direct 
transformation of a C-H bond to a C-O bond under the influence of a catalytic amount of 
a Lewis acid (30 – 50 mol%) was occured via a tandem hydride transfer/cyclization 
sequence. 
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Scheme 3.24 The electrophilic Lewis acid catalyzed  
hydride transfer/cyclization of aldehyde 
 
 In 2007, Hall
64
 reported the triflic acid (TfOH) catalyzed addition of 2-alkoxy-
carbonyl allylboronates 3.130 to aldehydes 3.131 (Scheme 3.25). This methodology 
allowed access to the !,"-disubstituted 5-membered ring lactones 3.132, with an exo-
methylene at the #-position, in good yield with a diastereoselectivity of > 19 : 1 (trans : 
cis). The mechanism involved a carbocation intermediate 3.135 as the source of 
stereochemical inversion (Scheme 3.26).  Hall et al. carried out 
18
O labeling studies to 
track the path of the aldehyde oxygen in the reaction sequence. The study showed that 
none of the aldehyde oxygen was present in the final lactone product 3.132. The 
mechanism that they proposed was that the initially formed borate product 3.133 led to 
the formation of a carbocation intermediate 3.134. The next step involved capture of the 
carbocation 3.134 by the neighboring ester (either be before or after the bond rotation). 
This led to the observed diastereoselectivities in the lactone product 3.132.  
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Scheme 3.25 Triflic acid-catalyzed allylboration/lactonization 
 
Scheme 3.26 Triflic acid-catalyzed allylboration/lactonization mechanism 
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Recently, the intramolecular PIFA [phenyliodine(III)-bis(trifluoroacetate)]-
mediated alkyne carboxylation reaction was demonstrated by Tellituu
65
 (Scheme 3.27). 
The efficient intramolecular electrophilic cyclization of easily accessible alkynyl 
carboxylic acids 3.135 was promoted by PIFA 3.136 leading to the lactone skeleton 
3.138. A mechanistic proposal for these transformations is shown in Scheme 3.28. The 
mechanism involves activation of the triple bond of the substrate 3.135 by PIFA 3.136 
which leads to the formation of an electrophilic intermediate 3.137 which further reacts 
intramolecularly with the nucleophilic carboxyl group. 
 
 
 
Scheme 3.27 PIFA-mediated intramolecular alkyne carboxylation 
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Scheme 3.28 The mechanism of PIFA-mediated intramolecular alkynecarboxylation 
 
3.3.3 Reductive Cyclization 
Reductive cyclization is one of the most stereoselective and high-yielding 
methods to obtain cyclic ethers.
66 
Some examples are described below.  
In 2003, Solladié et al.
67
 reported the stereocontrolled formation of a cis-2,5-
disubstituted thf and a cis-2,6-disubstituted thp (Eq. 3.23). Reductive cyclization of the 
hydroxysulfinyl arylketone 3.139a with TMSOTf (1 eq), followed by treatment with an 
excess of Et3SiH (2 – 5 eq) gave rise to only one diastereomer of the thp derivative 
3.140a in 81 % yield in 15 min. On the other hand, under the same conditions, the 
reaction of methylketone 3.139b underwent the 1 hour-cyclization with competitive 
enolization giving the thp derivative 3.140b in low yield (43 %). Changing the order of 
the reagent addition by first adding Et3SiH, followed by TMSOTf, the reaction of 3.139b  
led to better yield (97 %) of 3.140b.  
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 The invention of catalytic methods for the reductive coupling of alkynes and 
aldehydes has been the subject of recent investigation.
68
 In 2006, Krische et al.
69
 
demonstrated the first catalytic enantioselective reductive cyclization of an acetylenic 
aldehyde (Eq. 3.24). The catalytic hydrogenation of 3.141 using a chirally modified 
cationic rhodium catalyst derived from Rh(COD)2OTf and phosphine enabled a highly 
enantioselective reductive cyclization to afford cyclic alkylidene furan 3.144 in good 
yield (73 %) with high enantioselectivity (99 % e.e.). The reaction was carried out by 
treating a 1,2-dichloroethane solution (0.1 M) of substrate 3.141 with hydrogen (1 atm) at 
45°C and 2-naphthoic acid 3.142 using the cationic catalyst precursor Rh(COD)2OTf and 
(R)-Cl,MeO-BIPHEP 3.143 as a ligand.
70
 The catalytic mechanism involves an oxidative 
coupling, followed by hydrogenolytic cleavage of the resulting metallacycle via !-bond 
metathesis (Scheme 3.29). It was proposed that the addition of the Brønsted acid (2-
naphthoic acid 3.142) either helped the cleavage of the metallacyclic intermediate
71
 3.145 
or suppressed the proton loss from cationic rhodium dihydrides which led to the neutral 
monohydride complexes 3.146, and are typically less prone to engage in oxidative 
coupling pathways.
72 
The addition of Brønsted acid 3.142 was believed to increase both 
rate and conversion in hydrogen mediated C-C coupling reactions of alkynes to a 
carbonyl partner.
71 
 202 
 
 
 
Scheme 3.29 The catalytic cycle mechanism of diastereoselective reductive 
cyclization of acetylenic aldehydes via rhodium catalyzed hydrogenation 
 
Keck et al.
73
 recently showed a synthetic approach to 2-hydroxy thp derivatives 
3.149 via SmI2 promoted cyclization (Scheme 3.29a). The treatment of iodide 3.147 with 
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SmI2 led to the intramolecular reductive cyclization which gave rise to the resulting 
product 3.149 in good to quantitative yield. 
 
Scheme 3.29a The SmI2 promoted cyclization to the synthesis of 2-alkoxy pyran 
 
3.3.4 Transition Metal Catalyzed Cyclization 
Due to their well-known ability to activate the carbon-carbon multiple bond,
74
 a 
number of transition metals such as Pt, Au, Cu, Ag, Ti, Ir, etc. have successfully been 
utilized as catalysts in the synthesis of cyclic ether containing natural products.
75 
 
In 2004, Weidenhoefer et al.
76
 reported that the intramolecular hydroalkoxylation 
of unactivated !- and "-hydroxy olefins can be catalyzed by platinum(II) complexes 
[PtCl2(H2C=CH2)2]2 3.151 (Eq. 3.25). The platinum-catalyzed hydroalkoxylation of !- 
and "-hydroxy olefins 3.150 tolerated various substitution patterns and a number of 
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functional groups (R) including pivaloate and acetate esters, amides, silyl and benzyl 
ethers, and pendant hydroxyl and olefinic groups. The effect of various solvents (dioxane, 
CCl4, dichloroethane) and phosphine ligands (PPh3, P(OMe)3, P(p-C6H4Cl)3, P(2-furyl)3, 
P(p-C6H4OMe)3, P[3,5-C6H3(CF3)2]3 were also examined. After testing the various 
ligands and solvents, Cl2CHCHCl2 and P(p-C6H4CF3)3 were chosen to be the solvent and 
ligand of choice, respectively. The reaction was carried out using 1 mol% catalyst 3.151 
which gave the corresponding products 3.152 in 43 – 98 % yield. 
 
  
A couple of years later, Weidenhoefer
77
 showed that the Au(I)-catalyzed 
intramolecular hydroalkoxylation of !-hydroxy and "-hydroxy allenes was an effective 
method for the formation of various corresponding cyclic ethers. Treatment of !-hydroxy 
and "-hydroxy allenes 3.153 with 5 mol% of Au(I) catalyst 3.154 and 5 mol% of AgOTs 
at ambient temperature afforded the corresponding oxygen heterocycles 3.155 in 75 – 99 
% yield (Eq. 3.26).  
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The regioselectivity of Au-catalyzed hydroalkoxylation of hydroxyallene 3.156 
depended primarily on the catalyst system. 4,5-Hexadienylalcohol 3.156 underwent 
Au(I)-catalyzed intramolecular hydroalkoxylation catalyzed by 3.157 and AgOTf 
(Scheme 3.30), which led to the formation of a mixture of thf 3.158 (48 %) and 
dihydropyran 3.159 (37 %). It was observed that when AgOTs was used as a catalyst 
(instead of AgOTf), the speed of the reaction improved drastically. The reaction occurred 
in 3 minutes with high exo-selectivity resulting mainly in the thf 3.158 in good yield (98 
%). It was also reported that in the absence of Au(I) catalyst 3.157, under the similar 
conditions, no consumption of the substrate was detected after 48 h.  
 
 
Scheme 3.30 Au(I)-catalyzed intramolecular hydroalkoxylation of hydroxyallene 
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Another synthesis of lactones employing a gold (Au(I)) catalyzed cyclization (Eq. 
3.27) was reported by Genêt and Michelet.
78
 A highly efficient gold-catalyzed cyclization 
reaction of various functionalized acetylenic acids 3.160 was carried out at room 
temperature using 5 mol% AuCl in acetonitrile. The reaction underwent exo-selectively 
leading to the functionalized !-lactones 3.161 in good to excellent yields ranging from 72 
– 98 %. The reaction conditions were compatible with several functional groups, such as 
ester, alkene, alkyne, chloro, and free or protected alcohol. 
 
 
Genêt and Michelet
79
 also reported an Ir(I) catalyzed tandem cycloisomerization/ 
hydroalkoxylation of bis-homopropargylic alcohol. This was found to be an efficient, 
selective, and economical method for accessing the ketal building blocks 3.165 (Eq. 
3.28).The bis-homopropargylic alcohol 3.162 was treated with a catalytic amount of 
[{Ir(cod)Cl}2] 3.164 at room temperature in the presence of solvents 3.163 such as 
methanol, ethanol, or allyl alcohol which led to the formation of the product 3.165 in 71 
to 99% yield.  
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The mechanism involving a metal-vinylidene intermediate was ruled out because of the 
absence of the expected 6-endo-cyclization. Since the reaction showed preference 
towards exo-selectivity, the mechanism shown in Scheme 3.31 was proposed. The first 
step involves the Lewis acid type activation of the Ir(I) catalyst 3.164 followed by 
treatment with the alkyne 3.162 which leads to the formation of the complex 3.166. The 
next step is the intramolecular cyclization of the hydroxy group which occurrs anti to the 
!-complex 3.166 resulting in the !-complex 3.167. Protonolysis (proton transfer) 
followed by the addition of the alcohol solvent 3.163 leads to the formation of the cyclic 
ketal 3.165 in an exo-fashion. 
 
Scheme 3.31 The mechanism of the formation of cyclic ketal  
from bis-homopropargylic alcohol via Ir(I) catalysis 
 
Recently, Li et al.
80
 reported the copper-catalyzed intramolecular coupling of the 
vinyl bromides with alcohols (Scheme 3.32). Using the optimized conditions based on the 
effect of ligand and base, the intramolecular O-vinylation of "-bromohomoallylic alcohol 
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3.168 (n = 0) with 10 mol% of CuI as the catalyst, 2 eq of Cs2CO3 as a base and 20 mol% 
of 1,10-phenanthroline 3.172 as the ligand in refluxing acetonitrile led to the formation of 
the corresponding 2-methyleneoxetanes 3.169 in good to excellent yields via a 4-exo ring 
closure. Although the reason for the preference of 4-exo cyclization was not clear, it was 
believed that Cu(I) possibly coordinated to the alkoxide prior to its oxidative insertion 
into the C-Br bond. Another reason is that the transition state for 4-exo cyclization as a 
Cu-containing five-membered ring structure could be sterically more easily accessible 
and thermodynamically more stable than that of the corresponding 5-exo, 6-exo, or 6-
endo cyclization. Under the same conditions, in the same way with the reaction of other 
substrates (n = 1 and 2) also led to 5-and 6-exo ring closure over other cyclization modes 
and led to the formation of 3.170 and 3.171, respectively.    
 
Scheme 3.32 Copper-catalyzed intramolecular coupling of vinyl bromides 
with alcohols 
 
Krische et al.
81
 reported the first use of a cationic silver complex (AgSbF4) as a 
catalyst for intra- and intermolecular alkyne-carbonyl coupling reactions (Scheme 3.33). 
The alkyne 3.173 represents the synthetic equivalent of the Wittig reagent 3.174 (Figure 
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3.2). This transformation in which the intramolecular reaction leads to the formation of 
conjugated enone thf 3.175 was originally aimed to serve as an economical alternate to 
the use of stabilized Wittig reagents in carbonyl olefination. The major disadvantage of 
the Wittig reaction is the generation of the undesired triphenylphosphine oxide. The 
intramolecular coupling of alkyne and carbonyl neighboring group of 3.173 was 
catalyzed by AgSbF6. The result obtained was compared to the corresponding Brønsted 
acid (HBF4) and Lewis acid (BF3) catalyst systems,
 
which were the typical catalyst used 
in the Wittig reaction.
82 
The results of the intramolecular cyclization of the substrate 
3.173 using three different catalyst systems are shown below in Scheme 3.33.  The 
reaction of the alkyne 3.173 (R = Ph, R’= H) with small amounts of AgSbF6 gave the 
resulting product 3.175 in better yield as compared to those obtained with BF3(OEt2) and 
HBF4. 
 
Figure 3.2 The aldehyde as the synthetic equivalent of Wittig reagent in the 
Krische’s reaction 
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Scheme 3.33 Intramolecular alkyne-carbonyl coupling catalyzed 
by AgSbF6, HBF4, and BF3(OEt2) 
The silver(I) triflate catalyzed intramolecular additions of hydroxyl or carboxyl 
groups to the olefins was shown by He et al.
83
 Treatment of the alcohol 3.176 (Eq. 3.29) 
and the carboxylic acid 3.177 (Eq. 3.30) using 5 mol% AgOTf led to the formation of the 
cyclic ethers (3.178 or 3.180) or lactones (3.179 or 3.181) in good to excellent yields (71 
– 98 %) with high regioselectivity (either 100 : 0 or > 10 : 1). A variety of substrates 
could be subjected to this reaction under relatively mild conditions. 
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In 2004, Franck and Figadère.
84
 reported the synthesis of trans-2,5-disubstituted 
thf 3.185a with very good stereoselectivity (trans : cis up to 100 : 0) (Scheme 3.34). The 
treatment of !-lactol (derived from (S)-glutamic acid (3.183a, 3.183b) with chiral N-
acetyloxazolidin-2-thione (3.182a, 3.182b) as an nucleophile in the presence of both 1 eq 
of titanium(IV) chloride (TiCl4) and diisopropylethyl amine (DIPEA) led to the formation 
of the product 3.185a and 3.185b. The proposed mechanism was that the chlorotitanium 
enolate of 3.182a (or 3.182b) reacted with the lactol acetate (3.183a, 3.183b). The adduct 
3.184a and 3.184b that was obtained was directly transesterified to the trans- and cis-
methyl ester (3.185a and 3.185b). In this case the absolute configuration (R or S-) and the 
bulkiness (R = H or Ph) of the nucleophile oxazolidithione 3.182a and 3.182b and the 
protecting group (R’ = TBDPS or TBDMS) of lactol ester 3.183a and 3.183b played an 
important role in giving the high diastereoselctivity. Reaction of the chlorotitanium 
enolate of (R)-3.182a with lactol acetate 3.183a, followed by methanolysis resulted in the 
methyl ester 3.185a and 3.185b in 55 % yield with 77 : 23 d.s ratio (Entry 1). Replacing 
(R)-3.182a with the more bulky oxazolidin-2-thione (R)-3.182b gave the product with 
exclusive d.s ratio of 100 : 0 (Entry 2). Conversely, substitution of TBDPS with a less 
bulky protecting group like TBDMS (3.183b) gave rise to lower diastereoselectivity (90 : 
10, Entry 3). The reaction of titanium enolate of (S)-3.182b with 3.183b, under the same 
condition, produced the methyl ester in the same yield (51 %) with lower 
diastereoselectivity (75 : 25, Entry 4). 
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Scheme 3.34 Diastereoselective addition of the titanium enolate of oxazolidin-2-
thione, followed by methanolysis 
 
3.3.5 Pd Catalyzed Asymmetric Cyclization  
 Palladium has been one of the most commonly used transition metal catalysts in 
the stereoselective synthesis of heterocycles.
85
 Pd-catalysts have also been used for the 
synthesis of thf and thp containing molecules.
86
  
A stereoselective palladium-catalyzed method for the synthesis of substituted 
tetrahydrofurans 3.189a and 3.189b from !-hydroxy alkenes 3.186 and aryl bromides 
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3.188a and 3.188b was reported by Wolfe and co-workers
87
 (Scheme 3.35). The reaction 
employed the use of 1 mol% of Pd2(dba)3 and 2 mol% of DPEphos 3.187 as a ligand.  
 
Scheme 3.35 Tetrahydrofuran synthesis via the palladium-catalyzed reaction of  
!-hydroxy alkenes and aryl bromides 
 
The mechanism proposed for this reaction was as follows (Scheme 3.36). The reaction of 
ArBr and Pd2(dba)3 resulted in the formation of a Heck organopalladium adduct, 
LnPd(Ar)Br, 3.190 which was then captured by the alcohol 3.186. The resulting 
Pd(Ar)(OR) intermediate 3.191a
88
 underwent the intramolecular insertion of the olefin 
into the Pd-O bond
89
 (Path 1) followed by C-C bond-forming reductive elimination.
90
 
The intermediate 3.190 could alternatively undergo insertion of the olefin into the Pd-C 
bond followed by sp
3
 C-O bond-forming reductive elimination (Path 2).
91
 By both 
mechanisms the final resulting product 3.189 was formed with both a C-C and a C-O 
bond in preference of anti-1’,2 stereochemistry with high 2,5-diastereoselectivities (> 20 
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: 1). Related transformations using Pt- or Ni-complexes are rare and needed 
stoichiometric amounts of reagents in the reaction.
89,91 
 
 
Scheme 3.36 The mechanism of tetrahydrofuran synthesis via the palladium-
catalyzed reaction of !-hydroxy alkene and aryl bromide 
 
The enolate oxygen can act as a nucleophile in the intramolecular addition of 
allylic substrates according to the Hayashi’s study
92
 (Eq. 3.31). Allylic carbonate 3.190 
was cyclized in the presence of Pd(0) to yield both (R)- and (S)- 3.191a and 3.191b in the 
ratio of 3 : 1 in 97 % e.e. (98 % overall yield). 
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The stereocontrolled synthesis of the highly substituted thf core of fragment 3.194 
of amphidinolide K 3.195 was carried out via palladium-induced cyclization (Eq. 3.32, 
Scheme 3.37).
93
 The syn-1,4-diol benzoate precursor 3.193a was slowly introduced into 
the reaction mixture of NaH, Me3SnCl and Pd(0) catalyst in THF at 60
o
C. The cis-2,5- 
disubstituted thf 3.194 was formed in 88 % yield with a ratio of cis/trans 13 : 1. 
Surprisingly, (Eq. 3.33) when starting with anti-1,4-diol derivative 3.193b, the product 
cis-2,5-disubstituted thf 3.194 was still formed in 71 % yield with a ratio of  cis : trans = 
12 : 1. This implied that the stereochemistry of the thf ring formed was independent of 
those of precursors. 
 
Scheme 3.37 The synthesis of thf core of amphidinolide K 
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Trost’s ligands (R,R)-BPA 3.14a and (S,S)-BPA 3.14b were employed in the 
construction of thf and thp rings by Burke.
94
 The meso diol 3.195a was cyclo 
desymmetrized in the palladium(0) catalyzed cyclization using (R,R)-BPA 3.14a (Eq. 
3.34) resulting in cis-thf 3.196 in 81 % yield.
94a
 The reaction of 3.195b led to the 
formation of the major product 3.196 (trans-stereochemistry) in 87 % yield (Eq. 3.35). 
Similarly, in the presence of (S,S)-BPA 3.14b, with substrate 3.197, the reaction gave thp 
3.198 in 96 % yield (Eq. 3.36).
94b 
 
 
Fagnou et al.
95
 employed a novel phosphine ligand 3.199 in the intramolecular 
formation of biaryl compounds such as 3.200 shown in Eq. 3.37. A highly active and 
robust catalyst system of 5 mol% of Pd(OAc)2 and 0.1 mol% 2-(diphenylphosphino)-2’-
(N,N-dimethylamino)biphenyl 3.199 as a ligand allowed the intramolecular arylation 
reaction of aryl bromide 3.200
96
 with excellent reactivity. In the presence of K2CO3, the 
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3.201 was generated in 96 % yield and 4 % of the undesired debrominated ether 3.202. 
The highlight of the reaction was the use of such a lower catalyst loading (as little as 0.1 
mol%) as compared to similar transformations.
97 
 
 
Palladium-catalyzed intramolecular enyne coupling reactions were reported in 
2005 by Lu.
98
 The reaction of substrates 3.203a proceeded smoothly in the presence of 
Pd(OAc)2 and 2.2’-bipyridine 3.204 as a ligand (Eq. 3.38). The O-heterocycles products  
3.205a were obtained in moderate to good yields. Indeed, most of electron-rich alkyne 
substrates (tethered atom = N, O) can proceed smoothly to afford desirable cyclization 
products in this catalytic system. 
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The reaction involved the acetoxypalladation of the alkyne 3.203a, followed by the 
insertion of the alkene and the protonolysis of the carbon-palladium bond as shown in 
Scheme 3.38. 
 
Scheme 3.38 The mechanism of Pd(II)-catalyzed intramolecular  
enyne coupling reactions 
 
The tethering group significantly affected the electronic nature of the alkyne and 
influenced the competition between the protonolysis step and the olefin insertion. As an 
example, Pd(II)-catalyzed reaction of 3.203b under the same catalytic system, led to the 
compound 3.205b which is the simple hydroacetoxylation product in a low yield (Eq. 
3.39). The protonolysis of the vinylpalladium species which is formed from 
acetoxypalladation of alkynoates before the insertion of the olefinic double bond resulted 
in the compound 3.206 with 14 % yield. 
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Recently, Morken et al.
99
 reported the stereoselective synthesis of furans by the 
palladium-catalyzed reaction of acyclic allylic alcohol based on previously reported 
studies. According to Oshima and Utimoto’s study in1987,
100
 the reaction of vinyl ethers 
3.208 with allyl alcohols 3.207a afforded substituted five-membered cyclic acetals 
3.209a using 0.3 - 1 eq of Pd(OAc)2 (Eq. 3.40). Although Larock
101
 had studied the 
stereoselection of this reaction, the cyclic allylic alcohols were the substrates used. 
Morken showed the reaction of acyclic substrates 3.207 with vinyl ethers 3.208 using 
0.025 – 0.1 eq of  Pd(OAc)2
 
as a catalyst in the presence of 2.5 eq of Cu(OAc)2 as an 
effectively stoichiometric oxidant in acetonitrile solvent (Eq. 3.41). The reaction is 
applicable for a number of functional groups and provided cyclic acetals 3.209 with good 
stereoselection (> 15 : 1 d.s ratio) in 36 – 75 % yield. 
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The reaction proceeded by the generation of oxonium ion 3.210 derived from the vinyl 
ether 3.208 and the palladium(II) catalyst (Scheme 3.39). The addition of the allylic 
alcohol 3.207 to the oxonium ion 3.210 gave the complex 3.211. Subsequent 
stereoselective carbopalladation of the tethered alkene through a chair-like transition 
structure 3.212 gave rise to the high stereoselectivity. The !-H elimination of 3.213 
resulted in the furan product 3.209 in a stereoselective manner. 
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Scheme 3.39 The mechanism of stereoselective synthesis of furans by  
the Pd catalyzed Oshima-Utimoto reaction 
 
In 2005, the palladium(0) catalyzed intramolecular addition of oxygen 
nucleophiles of an allylic phosphonate was studied by Spilling.
19
 The reaction was 
initially performed on the racemic compound (Eq. 3.42 and 3.43). The functionalized 
racemic phosphonate with primary and tertiary alcohols (3.214 and 3.216) underwent 
cyclization in the presence of Pd(0) and diisopropyl ethylamine to result in the thf vinyl 
phosphonates 3.215 and 3.217 in good yield (79 and 73 %, respectively). The thp 
structure was also prepared using the same route starting from non-racemic 3.218a (71 % 
e.e.) (Eq. 3.44). The chirality of 3.218a was transferred completely to thp product 3.219a. 
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Thus, the intramolecular addition of oxygen nucleophile to the allylic phosphonate 
proceed stereospecifically.    
 
  
 Based on this information, further study on the methodology and the application 
of palladium-catalyzed intramolecular addition of phosphono allylic carbonate via 
functionalized precursor are described in the result and discussion part of this thesis. 
 
3.3.6 The Trapping of Hemiacetals  
 There are many literature examples of hemiacetal formations that were found to 
be of interest for the synthesis of thf and thp rings. For instance, in 1974, Overman
102 
reported that the reaction between allylic alcohol 3.220 and trichloro-acetaldehyde 
(chloral, 3.221) led to the formation of hemiacetal 3.222 (Scheme 3.40). The addition of 
mercury(II) trifluoroacetate, Hg(OCOCF3)2 in the hemiacetal mediated reaction allowed  
 223 
the oxymercuration to afford acetal 3.224 and diol 3.225 after removal of mercury and 
reduction of the CHCCl3 group.  
 
 
Scheme 3.40 The diol and acetal formed in the hemiacetal mediated reaction 
 
Bloodworth et al
103
 reported the preparation of 1,2,4-trioxanes 3.230 which is a 
moiety contained in the plant extract qinghaosu 3.231
104,59
 (Scheme 3.41). The peroxide 
fraction was proved to be associated with the antimalarial activity of the qinghaosu 3.231. 
The one pot intramolecular mercury(II) acetate-mediated cyclization of hemiperacetal 
3.228 derived from allylic hydroperoxide 3.227 gave rise to the formation of 
organomercurial 3.229. The cis-configuration of 3.229 was produced as a predominant 
isomer (80 - 90 %) since both R and CH2HgBr groups could adopt the equatorial 
position. Removal of bromomercury gave 1,2,4-trioxane 3.230. 
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Scheme 3.41 The one pot intramolecular mercury(II) acetate-mediated cyclization  
of hemiperacetal 
 
 In addition, in 2000 Leighton
105
 showed that 1,3-polyols 3.235 could prepare by 
the oxymecuration of a hemiacetal 3.234 derived from a homoallylic alcohol 3.232 
(Scheme 3.42). The desired hemiacetal 3.234 was formed from the reaction between 
homoallylic alcohol 3.232 and aliphatic aldehyde 3.233. Treatment of the alchol 3.232 
(R’ = n-oct) with propanal 3.233 provided 3.235 in 77 % yield with the overall 
diastereoselectivity > 10 : 1. 
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Scheme 3.42 Hemiacetal as nucleophile in the acetal formation 
 
The palladium mediated cyclization of !-oxoallene 3.236 with carbon monoxide 
and methanol was described by Walkup
106
 (Eq. 3.45). Similar reaction conditions had 
been used earlier for constructing compounds 3.237 derived from !-hydroxyoxoallene 
3.236.
106a,106b 
 
 
Under the same conditions as Eq. 3.45, the asymmetric reaction of aldehyde analogs of 
alcohol (R = H, 3.236a) resulted in complex mixtures (cis and trans) of products. 
However, in order to apply the methodology to the synthesis of nucleoside analog 
3.238,
119
 propylene oxide 3.239 as an acid sink and triethyl orthoacetate 3.240 as a water 
scavenger (according to the Tamaru’s literature)
129
 were employed (Scheme 3.43). The 
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reaction led to the clean conversion of 3.236a and 3.236b and gave the furanoside 
(3.237a and 3.237b) as a single diastereomer via the one-pot palladium(II) mediated 
acetalization-cyclization-methoxycarbonylation procedure.
107
  
 
Scheme 3.43 Hemiacetal formation in the syntheses of nucleoside analog 
 
Spilling and Thanavaro
108
 reported that when using allylic hydroxy phosphonate 
3.241 in a mixture of propanal and CDCl3, there was an equilibrium concentration of both 
hemiacetal diastereomers 3.242 formed. This was observed by 
31
P NMR analysis as 
shown in Scheme 3.44. The formation of organomercurial intermediate 3.243 was rapid 
and complete upon addition of Hg(O2CCF3)2. The removal of propanal, followed by 
demercuration with NaBH4 or NaCNBH3 afforded cyclic acetal 3.245 in moderate to high 
yields. 
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Scheme 3.44 Hemiacetal formation with allylic phosphonates 
 
3.4 Stereoselective Synthesis of (-)-Centrolobine 
(-)-Centrolobine
109
 (3.6b, Figure 3.3) is a tetrahydropyranic antibiotic which is 
isolated from the heartwood of Centrolobium robustum (porcupine tree) and the stem of 
Brosimum potabile. This natural product shows activity against “Leishmania 
amazonensis promastigotes”, which is a major health problem in Brazil. Promastigote is 
one of the morphological stages in the development of certain protozoa such as 
Leishmania. “Leishmaniasis” is a zoonotic disease caused by the protozoa of the genus 
Leishmania, which is transmitted to the host through the bite of an infected sand fly. The 
disease is characterized by a variety of clinical manifestations, depending on the 
Leishmania species involved and the type of immune response mounted by the host. 
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Figure 3.3 (-)-Centrolobine natural product and its unnatural enantiomer 
 
The asymmetric synthesis of (-)-centrolobine 3.6b has been reported by several 
groups.
37,38,110,111
 For example, in 2002, Solladié
38
 reported the first enantioselective 
synthesis of (-)-centrolobine based on aldehyde 3.246b, which was prepared from the 
intramolecular cyclization of diastereomerically pure 3.247. Ketone 3.247 was derived 
from enantiopure !-keto sulfoxide 3.248 via the stereoselective reduction. The compound 
3.248 was prepared via the condensation between glutaric anhydride 3.249 and (+)-(R)-
methyl-p-tolyl sulfoxide 3.250 (Scheme 3.45). This sequence of reactions was achieved 
with 26 % overall yield in 9 steps. 
 
Scheme 3.45 First enantioselective retrosynthesis of (-)-centrolobine 
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The other three literature examples of the synthesis of (-)-centrolobine 3.6b are 
shown in the Scheme 3.46. Rychnovsky
37
 showed that the tosylate protecting group 
would deactivate the aromatic ring so that the normal Prins cyclization
38
 took place. 
Aldehyde 3.251 was homoallylated to give an alcohol which was reacted via 
esterification and acetylation to give !-acetoxy ether 3.252. Prins cyclization, promoted 
by SnBr4 successfully generated compound 3.253. The tosylate group was then replaced 
with methyl ether to give 3.254. Bromide and benzyl group were removed to complete 
the synthesis of (-)-centrolobine 3.6b. (-)-Centrolobine 3.6b was synthesized in 8 steps in 
31 % yield.    
 In 2003, the stereoselective intramolecular reductive etherification was employed 
in the construction of cis-2,6-disubstituted tetrahydropyran by Evans.
111a
 Enantioselective 
allylation of aldehyde 3.255 using allyltributyltin and (R)-BINOL followed by OH 
protection gave compound 3.256 which was sequentially submitted to Grubbs cross 
metathesis with another alkene and selective hydrogenation to yield !,"-unstaurated 
ketone 3.257. For the last step, using bismuth tribromide and triethylsilane, (-)-
centrolobine 3.6b was provided in the 5 steps – a 53 % overall yield total synthesis.  
Another example was shown in 2006 by Blechert.
111b
 The synthesis started with 
alcohol 3.258 which was subjected to allylation with 3.259. The branched product of 
allylic etherification 3.260 was carried out through diastereoselective rearrangement 
using the Grubbs II catalyst. The addition of NaBH4 followed by heating to 100
o
C 
converted the metathesis catalyst into a catalyst for isomerization. Dihydropyran 3.262, 
which was isomerized from 3.260, was then introduced to the phenyl group of 3.261 via 
cross metathesis and the product was hydrogenated to complete the synthesis. The 
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synthesis of (-)-centrolobine 3.6b was successfully achieved in 5 steps with 22 % overall 
yield. 
 
 
Scheme 3.46 The literature examples of the retrosynthesis of (-)-centrolobine 
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The synthesis of the compound is based on the configuration of substrates that are 
the most readily available in the lab. Even though (-)-centrolobine 3.6b is the isolated 
natural product, the formal synthesis of its enantiomer; (+)-centrolobine 3.6a was 
described. However, based on the synthesis of 3.6a, the same techniques could be applied 
to the opposite configurations of the substrates in the same synthetic route under the same 
reaction conditions to yield natural product (-)-centrolobine 3.6b if desired.  
 
3.5 Stereoselective Synthesis of Amphidinolide C (Southern Part)  
Amphidinolides are groups of structurally unique macrolides isolated from the 
laboratory cultured marine dinoflagellate Amphidinium sp.
112,27b
 Amphidinolides are 
extremely scarce and subsequent biological studies have been very limited. 
Amphidinolide C
35 
3.5 (Figure 3.4) is a cytotoxic agent against tumor cells (L1210 and 
KB cells in vitro with IC50 5.8 and 4.6 ng/mL). It is one of the most potent members of 
the amphidinolide family, and contains a 25-membered macrolide having two thf rings. 
The 25-membered macrolactone ring may be essential for cytotoxicity, and the length of 
side chain is considered to affect the potency of the cytotoxic activity significantly. 
Relatively large amounts of amphidinolide C 3.5 have been isolated from three strains 
(Y-56, Y-62, and Y-71) of the genus Amphidinium, which were separated from the 
internal cells of the marine acoel flatworm Amphiscolops sp. This sample was used to 
reinvestigate the relative stereochemistry and to determine the absolute configurations at 
some chiral centers of amphidinolide C 3.5.
35c 
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Figure 3.4 Amphidinolide C structure 
 
In our retrosynthetic analysis, amphidinolide C 3.5 is separated into three 
fragments as shown in Figure 3.5. The southern fragment will be connected to the 
northern fragment via ester formation. The northern fragment, with the side chain (R) 
attached, will be then connected to the eastern Fragment by coupling the sulfone anion 
and an aldehyde. The eastern and southern fragment ends will finally be linked using a 
Stille coupling to complete the macrocyclization of this natural product. The synthesis of 
the southern fragment of amphidinolide C based on hemiacetal trapping chemistry will be 
the focus of this topic. 
 
Figure 3.5 Three subunits of amphidinolide C 
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3.6 Result and Discussion 
3.6.1 Chirality Transfer Analysis of Pd(0) Catalyzed Asymmetric Cyclization 
via Alcohol 
The palladium-catalyzed cyclization of phosphono allylic carbonate (R)-3.124a to 
afford nonracemic thf vinyl phosphonate (R)-3.125a (Eq. 3.46) was carried out in our 
laboratory by He.
19
 However, the proof of chirality transfer in this transformation was 
undocumented. Herein, the chirality transfer in the Pd cyclization from (R)-3.124a to (R)-
3.125a was determined using HPLC analysis. 
 
 
 
In order to precisely interpret the HPLC data, both racemic (+/-)-3.124 and (+/-) 
3.125 (Eq. 3.47) were required as standard references for HPLC analysis. The separation 
of the enantiomer peaks of racemic precursor (+/-)-3.124 was using two HPLC chiral 
stationary phases (in tandem Chiralpak AS + Whelko-S, 210 nm, 1 mL/min, hexane : 
EtOH = 95 : 5) (Scheme 3.47). The Pd catalyzed cyclization of (+/-)-3.124 was carried 
out to obtain vinyl phosphonate (+/-)-3.125 and the enantiomers were separated using a 
single HPLC chiral stationary phase (Chiralcel AD-H, 210 nm, 1 mL/min, hexane : EtOH 
= 90 : 1) (Scheme 3.48).  
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Component Retention Time (min) % Area 
1 103.75 46.77 
2 110.73 53.23 
 
Scheme 3.47 HPLC chromatogram and data of racemic alcohol precursor  
(+/-)-3.124 used for Pd(0) cyclization 
 
 
 
 
 
 
(R)       (S) 
(+/-)-3.124 (standard reference) 
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Component Retention Time (min) % Area 
1 13.03 48.37 
2 17.00 51.63 
 
Scheme 3.48 HPLC chromatogram and data of racemic thf vinyl phosphonate  
(+/)-3.125 obtained from Pd(0) cyclization 
 
After racemic HPLC standards were obtained, (R)-3.124a was prepared in high 
e.e. via the Grubbs metathesis between enantiopure (R)-acrolein phosphono carbonate 
and 4-penten-1-ol.
19,113
 The synthesis of (R)-3.124a proceeded via palladium-catalyzed 
cyclization under the same conditions as the racemic compound (Eq. 3.30) to yield vinyl 
phosphonate (R)-3.125a. Both (R)-3.124a and (R)-3.125a were analyzed for % e.e. using 
the previously described HPLC conditions. The chromatograms are shown in Scheme 
3.19 and 3.20. 
The separation of the phosphono carbonate precursor by HPLC of (R)-3.124a 
showed 90 % e.e. (Scheme 3.49). The magnitude of % e.e. matched with that of the vinyl 
phosphonate product (R)-3.125a as shown on the HPLC trace (89 % e.e., Scheme 3.50). 
These results implied that the Pd(0) catalyzed intramolecular cyclization proceeds with 
complete chirality transfer. 
(R)                                  (S) 
(+/-)-3.125 (standard reference) 
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Component Retention Time (min) % Area 
1 100.20 95.11 
2 110.73 4.89 
 
Scheme 3.49 HPLC chromatogram and data of alcohol precursor (R)-3.124a   
used for Pd(0) cyclization 
 
 
 
Component Retention Time (min) % Area 
1 12.60 94.28 
2 16.87 5.72 
 
Scheme 3.50 HPLC chromatogram and data of thf vinyl phosphonate (R)-3.125a 
obtained from Pd(0) cyclization 
(R) 
(S) 
(R)             
(S)             
(R)-3.124a 
90 % e.e. 
(R)-3.125a 
89 % e.e. 
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3.6.2 The Preparation of Larger Ring Cyclic Ethers 
 The investigation of the intramolecular nucleophilic addition was further extended 
to examine the effect of ring size (such as 7- or 8- membered rings). As shown in Scheme 
3.51, the 6-hepten-1-ol (3.263) and 7-octen-1-ol (3.267) were reacted with acrolein 
phosphonate 3.1 to give the corresponding phosphono allylic carbonate 3.264 and 3.268, 
respectively, both in 83 % yield. Unfortunately, the palladium cyclization of 3.264 and 
3.268 to obtain 7- and 8-membered ring cyclic ethers were unsuccessful. Despite, 
formation of a small amount of the desired products (3.265 and 3.269), a majority of the 
elimination products 3.266 and 3.270 were observed by NMR analysis. The NMR spectra 
of elimination products 3.266 and 3.270 showed the diene peak pattern in the 
1
H NMR 
spectrum between 5 – 8 ppm and the chemical shifts in the 
31
P NMR spectrum were 
further down field than those of the desired products (3.265 and 3.269). 
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Scheme 3.51 The attempt to the syntheses of 7- and 8-membered ring cyclic ethers 
 
3.6.3 Asymmetric Synthesis of Lactone via Carboxylic Acid 
 It was anticipated that the oxygen atom of the terminal carboxylic acid group on 
the phosphono allylic carbonate would also participate in a Pd cyclization to yield the thf 
and thp rings. Therefore, in order to make the precursor for the cyclization, the Grubbs 
cross metathesis of phosphono carbonate 3.1 and carboxylic acids (3.271, 3.272) were 
performed, however, the reaction failed (Scheme 3.52). After protecting the carboxylic 
acid of 3.271 and 3.272 using 2-(trimethylsilyl)ethanol (HOCH2CH2SiMe3), compounds 
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3.273 and 3.274 were successfully cross coupled with 3.1. After deprotection of 3.273a 
and 3.274a with trifluoroacetic acid (TFA, F3CCOOH), phosphonates 3.275 and 3.276 
were isolated in the excellent yields (92 and 98 %, respectively) and ready for the next 
step. 
 
 
Scheme 3.52 The synthesis of carboxylic acid precursor 
 
 As shown in Scheme 3.53, thf 3.277 was successfully synthesized from precursor 
3.275 in 84 % yield. However, the Pd cyclization to give the thp 3.278 failed and the 
competing elimination reaction was dominant. The 
1
H and 
13
C NMR spectrum showed 
the presence of eliminated crude product 3.279 in 55 % yield. 
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Scheme 3.53 The alternative approach to the syntheses of cyclic ethers 
 
3.6.4 Application to the Synthesis of (+)-Centrolobine 
1) Retrosynthetic Analysis of (+)-Centrolobine  
Our aim was to use inexpensive and readily available hydroxy phosphonates in 
our laboratory as the starting materials to synthesize enantiopure (+)-centrolobine 3.6a. 
The retrosynthetic analysis of centrolobine is shown in Scheme 3.54. (+)-Centrolobine 
3.6a can be synthesized from diastereomerically pure thp aldehyde 3.246a. The 
enantiomer of 3.246a (3.246b) had been reported in the literature
38
 as the precursor for 
the synthesis of 3.6b. In retrosynthetic approach, aldehyde 3.246a can be prepared via 
functional group interconversion of vinyl phosphonate 3.280 using ozonolysis. The 
diastereomerically pure vinyl phosphonate 3.280 will be formed via palladium-catalyzed 
intramolecular cyclization of carbonate phosphonate 3.281. The coupled product 3.281 
can be provided using ruthenium catalyzed cross metathesis between the enantiomerically 
pure (R)-alcohol with the terminal olefin 3.282a and (R)-acrolein phosphono carbponate 
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3.1a. This 3-step synthesis toward the formal synthesis of (+)-centrolobine 3.6a 
highlights the utility of Pd(0) catalyzed intramolecular addition of phosphono allylic 
carbonate intermediate 3.281 and the use of functional transformation of vinyl 
phosphonate 3.280. 
 
 
Scheme 3.54 Retrosynthesis of (+)-centrolobine 
 
As mentioned above, to synthesize the carbonate phosphonate intermediate 3.281, 
the preparation of enantiomerically pure (R)-alcohol 3.282a and (R)-acrolein phosphono 
carbonate 3.1a were required.  
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2) Preparation of (R)-Acrolein Phosphono Carbonate 
Enantiopure (R)-acrolein phosphono carbonate 3.1a was easily synthesized via 
sequential 1) asymmetric catalysis using titanium isopropoxide and dimethyl L-tartrate 
and 2) enzyme catalyzed kinetic resolution using CALB lipase according to the procedure 
described earlier in Chapter 1. The compound (R)-3.1a was obtained with excellent 
enantiopurity (97 % e.e.) which was proven by cross metathesis coupling of (R)-3.1a and 
styrene.
19
 The HPLC data obtained (whelko-S, EtOAc/hexane 20:80, 254 nm, 1 mL/min) 
for the cross coupled product (R)-cinnamyl phosphono carbonate 3.283 is shown in Table 
3.1. 
 
Table 3.1 HPLC Data of Enantiomerically Pure (R)-Cinnamyl Phosphono 
Carbonate 3.283 Derived from Enantiomerically Pure (R)-Acrolein Phosphono 
Carbonate 3.1a 
 
Component Retention Time (min) % Area 
1 12.38 98.44 
2 13.98 1.56 
 
 
3) Preparation of (R)-Alcohol Partner 
The synthesis of enantiomerically pure (R)-alcohol 3.282a was achieved with a 2-
step procedure (Scheme 3.55). First, the Grignard reagent, 5-pentenylmagnesium 
bromide (generated in situ in the reaction of 5-bromopentene and Mg metal)
114
 was 
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reacted with p-anisaldehyde 3.284 resulting in racemic alcohol 3.282. Alcohol (+/-)-3.282 
was then resolved by acylation using Birman catalyst Gen II (1.85) described earlier in 
Chapter 1. After 60 % conversion, the recovered alcohol (R)-3.282a was isolated in 38 % 
yield with 99 % e.e. (HPLC : Chiralcel-OD + Chiralcel-OB, i-PrOH/hexane 10:90, 254 
nm, 0.50 mL/min, Scheme 3.56).  
 
 
Scheme 3.55 Pathway 1 toward the synthesis of alcohol partner (R)-3.282a 
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Component Retention Time (min) % Area 
1 29.22 0.55 
2 32.38 99.45 
 
Scheme 3.56 Absolute configuration of (R)-3.282a 
 
The kinetic resolution gave the alcohol with excellent enantiopurity, but in low 
recovered yield. An alternative pathway (pathway 2) was employed to increase the yield. 
As shown in Scheme 3.57, (+/-)-3.282 was subjected to the oxidation reaction using 
Ti(Oi-Pr)4 and tert-butylhydroperoxide (t-BuOOH).
114
 The corresponding ketone 3.286, 
obtained in 64 % yield, was then reduced using (R)-CBS oxazaborolidene 3.287 and 
catecholborane 3.288.
115
 The resulting alcohol 3.282b was obtained in 84 % yield. 
Unfortunately, the HPLC trace showed a lower magnitude of e.e. obtained. However, the 
configuration of alcohol 3.282b from pathway 2, observed by HPLC (Scheme 3.58)  
appeared to be opposite from that of alcohol 3.282a (from pathway 1). According to the 
literature,
39
 this alcohol proved to have the (S)-configuration. It was important to note 
that by having two readily available enantiomers of alcohols, the cis- and trans-thf and 
thp can be both achieved as earlier described in the general objective.  
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Scheme 3.57 Pathway 2 toward the synthesis of alcohol partner 
 
 
 
Component Retention Time (min) % Area 
1 27.75 94.66 
2 33.77 5.34 
 
Scheme 3.58 Absolute configuration of (S)-3.282b 
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4) The Formal Synthesis of (+)-Centrolobine 
Enantiomerically pure (R)-alcohol 3.282a (99 % e.e.) and phosphonate 3.1a (97 
% e.e.) underwent the Grubbs cross metathesis. The cross coupled product 3.281 was 
isolated in 60 % yield in a ratio of trans- to cis- (at the double bond position) of 14 to 1 
(
31
P NMR).
19
 The palladium-catalyzed cyclization to the phosphono allylic carbonate 
generated the thp vinyl phosphonate 3.280 in 85 % yield in a cis- to trans- (across the 
ring) ratio of 13 to 1 as assigned by 
31
P and 
1
H NMR spectroscopy.
19 
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Scheme 3.59 The formal synthesis of (+)-centrolobine 3.6a 
 
Vinyl phosphonate 3.280 was then subjected to ozonolysis
116
 to give pure 
aldehyde 3.246a in 77 % yield after chromatographic purification. The thp aldehyde 
3.246a was identical in all respects with the reported 
1
H, 
13
C NMR and IR spectral 
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data.
117
 The optical rotation [!]
26
D = +4 (c = 1, CHCl3) confirmed the absolute 
configuration by comparison with the known enantiomer [3.246b, Figure 3.6, literature
38
 
[!]
26
D = -6 (c = 0.874, CHCl3)]. According to the same literature, it was reported that the 
conversion of aldehyde 3.246b into (-)-centrolobine 3.6b occurred by the sequence of the 
Wittig reaction and catalytic hydrogenation. Thus, the synthesis of aldehyde 3.246a 
represents a formal synthesis of (+)-centrolobine 3.6a.  
 
 
Figure 3.6 The opposite enantiomer of 3.246a (3.246b, reported in the literature)
38 
 
3.6.5 The Synthesis of Thf and Thp Acetals 
 Our desire was to form the hemiacetal 3.290 in the equilibrium between aldehyde 
3.289 and alcohol (ROH) (Scheme 3.60). In the presence of palladium(0), the palladium 
" allyl complex 3.291 would be generated. The addition of the hemiacetal hydroxy group 
to the neighboring palladium " allyl phosphonate would result in thf (n = 1) and thp (n = 
2) compound 3.292 in a stereoselective manner.  
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Scheme 3.60 Proposed strategy of the synthese of thf and thp acetals based on 
hemiacetal trapping with palladium ! allyl 
 
In an initial attempt to prepare the aldehydes 3.289a and 3.289b, the acrolein 
phosphono carbonate 3.1a was reacted with 4-pentenal and 5-hexenal (3.293 and 3.294) 
in a cross metathesis reaction (Scheme 3.61). However, both reactions failed. Changing 
the preparation method from Grubbs metathesis to alcohol oxidation of the available 
allylic phosphonate with terminal olefin 3.124a and 3.218a using PCC in CH2Cl2, the 
corresponding aldehydes 3.289a and 3.289b were obtained in good yield (88 and 72 % 
yield, respectively).  
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Scheme 3.61 The preparation of aldehyde precursors for hemiacetal formation 
 
Aldehyde 3.289a was treated with palladium tetrakis(triphenylphosphine) in a 
mixture of THF and methanol (1/1 v/v) (Scheme 3.62). Trapping the hemiacetal with the 
phosphono substituted palladium ! allyl complex gave a 1 : 3 diastereomer mixture of thf 
methoxy acetal 3.295 after column chromatography in 81 % yield. Hydrolysis of the 
resulting acetal 3.295 with Dowex-50 in a mixture of H2O and THF (1/2 v/v) led to the 
formation of the thf hemiacetal 3.296 in the ratio of 1 : 1.3 after purification. Subsequent 
acetylation with acetic anhydride provided the diastereomer mixture of thf acetoxy acetal 
3.297 (after purifying) in the ratio of 1 : 0.9.   
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Scheme 3.62 The synthesis of thf methoxy and acetoxy acetals 
 
 Thf acetoxy acetal 3.297 was also easily obtained via a 2 step-one-pot synthesis 
starting from the same aldehyde precursor 3.289a (Scheme 3.63). By replacing methanol 
with H2O, the palladium-catalyzed addition, under the same reaction conditions afforded 
the intermediate thf acetal 3.296 directly. After removal of the solvent, the residue was 
acetylated to give a 1 : 1 diastereomer mixture of compound 3.297 in 68 % overall yield 
(2 steps). 
 
Scheme 3.63 One pot synthesis of thf acetoxy acetals 
 
 The treatment of the homologous aldehyde 3.289b under similar conditions gave 
thf methoxy acetal 3.298 and acetoxy acetal 3.299. Upon further chromatography, the 
palladium-catalyzed cyclization in the solvent mixture of THF and methanol gave only 
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one diastereomer of thp methoxy acetal 3.298 in 66 % yield (Scheme 3.64). A 1 : 1 
diastereomer mixture of thp acetoxy acetal 3.299 was given via a 2 step-one pot synthesis 
in 63 % overall yield after chromatography. 
 
Scheme 3.64 Thp methoxy and acetoxy acetals derived from aldehyde 3.289b 
 
3.6.6 Chirality Transfer Analysis of Pd(0) Catalyzed Asymmetric Cyclization 
via Hemiacetal Trapping 
The extent of chirality transfer in the preparation of cyclic ethers via the trapping 
of hemiacetals with phosphono substituted palladium ! allyl complexes was examined 
(Scheme 3.65). The experiment started with the preparation of enantiomerically pure 
carbonate phosphonate 3.124a (100 % e.e., observed by chiral HPLC using Chiralpak 
AS, 210 nm, 1 mL/min, hexane : EtOH = 90 : 10, Scheme 3.66). The oxidation of 3.124a 
with PCC gave aldehyde derivative 3.289a. The aldehyde precursor 3.289a was 
submitted to palladium-catalyzed asymmetric cyclization to produce the hemiacetal thf 
3.296. Subsequent acetylation gave acetoxy thf acetal 3.297 in which HPLC on the chiral 
stationary phase was complicated by the mixture of diastereomers resulting in 
overlapping peaks. Therefore, the acetal stereocenter of 3.297 was removed by reduction 
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with TMSOTf and triethylsilane (Et3SiH) to yield the thf vinyl phosphonate 3.125a 
where the enantiopurity can be measured by HPLC using Chiralcel AD-H, 210 nm, 1 
mL/min,  hexane :  EtOH  =  90 : 10 (Scheme 3.67).  Compared  to  the  racemic standard  
(+/-)-3.125, the chromatogram showed 100 % e.e. of compound (R)-3.125a. Based on 
this result, we conclude that there is no loss of stereochemistry during palladium-
catalyzed asymmetric cyclization via hemiacetal trapping. 
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Scheme 3.65 Complete chirality transfer in trapping of hemiacetal with Pd ! allyl 
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Component Retention Time (min) % Area 
1 13.229 44.41 
2 16.119 55.59 
 
Component Retention Time (min) % Area 
1 13.023 100 
2 - - 
 
Scheme 3.66 HPLC chromatogram of alcohol precursor 3.124a  
for hemiacetal trapping 
 
 
 
 
 
 
3.124a 
(+/-)-3.124 (std. ref.) 
(S) (R) 
(R) 
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Component Retention Time (min) % Area 
1 16.259 49.22 
2 21.744 50.78 
 
Component Retention Time (min) % Area 
1 16.795 100 
2 - - 
 
Scheme 3.67 HPLC chromatogram of vinyl phosphonate 3.125a  
derived from hemiacetal trapping 
 
3.6.7 Syntheses of Other Acetals 
 It was proposed that the reaction of alcohol substrate 3.300 with an aldehyde 
(RCHO) in the presence of palladium(0) would also result in the formation of acetal 
3.301 as shown in Eq. 3.48. 
??? 
(R) 
 
(+/-)-3.125 (std. ref.) 
(R) 
(S) 
3.125a 
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The required alcohol phosphonate precursor 3.300 was prepared in 74 % yield 
(based on recovered starting material) via the Grubbs cross metathesis of phosphono 
carbonate 3.1 with 3-buten-1-ol 3.302 (Eq. 3.49). The resulting phosphonate 3.300 was 
used in the palladium-catalyzed cyclization.   
 
 
 
Not surprisingly, the treatment of 3.300 with propanal 3.303 in the presence of 
palladium(0) provided the formation of acetal 3.305 in 68 % yield via the hemiacetal 
trapping of palladium ! allyl complex 3.304 (Eq. 3.50). 
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 An unexpected reaction occurred when using chloral 3.306 (Scheme 3.68). The 
31
P NMR spectrum of the reaction solution showed both peaks of hemiacetal 
diastereomers 3.309 formed. However, an attempt to push the reaction by the addition of 
diisopropyl ethylamine (i-Pr2NEt), yielded the formylated product 3.308 instead of acetal 
3.307. The formylation of chloral was believed to proceed via the haloform reaction 
pathway as shown in Eq. 3.51.  
 
 
Scheme 3.68 The presence of both hemiacetal diastereomers in the 
concentration equilibrium shown in 
31
P NMR spectrum 
 
Hydroxyphosphonat
e 
19.8 ppm 
Hemiacetal 
20.8, 20.9 
ppm 
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3.6.8 Syntheses of Acetal Derivatives 
The utility of cyclic hemiacetal intermediate was further demonstrated. The Lewis 
acid [trimethylsilyl triflate (TMSOTf)] catalyzed addition of some representative 
nucleophiles (3.310 – 3.314, Figure 3.7) to the (+/-) thf methoxy acetal 3.295 were 
examined.  
 
 
Figure 3.7 Some nucleophiles used in the addition of thf acetal 
 
The nucleophilic addition proceeded in CH3CN solvent at -20
o
C. As shown in the 
results in Table 3.2, the treatment of (+/-)-3.295 with allyl trimethylsilane 3.310 and 
TMSOTf gave allyl substituted thf 3.317 as a 2.3 : 1 mixture of diastereomers in 95 % 
yield (Entry 1).  
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The nucleophile, 2,4-bis-(trimethylsilyloxy)pyrimidine 3.311 was freshly 
prepared via the reaction of uracil 3.315 and trimethylsilyl chloride (according to the 
literature
118
). The nucleoside analog 3.318
119
 was prepared as a 2.9 : 1 mixture of 
diastereomers in 61 % yield (Entry 2).  
Surprisingly, the reaction of (+/-)-3.295 with 2-mercaptobenzoxazole (HSBox, 
3.312) and 2-mercaptothiazoline (HSTaz, 3.313) after 4 h still showed the presence of a 
large amount of unreacted starting material and some other compounds. The resulting 
compounds were isolated, but still not clearly identified. However, in both cases, there 
was no presence of products 3.319 and 3.320, respectively observed (Entry 3 and 4).  
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Table 3.2 Lewis Acid Catalyzed Nucleophilic Addition of Acetals in CH3CN at -20
o
C 
Entry Precursor Nucleophile Product % 
Yield 
d.s. 
ratio 
1 methoxy  
acetal  
(+/-)-3.295 
 
 
95 2.3 : 1 
2 (+/-)-3.295 
 
 
61 2.9 : 1 
3 (+/-)-3.295 
 
 
- - 
4 (+/-)-3.295 
 
 
- - 
5 (+/-)-3.295 
 
 
- - 
6 acetoxy 
acetal  
(+/-)-3.297 
 
 
- - 
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Tert-butyl(t-butyldimethyl)silyl enol ether 3.314 was prepared according to the 
literature
120
 to use as a nucleophile for the reaction in Entry 5. Unexpectedly, thf methoxy 
acetal (+/-)-3.295 failed to react with this silyl ketene acetal 3.314. Replacing the 
methoxy of (+/-)-3.295 with the acetoxy group ((+/-)-3.297, Entry 6), the reaction gave 
only thf acetal 3.125 (observed from NMR and MS analysis) via the reduction of the 
oxacarbenium ion and no formation of 3.321 via the nucleophilic addition was observed. 
Another route to achieve the equivalent reaction was achieved by using the Reformatsky 
reaction of acetoxy acetal (+/-)-3.297 as shown in Eq. 3.52. The reaction of ethyl 
bromoacetate (BrCH2CO2Et) with zinc powder generated the corresponding zinc enolate 
in situ. After the addition of acetal (+/-)-3.297, C-acetate compound 3.322 was formed in 
61 % yield as a 1.2 : 1 mixture of diastereomers. 
 
 
3.6.9 Application to the Synthesis of Amphidinolide C (Southern Part) 
  1) Retrosynthetic Analysis of Southern Part of Amphidinolide C 
As part of our work on the synthesis of the O-heterocyclic compounds, we were 
interested in applying the hemiacetal chemistry toward the synthesis of the southern 
fragment of amphidinolide C 3.5. The retrosynthesis (Scheme 3.69) started from the 
stereoselective formation of alcohol 3.323 by the reaction of 2-propenylstannane 3.324 
which is highly reactive with aldehyde 3.327 in the presence of Lewis acids such as 
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MgBr2.Et2O or BF3. Et2O.
121
 Bis-tributylstannane 3.324 can be prepared via the allylation 
reaction of 1-(methoxy)methoxyallene 3.325 with hexabutyldistannane (Bu3Sn)2.
121
 
MOM-allenyl ether 3.325 can be obtained by the isomerization of MOM-protected 
propargyl alcohol 3.326 with potassium t-butoxide.
122 
 The key aldehyde 3.327 required in this synthesis contains 3 stereocenters on the 
thf ring as shown in Scheme 3.69. It can be prepared via the ozonolysis of the 
corresponding vinyl phosphonate 3.328 which contains the 3 specific stereocenters (C1 – 
C3) as shown. The expected stereochemistry of 3.328 out of the Reformastky reaction of 
the vinyl phosphonate 3.329 should be highly selective due to 1,3 and 1,2 directing 
effects. The compound 3.329 can be prepared via hemiacetal trapping-palladium(0) 
catalyzed cyclization of allylic phosphonate 3.330 The aldehyde 3.330 can be generated 
by the Grubbs cross metathesis of phosphono carbonate (S)-3.1b with 3.333. The C1 
stereocenter (next to aldehyde group) of aldehyde 3.330 can be obtained by the allylation 
reaction of oxazolidinone 3.331 with allyl iodide 3.332. The C2 stereocenter of aldehyde 
3.330 is provided by (S)-enantiopure phosphono carbonate 3.1b. Enantiomerically pure 
3.1b can be prepared via sequential asymmetric catalysis (Pudovik reaction) and 
enzymatic catalyzed kinetic resolution (using (R)-selective lipase AY).  
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Scheme 3.69 Retrosynthesis of southern part of amphidinolide C 
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  2) Synthesis of Southern Part of Amphidinolide C 
As shown in Scheme 3.70, the reaction between 3.331 and 3.332 gave the 
allylated product 3.333
123
 which had one additional fixed stereocenter at C1. Grubbs 
metathesis of compound 3.333 with phosphono carbonate (S)-3.1b (83 % e.e.) resulted in 
the compound 3.334 having another additional stereocenter at C2 in 64 % yield based on 
recovered starting material. The diastereomer mixtures from 3 chiral centers resulted in 
complex 
31
P and 
1
H NMR analysis and the diastereoselectivity ratio of the compound 
3.334 was not easily measured. Reduction of the oxazolidine group on 3.334 was first 
performed using DIBAL-H. A small amount of aldehyde 3.330 was observed on TLC 
and the large amount of unreacted starting material remained after 4 h at -78
o
C. Either 
increasing the temperatute to -40
o
C or adding more reducing agent caused the formation 
of unidentified by products. Lithiumborohydride (LiBH4) reduction gave alcohol 3.335
124
 
in 75 % yield based on recovered starting material. The aldehyde 3.330 was formed in 94 
% yield via the Dess-Martin oxidation
125
 of alcohol 3.335. Hemiacetal trapping with a 
palladium ! allyl complex, followed by acetylation afforded thf acetoxy acetal 3.329, in 
which another stereocenter at C3 was formed. The acetoxy acetal 3.329 was then 
subjected to the Reformatsky reaction
126
 to give 3.328 in 80 % yield.  
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Scheme 3.70 The synthesis of southern part of amphidinolide C 
 
The 
1
H NMR spectrum of 3.329 showed an unexpected pair of methyl doublets, 
assigned to the ring methyl (Figure 3.8). In addition, although the 
1
H NMR spectra of the 
two acetals (3.329 and 3.328) were too complicated to interpret due to the mixture of 
diastereomers, each spectrum clearly showed the presence of a
 
peak for the C2–Me 
position of both diastereomers in the ratio range between 2 : 1 and 3 : 1. This led to 
doubts about the anticipated versus the obtained stereochemistry. Hence, before 
submitting compound 3.328 to ozonolysis, the stereochemistry of thf acetal 3.329 and 
3.328 were first examined in this step.  
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Figure 3.8 
1
H NMR of acetoxy acetal 3.329 
 
In order to clearify the stereochemistry, the chiral stereocenter on C3 which was 
adjacent to the acetoxy group (OAc) of compound 3.329 was removed by reduction using 
triethylsilane and trimethylsilyl triflate (Eq. 3.53). The 
1
H NMR spectrum of the resulting 
product, vinyl phosphonate 3.336 (Figure 3.9) was much cleaner than that of 3.329 or 
3.328 and it was clearly shown the presence of the diastereomer ratio of 3 : 1, supporting 
the 
1
H NMR data obtained earlier from compound 3.329 and 3.328. The vinyl 
phosphonate 3.329 was subjected to hydrolysis with Dowex-50, followed by the 
oxidation with TPAP (Pr4NRuO4), to produce the ketone intermediate 3.336b with the 
diasteroselectivity ratio of 2 : 1 after purification.  
H @ C2 
H @ CH3 
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Figure 3.9 
1
H NMR of vinyl phosphonate 3.336 
 
According to our previous result in topic 3.6.6 of this chapter, based on the 
chirality transfer analysis by HPLC using compound 3.289a which has no chiral center 
next to the aldehyde group, the hemiacetal proceeded with no loss of stereoselectivity as 
H @ C2 
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summarized earlier. It was concluded here that the scrambling of stereoselectivity of the 
reaction of compound 3.330 appeared to be due to the chiral center next to the aldehyde 
group and occurred during the palladium-catalyzed cyclization step.  
 
  3) Alternative Approach 
Up to this point, we were in need of a stereospecific method for the synthesis of 
the target core of amphidinolide C 3.5. As shown in the Scheme 3.71, it is proposed that 
these two steps of the reactions, homoallylation and methoxycarbonylation, will provide 
compound 3.340a having 3 chiral centers with the correct stereochemistry.  
 
Scheme 3.71 Alternatively proposed route to the synthesis of southern part of 
amphidinolide C 
 
The first step involves the nickel catalyzed homoallylation of aldehyde 3.337 with 
isoprene 3.338 promoted by triethylborane (BEt3). This reaction would provide 
hydroxyalkene 3.339a. According to the Tamaru,
127
 in the presence of catalytic amount 
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(10 mol%) of Ni(acac)2, the homoallylation of benzaldehyde 3.337 with an excess 
amount of isoprene 3.338 would provide reductive-coupling product 1,3-anti-3.339a in 
good yield (90 %) with excellent selectivity (anti : syn 15 : 1). Triethylborane acts as a 
Lewis acid to activate carbonyl compound and as a reducing agent to promote the 
homoallylation as the mechanism reported in the literature (Scheme 3.72). 
 
 
Scheme 3.72 The mechanism of homoallylation of benzaldehyde with isoprene 
reported in the literature
76 
 
 The second step reaction is the palladium(II) catalyzed intramolecular cyclization 
of hydroxyalkene 3.339a with CO and methanol to yield methoxycarbonylated product 
3.340a. According to the Semmelhack
128
 (Scheme 3.73), 2,5-disubstituted thf (3.340a, 
3.340b) will be provided in the favor of cis- or trans- depending on the configuration at 
C1 of hydroxy alkene (3.339a, 3.339b). For example, the reaction of 1,3-anti-precursor 
3.339a proceeded via the transition state (a) arising from conformation with the 
minimum non-bonding interaction. Therefore, the reaction led to the formation of trans-
2,5-disubstituted thf 3.340a as the major product in the ratio of 90 : 10. In the same 
manner, the reaction of 1,3-syn-precursor 3.339b  proceeded via the transition state (b) 
resulting in the cis-isomer 3.340c in 87 : 3 selectively. 
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Scheme 3.73 Palladium-catalyzed cyclization of hydroxyalkene with CO and MeOH 
 
As shown in Scheme 3.74, the coordination of palladium(II) with the double bond 
on hydroxy alkene 3.339a resulted in the intramolecular nucleophilic addition of the 
oxygen leading to the palladium(II) intermediate (a). The carbonyl insertion by CO, 
followed by reductive elimination of Pd(0) yielded the trans-cyclic thf 3.340a. Following 
the methoxycarbonylation procedure according the literature,
128
 the reaction resulted in 
trans-2,5-disubstituted thf 3.340a (one diastereomer formed as observed by NMR) in 69 
% yield.  The addition of trimethyl orthoformate added in the procedure for this second 
step is necessary to help stabilize the catalyst, otherwise the reaction did not work. 
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Scheme 3.74 The mechanism of methoxycarbonylation of homoallylic alcohol 
 
As a matter of fact, the phenyl group of final compound 3.340a needed to be 
replaced with the desired moiety for the synthesis of the southern part of amphidinolide C 
3.5. Therefore, other aldehyde precursors were needed to replace the benzaldehyde in 
Scheme 3.71. Erythronolactol 3.341 failed to react with isoprene 3.338 in the first step 
(Eq. 3.54, Scheme 3.75). The reaction of compound 3.342, which is the silyl protected 
form of 3.341, did not work either (Eq. 3.55).  
The homoallylation of aldehyde trans-4-benzyloxy-2-buten-1-ol 3.343a was 
successful to give the homoallylated product 3.344a in 61 % yield (based on recovered 
starting material) (Eq. 3.56). However, the product obtained would lead to the wrong 
alkene stereochemistry. Unfortunately, (Eq. 3.57) the formation of cis-4-benzyloxy-2-
buten-1-ol 3.344b, which would offer the right stereochemistry was unsuccessful due to 
the change of the cis-isomer 3.343b into the more favorable form of the trans-isomer 
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3.343a under the reaction conditions. The quick conversion from the cis- to trans-isomer 
was observed on a TLC plate during the reaction progress within the first hour. 
 
Scheme 3.75 The failure of the attempt to the synthesis of southern part of 
amphidinolide C 
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3.7 Summary 
1) Allylic hydroxy phosphonates are versatile intermediates for the asymmetric synthesis 
of natural products and enzyme inhibitors.  A variety of substituted allylic hydroxy 
phosphonates and carbonate derivatives can be prepared via cross metathesis of 
phosphonates with substituted alkenes. The stereospecifically intramolecular palladium-
catalyzed addition of oxygen nucleophiles to phosphono allylic carbonates results in the 
efficient stereoselective synthesis of tetrahydrofurans and pyrans; the crucial chiral, 
nonracemic building blocks for the synthesis of biologically active molecules. 
2) Oxidation of hydroxy substituted phosphono allylic carbonates gave the aldehyde 
substituted phosphonates in good yield. Stereospecific palladium(0) catalyzed cyclization 
in the presence of an alcohol such as methanol or water gave acetal tetrahydrofuran and 
tetrahydropyran vinyl phosphonate products derived from hemiacetal trapping. The 
tetrahydrofuran acetals underwent Lewis acid catalyzed addition of nucleophiles to give 
diastereoisomeric mixtures of the substituted tetrahydrofurans. 
3) The acetal tetrahydrofuran vinyl phosphonates, derived from hemiacetal trapping by a 
! allyl complex, were formed in good yield with complete transfer of chirality. However, 
a chiral center next to the aldehyde moiety was partially racemized under the reaction 
conditions resulting in the erosion of the diastereomer ratios in the product. 
4) The alternative 2 step approach, homoallylation and methoxycarbonylation, starting 
from a benzaldehyde precursor gave the thf building block with the right stereochemistry 
for the synthesis of amphidinolide C (Southern part). However, the phenyl group of the 
thf intermediate is needed to be substituted with other functional groups. Replacement of 
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benzaldehyde with other aldehydes in the homoallylation are currently in progress in our 
lab. 
 
3.8 Experimental Section 
General Experimental 
1
H, 
13
C{
1
H} and 
31
P{
1
H} NMR spectra were recorded on a Bruker Avance 300 MHz 
NMR spectrometer in CDCl3 at room temperature. 
1
H NMR spectra were referenced to 
CDCl3 (7.27 ppm), 
13
C{
1
H} NMR spectra were referenced to the center line of CDCl3 
(77.23 ppm) and 
31
P{
1
H} NMR spectra were referenced to external 85 % H3PO4 (0 ppm). 
Coupling constants, J, are reported in Hz. Infrared spectra were recorded on a Thermo 
Nicolet Avatar 360 FT-IR spectrometer. Analytical thin layer chromatography (TLC) 
analyses were performed on silica gel plates, 60PF254. Visualization was accomplished 
with UV light, KMnO4 solution or iodine. Silica gel 60 Merck (0.040-0.063 mm) was 
used for chromatography. Enantiomer ratios were measured by chiral stationary-phase 
HPLC on different conditions, or by 
31
P NMR spectroscopy using quinine as the shift 
reagent. Mass spectral analyses were performed using a JEOL MStation (JMS-700) mass 
spectrometer; electron impact (EI) direct insertion at 70 eV, or fast atom bombardment-
FAB [MH
+
 or MNa
+
]. All reactions were conducted under argon atmosphere using oven-
dried glassware. All of the commercially available chemicals were purchased from 
Sigma-Aldrich, Strem or Acros. Methylene chloride was distilled from CaH2 and THF 
was dried, then distilled from sodium benzophenone ketyl atmosphere. Dimethyl 
phosphite, titanium isopropoxide and propionic anhydride were distilled under reduced 
pressure. Chloroform was distilled at atmosphere. Other reagents were obtained from 
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commercial sources and used without purification. The enzymes were purchased from 
Fluka Chemical Co. Most of the enzymes were generously donated by Amano Co., Ltd. 
USA. 
 
(E)-1-(Dimethoxyphosphoryl)-8-hydroxyoct-2-enylmethylcarboonate (3.264) 
Dimethyl [1-(methoxycarbonyloxy)-2-propenyl] phosphonate (+/-)-3.1 (1eq, 0.53 g, 2.4 
mmol), 6-heptenol (2 eq, 0.54 g, 4.8 mmol), CuI (15 mol%, 0.0677 g, 0.36 mmol) and the 
2
nd
 generation Grubbs catalyst (7 mol%, 0.1409 g, 0.17 mmol) were stirred in CH2Cl2 (5 
mL) at 40
o
C for 3 h (79 % conversion) to give, after chromatography (SiO2, hexane : 
EtOAc), the phosphonate 3.264 as a dark yellow oil (0.48 g, 83 %) (E:Z, 19:1). IR (neat, 
NaCl) 3440, 1755 cm
-1
; 
1
H NMR (CDCl3) ! 5.96 (1H, m), 5.56 (1H, m),  5.45 (1H, dd, 
JHH = 7.9 Hz, JHP = 12.4 Hz), 3.823 (3H, s), 3.822 (3H, d, JHP = 10.7 Hz), 3.81 (3H, d, 
JHP = 10.6 Hz), 3.63(2H, t, JHH = 6.3 Hz), 2.13 (2H, m), 1.46 (6H, m); 
13
C NMR (CDCl3) 
! 154.6 (d, JCP = 9.9 Hz), 138.7 (d, JCP = 12.4 Hz), 120.2 (d, JCP = 3.8 Hz), 72.8 (d, JCP = 
171.3 Hz), 62.2, 55.2, 53.8 (d, JCP = 7.1 Hz), 53.7 (d, JCP = 6.4 Hz), 32.3, 32.2, 28.2 (d, 
JCP = 2.3 Hz), 25.1; 
31
P NMR (CDCl3) ! 20.63, 20.47; HRMS (EI, M
+
) calcd for C12H23-
O7P: 310.1181, found 310.1173. 
 
(E)-1-(Dimethoxyphosphoryl)-9-hydroxynon-2-enylmethylcarboonate (3.268) 
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Dimethyl [1-(methoxycarbonyloxy)-2-propenyl] phosphonate (+/-)-3.1 (1 eq, 0.54 g, 2.4 
mmol), 7-octenol (2 eq, 0.61 g, 4.8 mmol), CuI (15 mol%, 0.0682 g, 0.36 mmol) and the 
2
nd
 generation Grubbs catalyst (7 mol%, 0.1418 g, 0.17 mmol) were stirred in CH2Cl2 (5 
mL) at 40
o
C for 3 h (77 % conversion) to give, after chromatography (SiO2, hexane : 
EtOAc), the phosphonate 3.268 as a dark yellow oil (0.5 g, 83 %) (E:Z,19:1). IR (neat, 
NaCl) 3425, 1755 cm
-1
; 
1
H NMR (CDCl3) ! 5.96 (1H, m), 5.56 (1H, m),  5.44 (1H, dd, 
JHH = 7.8 Hz, JHP = 12.5 Hz), 3.83 (3H, d, JHP = 10.7 Hz), 3.824 (3H, s), 3.821 (3H, d, 
JHP = 10.6 Hz), 3.63(2H, t, JHH = 6.3 Hz), 2.11 (2H, m), 1.42 (8H, m); 
13
C NMR (CDCl3) 
! 155.0 (d, JCP = 9.9 Hz), 139.1 (d, JCP = 12.4 Hz), 120.5 (d, JCP = 3.9 Hz), 73.3 (d, JCP = 
171.1 Hz), 63.0, 55.5, 54.1 (d, JCP = 7.0 Hz), 53.9 (d, JCP = 6.4 Hz), 32.8, 32.4 (d, JCP = 
1.1 Hz), 28.9, 28.6 (d, JCP = 2.3 Hz), 25.6; 
31
P NMR (CDCl3) ! 20.74, 20.49; HRMS (EI, 
M
+
) calcd for C13H25O7P: 324.1338, found 324.1336. 
 
(E)-2-(Trimethylsilyl)ethyl-6-(dimethoxyphosphoryl)-6-(methoxycarbonyloxy)hex-4-
enoate (3.273a) 
Dimethyl [1-(methoxycarbonyloxy)-2-propenyl] phosphonate (+/-)-3.1 (1eq, 2.89 g, 12.9 
mmol), 4-pentenoic acid,2-(trimethylsilyl)ethyl ester 3.273 (2 eq, 4.44 g, 25.8 mmol), 
CuI (20 mol%, 0.98 g, 5.2 mmol) and the 2
nd
 generation Grubbs catalyst (5 mol%, 1.09 g, 
1.3 mmol) were stirred in CH2Cl2 (5 mL) at 40
o
C for 3 h (79 % conversion) to give, after 
chromatography (SiO2, hexane : EtOAc), the product as a dark yellow oil (2.98 g, 74 %). 
IR (neat, NaCl) 1756, 1442 cm
-1
; 
1
H NMR (CDCl3) ! 5.95 (1H, m), 5.63 (1H, m), 5.54 
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(1H, dd, JHH = 7.4 Hz, JHH = 12.9 Hz), 4.17 (2H, m), 3.83 (3H, s), 3.81 (3H, d, JHP = 10.6 
Hz), 3.82 (3H, d, JHP = 10.6 Hz), 2.41 (4H, m), 0.99 (2H, t, JHH = 8.4 Hz), 0.05 (9H, s); 
13
C NMR (CDCl3) ! 172.8, 154.8 (d, JCP = 9.4 Hz), 136.2 (d, JCP = 12.3 Hz), 121.7 (d, 
JCP = 3.7 Hz), 72.8 (d, JCP = 170.6 Hz), 62.8, 55.5, 54.0 (d, JCP = 7.1 Hz), 53.8 (d, JCP = 
6.3 Hz), 33.5 (d, JCP = 2.4 Hz), 27.7, 17.4, -1.4; 
31
P NMR (CDCl3) ! 20.47, 20.08; HRMS 
(FAB, MNa
+
) calcd for C15H29O8PSiNa: 419.1267, found 419.1276. 
 
(E)-2-(Trimethylsilyl)ethyl-7-(dimethoxyphosphoryl)-7-(methoxycarbonyloxy)hept-
5-enoate (3.274a) 
Dimethyl [1-(methoxycarbonyloxy)-2-propenyl] phosphonate (+/-)-3.1 (1eq, 1.80 g, 8.02 
mmol), 5-hexenoic acid,2-(trimethylsilyl)ethyl ester 3.274 (2 eq, 3.44 g, 16.0 mmol), CuI 
(20 mol%, 0.31 g, 1.6 mmol) and the 2
nd
 generation Grubbs catalyst (5 mol%, 0.34 g, 0.4 
mmol) were stirred in CH2Cl2 (2 mL) at 40
o
C for 3 h (85 % conversion) to give, after 
chromatography (SiO2, hexane : EtOAc), the product as a dark yellow oil (2.0 g, 72 %). 
IR (neat, NaCl) 1756, 1442 cm
-1
; 
1
H NMR (CDCl3) ! 5.94 (1H, m), 5.59 (1H, m), 5.44 
(1H, dd, JHH = 7.5 Hz, JHH = 12.8 Hz), 4.15 (2H, m), 3.824 (3H, s), 3.820 (3H, d,  JHP = 
10.7 Hz), 3.81 (3H, d, JHP = 10.7 Hz), 2.28 (2H, t, JHH = 7.5 Hz), 2.14 (2H, m), 1.74 (2H, 
m), 0.98 (2H, t, JHH = 8.8 Hz), 0.04 (9H, d, JHP = 1.1 Hz); 
13
C NMR (CDCl3) ! 174.9, 
156.2 (d, JCP = 9.7 Hz), 138.8 (d, JCP = 12.3 Hz), 122.8 (d, JCP = 3.8 Hz), 74.4 (d, JCP = 
170.1 Hz), 64.0, 56.9, 55.3 (d, JCP = 7.2 Hz), 55.2 (d, JCP = 7.8 Hz), 35.1, 33.2, 25.4 (d, 
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JCP = 2.5 Hz), 18.8, 0.0; 
31
P NMR (CDCl3) ! 20.59, 20.24; HRMS (FAB, MH
+
) calcd for 
C16H32O8PSi: 411.1604, found 411.1609. 
 
(E)-6-(Dimethoxyphosphoryl)-6-(methoxycarbonyloxy)hex-4-enoic acid (3.275) 
To a solution of (E)-2-(trimethylsilyl)ethyl-6-(dimethoxyphosphoryl)-6-(methoxy-
carbonyloxy)hex-4-enoate (3.273a) (1 eq, 1.91 g, 4.83 mmol) in 0.5 mL dry CHCl3 was 
added trifluoroacetic acid (2.5 eq, 0.90 mL, 12.1 mmol). The reaction flask was put in an 
oil bath at 50
o
C and the solution was stirred overnight. The excess trifluoroacetic acid 
and solvent was removed in vacuo to give the pure compound as a yellow oil (92 %). IR 
(neat, NaCl) 3022, 1759, 1443 cm
-1
; 
1
H NMR (CDCl3) ! 11.44 (1H, s, b), 5.99 (1H, m),  
5.63 (1H, m), 5.50 (1H, dd, JHH = 7.6 Hz, JHH = 12.8 Hz), 3.85 (6H, d,  JHP = 10.8 Hz), 
3.83 (3H, s), 2.48 (4H, m); 
13
C NMR (CDCl3) ! 178.6, 154.8 (d, JCP = 10.0 Hz), 136.7 (d, 
JCP = 12.7 Hz), 121.4 (d, JCP = 3.9 Hz), 72.5 (d, JCP = 173.5 Hz), 55.8, 54.8 (d, JCP = 6.9 
Hz), 54.7 (d, JCP = 6.4 Hz), 33.0, 27.4; 
31
P NMR (CDCl3) ! 20.28; HRMS (FAB, MH
+
) 
calcd for C10H18O8P: 297.0739, found 297.0732. 
 
(E)-7-(Dimethoxyphosphoryl)-7-(methoxycarbonyloxy)hept-5-enoic acid (3.276) 
To a solution of (E)-2-(trimethylsilyl)ethyl-7-(dimethoxyphosphoryl)-7-(methoxycarbo-
nyloxy)hept-5-enoate (3.274a) (1 eq, 2.00 g, 4.87 mmol) in 0.5 mL dry CHCl3 was added 
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trifluoroacetic acid (2.5 eq, 0.90 mL, 12.2 mmol). The reaction flask was put in an oil 
bath at 50
o
C and the solution was stirred overnight. The excess trifluoroacetic acid and 
solvent was removed in vacuo to give the pure compound as a yellow oil (1.48 g, 98 %). 
IR (neat, NaCl) 3207, 1755, 1443 cm
-1
; 
1
H NMR (CDCl3) ! 10.32 (1H, s, b), 5.96 (1H, 
m),  5.57 (1H, m), 5.49 (1H, dd, JHH = 7.5 Hz, JHH = 11.5 Hz), 3.862 (3H, d,  JHP = 10.9 
Hz), 3.860 (3H, d,  JHP = 11.1 Hz), 3.84 (3H, s), 2.37 (2H, m), 2.19 (2H, m), 1.77 (2H, 
m); 
13
C NMR (CDCl3) ! 178.6, 154.8 (d, JCP = 10.0 Hz), 136.7 (d, JCP = 12.7 Hz), 121.4 
(d, JCP = 3.9 Hz), 72.5 (d, JCP = 173.5 Hz), 55.8, 54.8 (d, JCP = 6.9 Hz), 54.7 (d, JCP = 6.4 
Hz), 33.0, 27.4; 
31
P NMR (CDCl3) ! 20.73, 20.53; HRMS (FAB, MH
+
) calcd for C11H20-
O8P: 311.0896, found 311.0886. 
 
(E)-Dimethyl-2-(5-oxotetrahydrofuran-2-yl)vinylphosphonate (3.277) 
To a solution of (E)-6-(Dimethoxyphosphoryl)-6-(methoxycarbonyloxy)hex-4-enoic acid 
(3.275) (1 eq, 0.3 g, 1.01 mmol) in 1 mL dry THF was added Pd(PPh3)4 (0.05 eq, 0.06 g, 
50.5 "mol) and i-Pr2NEt (4 eq, 0.67 mL, 4.04 mmol). The flask was put in an oil bath at 
60
o
C and the solution was stirred for 3 h. The mixture was evaporated in vacuo and the 
crude product was purified by column chromatography (SiO2, EtOAc) to obtain the 
product as yellow oil (0.2 g, 84 %). IR (neat, NaCl) 1782 cm
-1
; 
1
H NMR (CDCl3) ! 6.79 
(1H, ddd, JHH = 3.4 Hz, JHH = 17.4 Hz, JHP = 21.4 Hz), 5.97 (1H, m),  5.07 (1H, s), 3.73 
(6H, d, JHP = 11.1 Hz), 2.53 (3H, m), 2.04 (1H, m); 
13
C NMR (CDCl3) ! 176.4, 149.3 (d, 
JCP = 5.9 Hz), 117.1 (d, JCP = 189.1 Hz), 78.7 (d, JCP = 22.5 Hz), 53.02 (d, JCP = 6.0 Hz), 
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52.99 (d, JCP = 5.1 Hz), 28.1, 28.0; 
31
P NMR (CDCl3) ! 20.09; HRMS (EI, M
+
) calcd for 
C8H13O5P: 220.0501, found 220.0508. 
 
(R)-(E)-Dimethyl [1-(methoxycarbonyloxy)-2-propenyl] phosphonate (3.1a) 
The preparation procedure and the characterization data of enantiomerically pure 3.1a 
was described earlier in chapter 1.
 
 
(+/-)-p-Methoxyphenyl-5-hexenol (3.282) 
The preparation procedure and the characterization data was described according to the 
literature.
114 
 
(R)-p-Methoxyphenyl-5-hexenol (3.282a) 
To a solution mixture of racemic p-methoxyphenyl-5-hexenol 3.282 (1 eq, 2.4 g, 11.6 
mmol) and Birman catalyst 2-3-dihydroimidazo[1,2-a]pyridine (Gen II, 1.85) (4 mol%, 
0.13 g, 0.47 mmol) in 50 mL dry chloroform was added diisopropylethylamine (0.75 eq, 
1.52 mL, 8.73 mmol) and the solution was stirred at 0
o
C for 15 min. Propionic anhydride 
(0.75 eq, 1.14 g, 8.73 mmol) was added and stirred continuously another 22 h while 
maintaining a temperature of 0
o
C. After the reaction had proceeded to 59 % conversion, 
the mixture was quenched with ethanol, followed by evaporation in vacuo. The mixture 
 282 
was partitioned between 0.2 M HCl and CH2Cl2. The organic layer was evaporated in 
vacuo and the crude mixture was purified by column chromatography (SiO2, hexane : 
EtOAc) (0.92 g, 38 %). % Enantiomeric excess was determined by HPLC using 
Chiralcel OD and OB, det. 254 nm, hexane/isopropanol 90:10, 0.50 mL/min (97 % 
e.e.). The characterization data was described according to the literature.
114 
 
p-Methoxyphenyl-5-hexenone (3.286) 
The preparation procedure and the characterization data were described according to the 
literature.
114 
 
(S)-p-Methoxyphenyl-5-hexenol (3.282b) 
The preparation procedure starting from 3.286 was described according to the literature
115
 
and the characterization data was described according to the literature.
114 
 
(E)-1-(Dimethoxyphosphoryl)-7-hydroxy-7-(4-methoxyphenyl)hept-2-enylmethyl 
carbonate (3.281) 
(R)-(E)-Dimethyl [1-(methoxycarbonyloxy)-2-propenyl] phosphonate 3.1a (97 % e.e., 1 
eq, 0.10 g, 0.51 mmol), (R)-p-methoxyphenyl-5-hexenol 3.282a (99 % e.e., 1 eq, 0.11 g, 
0.51 mmol), CuI (10 mol%, 0.0097 g, 0.05 mmol) and the 2
nd
 generation Grubbs catalyst 
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(5 mol%, 0.0216 g, 0.03 mmol) were stirred in CH2Cl2 (1 mL) at 40
o
C for 14 h ( 83 % 
conversion) to give, after chromatography (SiO2, hexane : EtOAc), the phosphonate 
3.281 as a dark yellow oil (0.13 g, 78 %) (E:Z,14:1). IR (neat, NaCl) 3424, 1754 cm
-1
; 
1
H 
NMR (CDCl3) ! 7.18 (2H, m), 6.78 (2H, m),  5.84 (1H, m), 5.45 (1H, m), 5.33 (1H, dd, 
JHH = 7.9 Hz, JHP = 12.4 Hz), 4.52 (1H, t, JHH = 5.9 Hz ), 3.72 (9H, m), 3.68 (3H, s), 1.77 
(6H, m); 
13
C NMR (CDCl3) ! 159.3, 155.1 (d, JCP = 9.9 Hz), 138.9 (d, JCP = 12.5 Hz), 
137.4, 127.5, 120.9 (d, JCP = 1.9 Hz), 114.1, 74.0, 73.4 (d, JCP = 171.1 Hz), 55.7 (d, JCP = 
4.7 Hz), 54.2 (d, JCP = 7.3 Hz), 54.1 (d, JCP = 7.9 Hz), 38.7, 32.5 25.1; 
31
P NMR (CDCl3) 
! 20.66, 20.44; HRMS (EI, M
+
) calcd for C18H27O8P: 402.1444, found 402.1440. 
 
(E)-Dimethyl-2-[6-(4-methoxyphenyl)tetrahydro-2H-pyran-2-yl)]vinylphosphonate 
(3.280) 
(E)-1-(Dimethoxyphosphoryl)-7-hydroxy-7-(4-methoxyphenyl)hept-2-enylmethylcarbo-
nate 3.281 (1 eq, 3.08g, 7.66 mmol) and Pd(PPh3)4 (5 mol%, 0.4424 g, 0.38 mmol) were 
dissolved in dry THF (18 mL). After diisopropylethylamine (4 eq, 5.06 mL, 3.06 mmol) 
was added, the reaction mixture was heated at reflux for 2 h. The solvent was evaporated in 
vacuo and the crude product (100 % conversion) was purified by column chromatography 
(SiO2, hexane : EtOAc) to give a pale yellow oil compound (2.12 g, 85 %) (cis : trans 
across the ring,13:1). IR (neat, NaCl) 1638, 1247 cm
-1
; 
1
H NMR (CDCl3) ! 730 (2H, m), 
6.88 (2H, m), 6.78  (1H, m), 5.98 (1H, ddd, JHH = 1.9 Hz, JHH = 17.2 Hz, JHP = 21.5 Hz), 
4.41 (1H, dd, JHH = 2.0 Hz, JHH = 11.0 Hz), 4.18 (1H, m), 3.81 (3H, s), 3.74 (3H, d, JHP = 
11.1 Hz), 3.72 (3H, d, JHP = 11.0 Hz), 2.08-1.23 (6H, m); 
13
C NMR (CDCl3) ! 159.3, 
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153.9 (d, JCP = 5.5 Hz), 135.6, 127.4, 114.0, 113.9 (d, JCP = 189 Hz), 79.8, 77.2, 55.7, 
52.734 (d, JCP = 5.6 Hz), 52.730 (d, JCP = 6.3 Hz), 33.8, 31.2 (d, JCP = 1.9 Hz), 24.4; 
31
P 
NMR (CDCl3) ! 22.90, 22.06; HRMS (FAB, MNa
+
) calcd for C16H23O5PNa: 349.1181, 
found 349.1183. 
 
(2S,6R)-6-(4-methoxyphenyl)tetrahydro-2H-pyran-2-carbaldehyde (3.246a) 
A round-bottomed flask connecting with a 2 way glass tube to admit ozone and argon, 
was charged with (E)-dimethyl-2-[6-(4-methoxyphenyl)tetrahydro-2H-pyran-2-yl)]vinyl-
phosphonate 3.280  (0.2 g, 0.6 mmol), 20 mL of CH2Cl2, and 20 mL of methanol. The 
flask was cooled and maintained at "78°C. After flushing with argon for 30 min, ozone 
was bubbled through the solution with stirring. When the solution turned blue, ozone 
addition was stopped. Argon was then passed through the solution until the blue color 
was discharged. The 2 way glass tube was replaced with a rubber septum and then 0.45 
mL of dimethyl sulfide (6 mmol) was added dropwise. After stirring for 30 min at -78
o
C, 
the heterogeneous mixture was allowed to room temperature and was stirred another 12 h 
at ambient temperature. The mixture was concentrated in vacuo and the crude product 
was purified by column chromatography (SiO2, hexane : EtOAc) to give a yellow oil 
compound (0.11 g, 77 %). The characterization data of this compound can be found in the 
literature.
117 
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(E)-1-(Dimethoxyphosphoryl)-6-oxohex-2-enylmethylcarbonate (3.289a) 
To a solution of pyridinium chlorochromate  (1.5 eq, 0.57 g, 2.7 mmol) in dry CH2Cl2 25 
mL, was added dropwise the solution of dimethyl[6-hydroxy-1-(methoxycarbonyl-oxy)-
2-hexenyl]phosphonate 3.124a (1 eq, 0.50 g, 1.8 mmol) in 4 mL dry CH2Cl2. The mixture 
was stirred for 2 h at room temperature. The black mixture was diluted with diethylether 
(40 mL). The brown suspension was then filtered through Florisil
TM
. The black tar 
remained in the flask was washed with ether. The washings were again filtered through 
Florisil
TM
 and the Florisil
TM
 was washed with ether (40 mL). The combined ether 
solution was evaporated in vacuo to give the dark yellow oil (0.43 g, 88 %) without 
purification. IR (neat, NaCl) 2926, 2854, 1754, 1443 cm
-1
; 
1
H NMR (CDCl3) ! 9.78 (1H, 
s), 5.97 (1H, m),  5.63 (1H, m), 5.46 (1H, dd, JHH = 7.4 Hz, JHP = 13.1 Hz), 3.83 (3H, s), 
3.822 (3H, d, JHP = 10.6 Hz), 3.820 (3H, d, JHP = 10.1 Hz), 2.59 (2H, t, JHH = 7.2 Hz), 
2.46 (2H, m); 
13
C NMR (CDCl3) ! 201.4, 155.1 (d, JCP = 9.7 Hz), 136.1 (d, JCP = 12.1 
Hz), 122.2 (d, JCP = 3.7 Hz), 73.0 (d, JCP = 170.7 Hz), 55.8, 54.3 (d, JCP = 7.1 Hz), 54.2 
(d, JCP = 6.3 Hz), 42.9 (d, JCP = 2.4 Hz), 25.2; 
31
P NMR (CDCl3) ! 20.03; HRMS (FAB, 
MNa
+
) calcd for C10H17O7PNa: 303.0610, found 303.0621. 
 
(E)-1-(Dimethoxyphosphoryl)-7-oxooct-2-enylmethylcarbonate (3.289b) 
To a solution of pyridinium chlorochromate  (1.5 eq, 0.55 g, 2.5 mmol) in dry CH2Cl2 25 
mL, was added dropwise the solution of dimethyl[7-hydroxy-1-(methoxycarbonyl-oxy)-
2-heptenyl]phosphonate 3.218a (1 eq, 0.50 g, 1.7 mmol) in dry CH2Cl2 4 mL. The 
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mixture was stirred for 2 h at room temperature. The black mixture was diluted with 
diethylether (40 mL). The brown suspension was then filtered through Florisil
TM
. The 
black tar remained in the flask was washed with ether. The washings were again filtered 
through Florisil
TM
 and the Florisil
TM
 was washed with ether (40 mL). The combined 
ethereal solution was evaporated in vacuo to give the dark yellow oil (0.36 g, 72 %) 
without purification. IR (neat, NaCl) 2960, 2855, 1757, 1443 cm
-1
; 
1
H NMR (CDCl3) ! 
9.77 (1H, s), 5.91 (1H, m),  5.58 (1H, m), 5.44 (1H, dd, JHH = 7.5 Hz, JHP = 12.9 Hz), 
3.81 (3H, s), 3.81 (3H, d, JHP = 10.7 Hz), 3.80 (1H, d, JHP = 10.6 Hz)), 2.44 (2H, t, JHH = 
7.28), 2.15 (2H, m), 1.74 (2H, m); 
13
C NMR (CDCl3) ! 202.4, 155.1 (d, JCP = 9.8 Hz), 
137.5 (d, JCP = 12.4 Hz), 121.9 (d, JCP = 3.9 Hz), 73.2 (d, JCP = 170.9 Hz), 55.8, 54.3 (d, 
JCP = 7.1 Hz), 54.1 (d, JCP = 6.3 Hz), 43.3, 31.9, 21.3; 
31
P NMR (CDCl3) ! 20.18; HRMS 
(FAB, MNa
+
) calcd for C11H19O7PNa: 317.0766, found 317.0759. 
 
(E)-Dimethyl-2-(5-methoxytetrahydrofuran-2-yl)vinylphosphonate (3.295) 
(E)-1-(Dimethoxyphosphoryl)-6-oxohex-2-enylmethylcarbonate 3.289a (1 eq, 2.82 g, 
10.1 mmol) was stirred in 3.5 mL dry methanol for 15 min. Dry THF 3.5 mL, Pd(PPh3)4 
(0.05 eq, 0.58 g, 0.5 mmol) followed by i-Pr2NEt (4 eq, 6.7 mL, 40.4 mmol) were added. 
The flask was put in an oil bath at 60
o
C and the solution was stirred for 3 h. The solvent 
was evaporated in vacuo and the crude product was purified by column chromatography 
(SiO2, hexane : EtOAc) to give the light yellow oil (1.93 g, 81 %). IR (neat, NaCl) 1637, 
1248, 1034 cm
-1
; 
1
H NMR (CDCl3) (diastereomer pairs ratios of 1 : 3) ! 6.81 (0.75H, 
ddd, JHH = 5.0 Hz, JHH = 17.1 Hz, JHP = 22.1 Hz) + 6.77 (0.25H, ddd, JHH = 4.2 Hz, JHH = 
 287 
17.0 Hz, JHP = 21.5 Hz), 5.87 (1H, ddd, JHH = 1.5 Hz, JHH = 17.1 Hz, JHP = 20.8 Hz), 5.08 
(0.25H, dd, JHH = 1.5 Hz, JHH = 4.9 Hz) + 5.02 (0.75H, m), 4.63 (1H, m), 3.71 (6H, d, JHP 
= 11.1 Hz), 3.36 (2.25H, s) + 3.34 (0.75H, s), 2.33-1.78 (4H, m); 
13
C NMR (CDCl3) 
(diastereomer pairs) ! 154.7 (d, JCP = 5.1 Hz) + 153.3 (d, JCP = 5.3 Hz), 114.9 (d, JCP = 
188.6 Hz) + 114.8 (d, JCP = 188.9 Hz), 106.1 + 105.9, 80.2 (d, JCP = 23.0 Hz), 55.3, 52.8 
(d, JCP = 5.6 Hz), 52.7 (d, JCP = 5.4 Hz), 33.3 + 31.8, 29.9 (d, JCP = 1.7 Hz) + 29.5 (d, JCP 
= 2.0 Hz); 
31
P NMR (CDCl3) ! 22.01, 21.92; HRMS (FAB, MH
+
) calcd for C9H18O5P: 
237.0892, found 237.0896. 
 
(E)-Dimethyl-2-(5-hydroxytetrahydrofuran-2-yl)vinylphosphonate (3.296) 
A vigorously stirred mixture of (E)-dimethyl-2-(5-methoxytetrahydrofuran-2-yl)vinyl-
phosphonate 3.295 (1 eq, 0.06 g, 0.25  mmol) and Dowex 50-X8 (5 mL) in THF-water 
(2/1 v/v, 4.5 mL) was maintained at 45
o
C for overnight. After separation of the resin, the 
filtrate was extracted with CH2Cl2. The organic extract was dried and evaporated in 
vacuo. The crude product was purified by column chromatography (SiO2, 10 % ethanol 
in EtOAc) to give the light yellow oil (46 mg, 82 % yield). IR (neat, NaCl) 1638, 1462, 
1030 cm
-1
; 
1
H NMR (CDCl3) (diastereomer pairs of 1 : 1) ! 6.79 (1H, m), 5.91 (1H, m), 
5.64 (0.5H, dd, JHH = 1.4 Hz, JHH = 4.7 Hz) + 5.57 (0.5H, m) 4.82 (0.5H, m), 4.60 (0.5H, 
m), 4.18 (2H, m), 3.73 (6H, d, JHP = 11.1 Hz), 2.35-1.69 (4H, m); 
13
C NMR (CDCl3) 
(diastereomer pairs) ! 154.8 (d, JCP = 5.1 Hz) + 153.4 (d, JCP = 5.4 Hz), 115.0 (d, JCP = 
188.8 Hz) + 114.8 (d, JCP = 189.1 Hz), 99.5 + 99.4, 80.3 (d, JCP = 23.1 Hz) + 77.9 (d, JCP 
= 21.6 Hz), 52.84 (d, JCP = 5.7 Hz ), 52.80 (d, JCP = 5.6 Hz ), 34.1 + 32.7, 29.8 (d, JCP = 
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1.7 Hz)  + 29.5 (d, JCP = 2.3 Hz ); 
31
P NMR (CDCl3) ! 22.09; HRMS (EI, MH
+
) calcd for 
C8H16O5P: 223.0735, found 223.0736. 
 
(E)-5-(2-(Dimethoxyphosphoryl)vinyl)tetrahydrofuran-2-yl acetate (3.297) 
Procedure 1  
To a solution of (E)-dimethyl-2-(5-hydroxytetrahydrofuran-2-yl)vinylphosphonate 3.296 
(1 eq, 0.02 g, 98.6 "mol), pyridine (1 eq, 0.01 mL, 98.6 "mol) and DMAP (0.1 eq, 1.2 
mg, 9.86 "mol) in CH2Cl2 (0.5 mL) was added acetic anhydride (1.5 eq, 0.01 mL, 0.15 
mmol) at 0
o
C. After stirring the mixture for 2 h at room temperature, the mixture was 
evaporated in vacuo and the residue was purified by column chromatography (SiO2, 3 % 
ethanol in EtOAc) to obtain product (diastereomer pairs of 1 : 1) as light yellow oil (0.02 
g, 91 %). 
Procedure 2 (2 steps-One pot)  
(E)-1-(Dimethoxyphosphoryl)-6-oxohex-2-enylmethylcarbonate 3.289a (1 eq, 3.27 g, 
0.11 mol) was stirred in 4 mL water for 15 min.  THF 4 mL and Pd(PPh3)4 (0.05 eq, 0.67 
g, 0.58 mmol) were added. The flask was put in an oil bath at 60
o
C and the solution was 
stirred for 3 h. The yellow precipitate was filtered off and the solvent was removed from 
filtrate by evaporation in vacuo to give the residue of (E)-dimethyl-2-(5-
hydroxy)tetrahydrofuran2-yl)vinylphosphonate 3.296. To a solution of this residue, 
pyridine (1 eq, 1.05 mL, 13 mmol) and DMAP (0.1 eq, 0.16 g, 1.3 mol) in CH2Cl2 (6 mL) 
was added acetic anhydride (1.5 eq, 1.85 mL, 19.5 mmol) at 0
o
C. After stirring the 
mixture for 2 h at room temperature, the mixture was evaporated in vacuo and the crude 
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product was purified by column chromatography (SiO2, 3 % ethanol in EtOAc) to obtain 
product as a light yellow oil (3.27 g, 68 % yield over 2 steps). IR (neat, NaCl) 1723, 1639 
cm
-1
; 
1
H NMR (CDCl3) (diastereomer pairs of 1 : 1) ! 6.73 (1H, m), 6.33 (0.5H, dd, JHH 
= 1.1 Hz, JHH = 4.8 Hz) + 6.30 (0.5H, m), 5.87 (1H, m), 4.83 (0.5H, m) + 4.70 (0.5H, m), 
3.712 (1.5H, d, JHP = 11.1 Hz) + 3.701 (1.5H, d, JHP = 11.1 Hz), 3.710 (1.5H, d, JHP = 
11.1 Hz) + 3.700 (1.5H, d, JHP = 11.1 Hz), 2.40-1.75 (4H, m), 2.04 (1.5H, s) + 2.02 
(1.5H, s); 
13
C NMR (CDCl3) (diastereomer pairs) ! 170.5, 153.1 (d, JCP = 5.4 Hz) + 151.9 
(d, JCP = 5.6 Hz), 115.3 (d, JCP = 188.8 Hz) + 115.1 (d, JCP = 199.0 Hz), 98.86 + 98.83, 
80.9 (d, JCP = 23.0 Hz) + 79.1 (d, JCP = 21.9 Hz), 52.6 (d, JCP = 4.8 Hz ), 52.5 (d, JCP = 
5.4 Hz ), 32.6 + 30.9, 29.1 (d, JCP = 1.7 Hz)  + 28.5 (d, JCP = 1.8 Hz), 21.48 + 21.43; 
31
P 
NMR (CDCl3) ! 21.59; HRMS (FAB, MH
+
) calcd for C10H18O6P: 265.0841, found 
265.0846. 
 
(E)-Dimethyl-2-(6-methoxytetrahydro-2H-pyran-2-yl)vinylphosphonate (3.298) 
(E)-1-(Dimethoxyphosphoryl)-7-oxooct-2-enylmethylcarbonate 3.289b (1 eq, 1.23 g, 
4.18 mmol) was stirred in 2.5 mL dry methanol for 15 min. Dry THF 2.5 mL, Pd(PPh3)4 
(0.05 eq, 0.24 g, 0.21 mmol) followed by i-Pr2NEt (4 eq, 2.8 mL, 16.7 mmol) were 
added. The flask was put in an oil bath at 60
o
C and the solution was stirred for 3 h. The 
solvent was evaporated in vacuo and the crude product was purified by column 
chromatography (SiO2, hexane : EtOAc) to give the light yellow oil (0.72 g, 66 %). 
Further chromatography gave only one pure diastereomer. IR (neat, NaCl) 1639, 1026 
cm
-1
; 
1
H NMR (CDCl3) ! 6.76 (1H, ddd, JHH = 3.3 Hz, JHH = 17.2 Hz, JHP = 22.8 Hz), 
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5.93 (1H, ddd, JHH = 1.9 Hz, JHH = 17.2 Hz, JHP = 21.0 Hz), 4.34 (1H, dd, JHH = 2.1 Hz, 
JHH = 9.4 Hz), 4.02 (1H, m), 3.71 (3H, d, JHP = 11.1 Hz), 3.68 (3H, d, JHP = 11.1 Hz), 
3.47 (3H, s), 1.91-1.15 (6H, m); 
13
C NMR (CDCl3) ! 152.7 (d, JCP = 5.7 Hz), 114.4 (d, 
JCP = 188.6 Hz), 75.2 (d, JCP = 21.0 Hz), 56.5, 52.81 (d, JCP = 6.0 Hz), 52.8 (d, JCP = 5.9 
Hz), 31.1, 30.6, 22.4; 
31
P NMR (CDCl3) ! 22.50; HRMS (FAB, MNa
+
) calcd for C10H19-
O5PNa : 273.0868, found 273.0875. 
 
(E)-6-(2-(Dimethoxyphosphoryl)vinyl)tetrahydro-2H-pyran-2-yl acetate (3.299) 
(E)-1-(Dimethoxyphosphoryl)-7-oxooct-2-enylmethylcarbonate 3.289b (1 eq, 2.35 g, 
7.98 mmol) was stirred in 3 mL water for 15 min.  THF 3 mL and Pd(PPh3)4 (0.05 eq, 
0.46 g, 0.4 mmol) were added. The flask was put in an oil bath at 60
o
C and the solution 
was stirred for 3 h. The reaction mixture was dried and evaporated in vacuo to give the 
residue of (E)-dimethyl-2-(6-hydroxy)tetrahydropyran-2-yl)vinyl-phosphonate. To a 
solution of this residue, pyridine (1 eq, 0.64 mL, 7.98 mmol) and DMAP (0.1 eq, 0.10 g, 
0.8 mmL) in CH2Cl2 (15 mL) was added acetic anhydride (1.5 eq, 1.13 mL, 12.0 mmol) 
at 0
o
C. After stirring the mixture for 2 h at room temperature, the mixture was evaporated 
in vacuo and the crude product was purified by column chromatography (SiO2, 
hexane/EtOAc) to obtain product as a light yellow oil (1.40 g, 63 % yield over 2 steps). 
IR (neat, NaCl) 1747, 1640 cm
-1
; 
1
H NMR (CDCl3) (diastereomer pairs of 1 : 1) ! 6.71 
(0.5H, ddd, JHH = 3.5 Hz, JHH = 16.8 Hz, JHP = 22.9 Hz) + 6.69 (0.5H, ddd, JHH = 3.6 Hz, 
JHH = 16.8 Hz, JHP = 23.0 Hz), 6.18 (0.5H, s, b) + 5.68 (0.5H, dd, JHH = 2.3 Hz, JHH = 9.5 
Hz), 5.86 (1H, ddd, JHH = 1.8 Hz, JHH = 17.2 Hz, JHP = 20.5 Hz), 4.41 (0.5H, m) + 4.46 
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(0.5H, m), 3.67 (6H, d, JHP = 11.1 Hz), 2.07 (1.5H, s) + 2.04 (1.5H, s), 2.01-1.23 (6H, m); 
13
C NMR (CDCl3) (diastereomer pairs) ! 169.7 + 169.4, 152.5 (d, JCP = 5.7 Hz) + 151.6 
(d, JCP = 5.7 Hz), 114.8 (d, JCP = 188.7 Hz) + 114.3 (d, JCP = 189.1 Hz), 94.5 + 92.1, 75.8 
(d, JCP = 21.6 Hz) + 70.4 (d, JCP = 21.2 Hz), 52.6 (d, JCP = 5.6 Hz ), 30.4 (d, JCP = 2.1 Hz)  
+ 29.8 (d, JCP = 2.0 Hz), 29.6 + 28.4, 21.52 (d, JCP = 21.9 Hz)  + 21.50 (d, JCP = 23.6 Hz), 
17.8; 
31
P NMR (CDCl3) ! 22.29, 22.08; HRMS (FAB, MNa
+
) calcd for C10H17O6P: 
301.0817, found 301.0824. 
 
(E)-Dimethyl-2-(5-allyltetrahydrofuran-2-yl)vinylphosphonate (3.317) 
To a solution of (E)-dimethyl-2-(5-methoxytetrahydrofuran-2-yl)vinylphosphonate (+/-)-
3.295 (1 eq, 0.05 g, 0.19 mmol) and allyltrimethylsilane 3.310 (2 eq, 0.06 mL, 0.39 
mmol) in 2 mL dry CH3CN at -20
o
C, was added TMSOTf (2 eq, 0.07 mL, 0.39 mmol). 
The solution was kept in fridge at -20
o
C. After 4 h, the solution was washed with 
saturated aqueous NaHCO3 and water. The product as the yellow oil was obtained 
without purification (0.05 g, 95 %). IR (neat, NaCl) 1640, 1463, 1248 cm
-1
; 
1
H NMR 
(CDCl3) (diastereomer pairs ratio of 1 : 2) ! 6.83 (0.33H, ddd, JHH = 4.1 Hz, JHH = 17.0 
Hz, JHP = 21.5 Hz) + 6.79 (0.67H, ddd, JHH = 4.1 Hz, JHH = 16.7 Hz, JHP = 21.4 Hz), 5.88 
(2H, m), 5.11 (2H, m), 4.62 (0.67H, m) + 4.52 (0.33H, m), 4.11 (0.67H, m) + 4.04 
(0.33H, m), 3.73 + 3.72 (6H, overlap d), 2.45-1.98 (4H, m), 1.67 (2H, m); 
13
C NMR 
(CDCl3) (diastereomer pairs) ! 154.5 (d, JCP = 5.2 Hz), 134.9 + 134.8, 117.4, 114.3 (d, 
JCP = 188.9 Hz) + 113.8 (d, JCP = 190.0 Hz), 79.9 + 79.2, 78.7 (d, JCP = 21.8 Hz) + 78.5 
(d, JCP = 21.8 Hz), 52.59 (d, JCP = 5.6 Hz ), 52.55 (d, JCP = 5.7 Hz ), 40.4 + 40.2, 31.8 + 
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31.1, 30.5 + 30.4; 
31
P NMR (CDCl3) ! 22.41; HRMS (FAB, MH
+
) calcd for C11H20O4P: 
247.1099, found 247.1103. 
 
(E)-Dimethyl-2-(5-(bis(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-
yl)vinylphosphonate (3.318) 
To a solution of (E)-dimethyl-2-(5-methoxytetrahydrofuran-2-yl)vinylphosphonate (+/-)-
3.295 (1 eq, 0.04 g, 0.17 mmol) and bis(O-trimethylsilyl)uracil 3.311 (2 eq, 0.09 g, 0.34 
mmol) in 2 mL dry CH3CN at -20
o
C, was added TMSOTf (2 eq, 0.06 mL, 0.34 mmol). 
The solution was kept in fridge at -20
o
C. After 4 h, the solution was washed with 
saturated aqueous NaHCO3 and water. The crude product was purified by column 
chromatography (SiO2, 10 % ethanol in EtOAc) to give the light yellow oil (8 mg, 61 %). 
IR (neat, NaCl) 3447, 1691 cm
-1
; 
1
H NMR (CDCl3) (diastereomer pairs ratio of 1 : 3) ! 
8.20 (1H, s), 7.37 (0.25H, d, JHH = 8.1 Hz) + 7.35 (0.75H, d, JHH = 8.1 Hz), 6.90 (0.25H, 
ddd, JHH = 5.0 Hz, JHH = 16.9 Hz, JHP = 22.2 Hz) + 6.77 (0.75H, ddd, JHH = 4.0 Hz, JHH = 
17.2 Hz, JHP = 21.1 Hz), 6.14 (1H, m), 5.98 (0.25H, ddd, JHH = 1.7 Hz, JHH = 15.1 Hz, 
JHP = 18.8 Hz) + 5.97 (0.75H, ddd, JHH = 1.7 Hz, JHH = 17.0 Hz, JHP = 19.2 Hz), 5.75 
(1H, dd, JHH = 2.2 Hz, JHH = 8.1 Hz), 4.98 (0.75H, m) + 4.65 (0.25H, m), 3.78 (0.75H, d, 
JHP = 11.1 Hz) + 3.75 (2.25H, d, JHP = 11.1 Hz), 3.77 (0.75H, d, JHP = 11.1 Hz) + 3.76 
(2.25H, d, JHP = 11.1 Hz), 2.48 (1H, m), 2.27 (1H, m), 2.10 (1H, m), 1.93 (1H, m); 
13
C 
NMR (CDCl3) (diastereomer pairs) ! 163.0, 151.2 (d, JCP = 6.0 Hz), 150.2, 139.6, 116.4 
(d, JCP = 189.5 Hz), 102.8 + 102.6, 88.1, 80.6 (d, JCP = 22.2 Hz), 52.93 (d, JCP = 5.5 Hz ), 
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52.90 (d, JCP = 5.5 Hz ), 32.7 + 32.3, 30.1; 
31
P NMR (CDCl3) ! 20.88, 20.35; HRMS 
(FAB, MH
+
) calcd for C12H18N2O6P: 317.0902, found 317.0915. 
 
(E)-Ethyl-2-(5-(2-(dimethoxyphosphoryl)vinyl)tetrahydrofuran-2-yl)acetate (3.322) 
 To a well-stirred suspension of (E)-5-(2-(dimethoxyphosphoryl)vinyl)tetrahydrofuran-2-
yl acetate (+/-)-3.297 (1.0 eq, 0.03 g, 0.12 mmol) and zinc dust (3.6 eq, 0.03 g, 0.42 
mmol) in dry CH2Cl2, was added ethylbromoacetate (2.4 eq, 0.03 mL, 0.28 mmol), then 
stirred for a few minutes at room temperature. TiCl4 (1.0 M solution in CH2Cl2) (0.1 eq, 
0.01 mL, 11.7 "mol) was added over a period of 5 min and stirred at 40
o
C in an oil bath. 
It was then filtered and the residue was washed with EtOAc. The organic layer was 
washed with aq. HCl (10 %) to dissolve a turbid suspension, water, brine and dried. 
Solvent removal and column chromatography (SiO2, 80 % EtOAc in hexane) of the 
residue afforded pure compound. (20 mg, 53 %). IR (neat, NaCl) 1732, 1635, 1032 cm
-1
; 
1
H NMR (CDCl3) (diastereomer pairs of 1 : 1) ! 6.78 (1H, m), 5.91 (1H, m), 4.64 (0.5H, 
m), 4.55 (0.5H, m), 4.45 (1H, m), 4.18 (2H, m), 3.74 (1.5H, d, JHP = 11.1 Hz) + 3.730 
(1.5H, d, JHP = 11.1 Hz), 3.731 (1.5H, d, JHP = 11.0 Hz) + 3.72 (1.5H, d, JHP = 11.1 Hz), 
2.61 (1H, m), 2.50 (1H, m), 2.16 (2H, m), 1.73 (2H, m), 1.279 (1.5H, t, JHH = 7.1 Hz) + 
1.277 (1.5H, t, JHH = 7.1 Hz) ; 
13
C NMR (CDCl3) (diastereomer pairs) ! 171.22 + 171.18, 
154.1 (d, JCP = 5.4 Hz) + 153.9 (d, JCP = 5.1 Hz), 114.5 (d, JCP = 188.8 Hz) + 114.1 (d, 
JCP = 189.1 Hz), 78.8 (d, JCP = 21.9 Hz) + 78.5 (d, JCP = 21.9 Hz), 76.7 + 76.0, 60.8, 
52.59 (d, JCP = 5.5 Hz ), 52.55 (d, JCP = 5.7 Hz ), 41.9 + 40.9, 31.6 (d, JCP = 1.7 Hz)  + 
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31.4 (d, JCP = 1.7 Hz ), 31.5 + 30.8, 14.4; 
31
P NMR (CDCl3) ! 22.27; HRMS (EI, M
+
) 
calcd for C12H21O6P: 292.1076, found 292.1047. 
 
(E)-1-(Dimethoxyphosphoryl)-5-hydroxypent-2-enylmethylcarbonate (3.300) 
Dimethyl [1-(methoxycarbonyloxy)-2-propenyl] phosphonate 3.1 (1eq, 0.99 g, 4.4 
mmol), 3-butenol 3.302 (2 eq, 0.75 mL, 8.8 mmol), CuI (10 mol%, 0.0840 g, 0.44 mmol) 
and the 2
nd
 generation Grubbs catalyst (7 mol%, 0.2622 g, 0.31 mmol) were stirred in 
CH2Cl2 (5 mL) at 40
o
C for 3 h ( 63 % conversion) to give, after chromatography (SiO2, 
hexane : EtOAc), the product as a dark yellow oil (0.55 g, 74 %). IR (neat, NaCl) 3419, 
1755 cm
-1
; 
1
H NMR (CDCl3) ! 5.97 (1H, m), 5.68 (1H, m),  5.47 (1H, dd, JHH = 7.5 Hz, 
JHP = 13.1 Hz), 3.83 (3H, JHP = 10.6 Hz), 3.829 (3H, m), 3.821 (3H, JHP = 13.1 Hz), 3.70 
(2H, t, JHH = 5.1 Hz), 2.38 (2H,m); 
13
C NMR (CDCl3) ! 155.1 (d, JCP = 9.9 Hz), 134.8 (d, 
JCP = 12.4 Hz), 123.7 (d, JCP = 4.1 Hz), 73.2 (d, JCP = 170.4 Hz), 61.7 (d, JCP = 3.2 Hz), 
55.8, 54.4 (d, JCP = 7.1 Hz), 54.2 (d, JCP = 6.5 Hz), 36.2; 
31
P NMR (CDCl3) ! 20.29; 
HRMS (EI, MH
+
) calcd for C9H18O7P: 269.0790, found 269.0797. 
 
(E)-Dimethyl-2(2-ethyl-1,3-dioxan-4-yl)vinylphosphonate (3.305) 
To a solution of (E)-1-(Dimethoxyphosphoryl)-5-hydroxypent-2-enylmethylcarbonate 
3.300 (1 eq, 0.21 g, 0.77 mol) and freshly distilled propanal 3.303 (12 eq, 0.67 mL, 9.23 
mmol) was added Pd(PPh3)4 (0.05 eq, 0.0445 g, 38.5 "mol). The flask was put in an oil 
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bath at 40
o
C and the solution was stirred for 2 h. The excess propanal was removed by 
evaporation in vacuo. The crude (47 % product) was purified by column chromatography 
(SiO2, 30 % hexane in EtOAc) to obtain product as a light yellow oil (0.06 g, 68 %). IR 
(neat, NaCl) 1686, 1030 cm
-1
; 
1
H NMR (CDCl3) ! 6.74 (1H, ddd, JHH = 3.4 Hz, JHH = 
17.2 Hz, JHP = 22.9 Hz), 5.93 (1H, ddd, JHH = 1.6 Hz, JHH = 17.2 Hz, JHP = 20.5 Hz), 4.52 
(1H, t, JHH = 5.1 Hz), 4.26 (1H, m), 4.12 (1H, m), 3.77 (1H, m), 3.71 (6H, d, JHP = 11.1 
Hz), 1.64 (4H, m), 0.93 (3H, t, JHH = 7.5 Hz); 
13
C NMR (CDCl3) ! 152.2 (d, JCP = 5.6 
Hz), 114.9 (d, JCP = 188.9 Hz), 103.2, 75.6 (d, JCP = 21.4 Hz), 66.7, 52.8 (d, JCP = 5.7 Hz 
), 31.1, 28.5, 8.6; 
31
P NMR (CDCl3) ! 22.26; HRMS (EI, MH
+
) calcd for C10H20O5P: 
251.1048, found 251.1052. 
 
(E)-5-(Dimethoxyphosphoryl)-5-(methoxycarbonyloxy)pent-3-enylformate (3.308) 
To a solution of (E)-1-(Dimethoxyphosphoryl)-5-hydroxypent-2-enylmethylcarbonate 
3.300 (1 eq, 0.21 g, 0.79 mmol) and chloral hydrate (6 eq, 0.779 g, 4.71 mmol) in 0.50 
mL dry THF was added Pd(PPh3)4 (0.05 eq, 0.045 g, 39.3 "mol). The flask was put in an 
oil bath at 40
o
C and the solution was stirred for 2 h. Diisopropyl ethylamine (1.4 eq, 0.10 
mL, 0.57 mmol) was injected and stirred for another 8 h. The solvent was evaporated in 
vacuo and the reaction crude (48 % product) was purified by column chromatography 
(SiO2, 30 % hexane in EtOAc) to obtain product as a light yellow oil (0.039 g, 71 %). IR 
(neat, NaCl) 2960, 2855, 1754, 1721, 1263 cm
-1
; 
1
H NMR (CDCl3) ! 8.01 (1H, s), 5.91 
(1H, m), 5.66 (1H, m), 5.44 (1H, dd, JHH = 6.8 Hz, JHP = 13.4 Hz), 4.21 (2H, t, JHH = 6.6 
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Hz), 3.81 (3H, s), 3.80 (3H, d,  JHP = 10.6 Hz), 3.79 (3H, d, JHP = 10.5 Hz), 2.45 (2H, m); 
13
C NMR (CDCl3) !161.0, 154.9 (d, JCP = 9.7 Hz), 132.7 (d, JCP = 12.4 Hz), 123.8 (d, JCP 
= 3.8 Hz), 72.7 (d, JCP = 170.6 Hz), 62.6 (d, JCP = 2.9 Hz), 55.7, 54.1 (d, JCP = 7.1 Hz), 
54.0 (d, JCP = 6.3 Hz), 31.8; 
31
P NMR (CDCl3) ! 19.83; HRMS (EI, M
+
) calcd for 
C10H17O8P: 296.0661, found 296.0667. 
 
(E)-Dimethyl 2-(tetrahydrofuran-2-yl)vinylphosphonate (3.125a) 
Triethylsilane (3 eq, 0.39 mL, 2.43 mmol) was added to a solution of (E)-5-(2-
(dimethoxyphosphoryl)vinyl)tetrahydrofuran-2-yl acetate 3.297 (0.213 g, 0.81 mmol) in 
CH2Cl2 (1 mL) at room temperature and the reaction mixture was stirred at room 
temperature for 15 min before cooled down to 0
o
C, followed by the addition of 
trimethylsilyl trifluoromethanesulfonate (TMSOTf) (2 eq, 0.29 mL, 1.62 mmol). After 
stirring for 3 h 45 min at 0
o
C, the mixture was diluted with sat. NaHCO3 solution and 
extracted with EtOAc. The organic layer was successively washed with water and brine, 
dried over Na2SO4 and evaporated in vacuo. The residue was purified by chromatography 
to yield the product as a light yellow oil (0.110 g, 67 %). 
 
(S)-(E)-Dimethyl [1-(methoxycarbonyloxy)-2-propenyl] phosphonate (3.1b) 
The preparation procedure and the characterization data of enantiomerically pure (S)-3.1b 
was same as those of the (R)-enantiomer (3.1a) and was described earlier in chapter 1, 
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except for the enzymatic catalyzed kinetic resolution, the CALB was replaced with lipase 
AY (Amano
TM
). 
 
(1S,5R,E)-6-((S)-4-Benzyl-2-oxooxazolidin-3-yl)-1-(dimethoxyphosphoryl)-5-methyl- 
6-oxohex-2-enyl methyl carbonate (3.334) 
(4S)-4-Benzyl-3-[(2R)-2-methyl-4-pentenoyl]-1,3-oxazolidin-2-one 3.333 (1 eq, 11.79 g, 
43.5 mmol), (S)-(E)-Dimethyl [1-(methoxycarbonyloxy)-2-propenyl] phosphonate 3.1b 
(1 eq, 9.93 g, 43.5 mmol), CuI (10 mol%, 0.83 g, 4.35 mmol) and the 2
nd
 generation 
Grubbs catalyst (5 mol%, 1.84 g, 2.17 mmol), were stirred in CH2Cl2 (15 mL) at 40
o
C for 
3 h (80 % conversion) to give, after chromatography (SiO2, hexane : EtOAc), the product 
as a dark yellow oil (10.52 g, 64 %). IR (neat, NaCl) 1777, 1756, 1697, 1442 cm
-1
; 
1
H 
NMR (CDCl3) ! 7.26 (5H, m), 5.94 (1H, m),  5.65 (1H, m), 5.44 (1H, dd, JHH = 7.4 Hz, 
JHP = 12.5  Hz), 4.64 (1H, m), 4.15 (1H, m), 3.777 (3H, d, JHP = 10.6 Hz), 3.771 (3H, d, 
JHP = 10.7 Hz), 3.72 (3H, s), 3.27 (1H, dd, JHH = 13.3 Hz, JHH = 3.3 Hz), 2.69 (2H, dd, 
JHH = 13.3 Hz, JHH = 9.9 Hz), 2.56 (1H, m), 2.24 (1H, m), 1.16 (3H, d, JHH = 6.8 Hz); 
13
C 
NMR (CDCl3) ! 176.2, 154.9 (d, JCP = 9.4 Hz), 153.3, 135.6, 134.9 (d, JCP = 12.4 Hz), 
129.6 (2 Ar-C), 129.2 (2 Ar-C), 127.50, 123.5 (d, JCP = 3.8 Hz), 72.9 (d, JCP = 170.6 Hz), 
66.3, 55.6, 55.5, 54.0 (d, JCP = 7.0 Hz), 53.9 (d, JCP = 6.2 Hz), 38.2, 37.4 (d, JCP = 2.6 
Hz), 36.6, 16.7; 
31
P NMR (CDCl3) ! 20.05; HRMS (FAB, MNa
+
) calcd for C21H28-
NO9PNa: 492.1339, found 492.1414. 
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(5R,E)-6-((S)-4-Benzyl-2-oxooxazolidin-3-yl)-1-(dimethoxyphosphoryl)-5-methyl-6-
oxohex-2-enyl methyl carbonate ((+/-)-3.334) 
IR (neat, NaCl) and 
1
H NMR (CDCl3) (same as 3.334); 
13
C NMR (CDCl3) (diastereomer 
pairs) ! 176.3 + 176.2, 154.8 (d, JCP = 9.3 Hz), 153.31 + 153.30, 135.7 + 135.6, 134.9 (d, 
JCP = 12.4 Hz) + 134.1 (d, JCP = 12.1 Hz), 129.6 (2 Ar-C), 129.1 (2 Ar-C), 127.50 + 
127.47, 123.5 (d, JCP = 3.9 Hz) + 123.2 (d, JCP = 4.0 Hz), 72.9 (d, JCP = 170.6 Hz) + 72.7 
(d, JCP = 170.6 Hz), 66.3, 55.7 + 55.6, 55.54 + 55.50, 54.0 (d, JCP = 6.8 Hz), 53.9 (d, JCP 
= 6.4 Hz) + 54.05 (d, JCP = 7.1 Hz), 54.00 (d, JCP = 7.2 Hz), 38.2 + 38.1, 37.3 (d, JCP = 
2.6 Hz) + 37.2 (d, JCP = 2.7 Hz), 36.9 + 36.6, 16.74 + 16.70; 
31
P NMR (CDCl3) ! 20.05, 
19.91. 
 
(1S,5R,E)-1-(Dimethoxyphosphoryl)-6-hydroxy-5-methylhex-2-enylmethylcarbonate 
(3.335) 
To a solution of (1S,5R,E)-6-((S)-4-benzyl-2-oxooxazolidin-3-yl)-1-(dimethoxyphospho-
ryl)-5–methyl–6–oxohex–2-enyl methyl carbonate 3.334 (34.61 mg, 0.74 mmol) and 0.03 
mL (1 eq, 0.74 mmol) of MeOH in 3 mL of THF at -20
o
C, was slowly added 0.37 mL (1 
eq, 0.74 mmol) of a 2.0 M solution of LiBH4 in THF. After leaving the solution stirred at 
-20
o
C, the reaction was quenched by the addition of 3.70 mL of 1.0 M aqueous sodium 
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potassium tartrate and stirred for an additional 10 min at room temperature. The mixture 
was then diluted with 7 mL of CH2Cl2 and another 3.70 mL of 1.0 M aqueous sodium 
potassium tartrate. The layers were separated and the aqueous layer was extracted with 
CH2Cl2 twice. The combined organic extracts were washed with brine, dried over 
anhydrous Na2SO4 and concentrated in vacuo to give, after chromatography (SiO2, 
hexane : EtOAc), the product as a light yellow oil (14.9 mg, 75 %). IR (neat, NaCl) 3426, 
1755 cm
-1
; 
1
H NMR (CDCl3) ! 5.98 (1H, m), 5.60 (1H, m),  5.45 (1H, dd, JHH = 7.7 Hz, 
JHP = 12.8 Hz), 3.83 (3H, s), 3.827 (3H, d, JHP = 10.6 Hz), 3.821 (3H, d, JHP = 10.6 Hz), 
3.48 (2H, t, JHH = 5.8 Hz), 2.22 (1H, m), 2.04 (1H, m), 1.77 (1H, m), 1.52 (1H, t, JHH = 
5.7 Hz), 0.92 (3H, d, JHH = 6.8 Hz); 
13
C NMR (CDCl3) ! 155.0 (d, JCP = 10.2 Hz), 137.1 
(d, JCP = 12.4 Hz), 122.1 (d, JCP = 4.1 Hz), 73.2 (d, JCP = 171.1 Hz), 67.7, 55.6, 54.1 (d, 
JCP = 7.1 Hz), 53.9 (d, JCP = 6.5 Hz), 36.6 (d, JCP = 1.0 Hz), 35.8 (d, JCP = 2.5 Hz), 16.6; 
31
P NMR (CDCl3) ! 20.39; HRMS (FAB, MH
+
) calcd for C11H22O7P: 297.1103, found 
297.1110. 
 
(1S,5R,E)-1-(Dimethoxyphosphoryl)-5-methyl-6-oxohex-2-enylmethyl carbonate 
(3.330) 
Dess-Martin periodinane (1.2 eq, 0.354 g, 0.84 mmol) was added in a single portion to a 
stirred solution of the alcohol 3.335 (0.206 g, 0.69 mmol) in 4 mL of CH2Cl2 at room 
temperature. The suspension was stirred at room temperature for 40 min and then washed 
with a saturated solution of sodium bisulfite. The upper aqueous phase was separated and 
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reextracted with CH2Cl2. The combined organic extracts were washed with a saturated 
NaHCO3, brine, dried over Na2SO4 and concentrated in vacuo to give the product without 
purification (94 %). IR (neat, NaCl) 2961, 2855, 1755, 1723 cm
-1
; 
1
H NMR (CDCl3) ! 
9.65 (1H, d, JHH = 1.1 Hz), 5.91 (1H, m),  5.65 (1H, m), 5.45 (1H, dd, JHH = 7.3 Hz, JHP = 
13.2 Hz), 3.83 (3H, s), 3.818 (3H, d, JHP = 10.6 Hz), 3.815 (3H, d, JHP = 10.6 Hz), 2.51 
(2H, m), 2.22 (1H, m), 1.12 (3H, d, JHH = 7.0 Hz); 
13
C NMR (CDCl3) ! 203.9, 154.9 (d, 
JCP = 9.7 Hz), 134.4 (d, JCP = 12.3 Hz), 123.4 (d, JCP = 3.9 Hz), 72.8 (d, JCP = 170.7 Hz), 
55.6, 54.1 (d, JCP = 7.2 Hz), 54.0 (d, JCP = 6.6 Hz), 45.9 (d, JCP = 2.5 Hz), 33.4 (d, JCP = 
1.1 Hz), 13.3; 
31
P NMR (CDCl3) ! 19.94; HRMS (FAB, MNa
+
) calcd for C11H19O7PNa: 
317.0766, found 317.0766. 
 
(3S,5S)-5-((E)-2-(Dimethoxyphosphoryl)vinyl)-3-methyltetrahydrofuran-2-yl)ace-
tate (3.329) 
Compound (1S,5R,E)-1-(dimethoxyphosphoryl)-5-methyl-6-oxohex-2-enylmethyl carbo-
nate 3.330 (7.162 g, 24.3 mmol) was stirred in 9 mL water for 15 min.  THF 9 mL and 
Pd(PPh3)4 (0.05 eq, 1.406 g, 1.22 mmol) were added. The flask was put in an oil bath at 
60
o
C and the solution was stirred for 3 h. The reaction solvent was directly removed by 
evaporation in vacuo to give the residue of hemiacetal. (7.075 g, crude). To a solution of 
this residue, pyridine (1 eq, 2.0 mL, 24.3 mmol) and DMAP (0.1 eq, 0.297 g, 2.43 mmol) 
in CH2Cl2 (35 mL) was added acetic anhydride (1.5 eq, 3.45 mL, 36.5 mmol) at 0
o
C. 
After stirring the mixture for 2 h at room temperature, the white solid in the mixture was 
filtered off and the reaction mixture was evaporated in vacuo and the crude product was 
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purified by column chromatography (SiO2, 3 % ethanol in EtOAc) to obtain product as a 
light yellow oil (4.719 g, 70 % yield over 2 steps). IR (neat, NaCl) 1742, 1030 cm
-1
; 
1
H 
NMR (CDCl3) (diastereomer pairs) ! 6.78 (0.67H, ddd, JHH = 3.6 Hz, JHH = 17.2 Hz, JHP 
= 21.6 Hz) + 6.77 (0.33H, ddd, JHH = 3.6 Hz, JHH = 18.0 Hz, JHP = 22.6 Hz), 6.20 & 5.81 
(1H, m), 5.95 (1H, m), 4.75 (0.67H, m) + 4.65 (0.33H, m), 3.69 (3H, d, JHP = 11.1 Hz) + 
3.68 (3H, d, JHP = 11.1 Hz), 2.36 (2H, m), 2.02 (3H, s), 1.45 (1H, m), 1.06 (0.67H, d, JHH 
= 6.9 Hz) + 1.01 (0.33H, d, JHH = 6.6 Hz); 
13
C NMR (CDCl3) (did not assign; too 
complicated spectrum due to diastereomers); 
31
P NMR (CDCl3) ! 21.80, 21.73, 21.67, 
21.59; HRMS (FAB, MH
+
) calcd for C11H19O6PNa: 301.0817, found 301.0812. 
 
Ethyl 2-((3S,5S)-5-((E)-2-(dimethoxyphosphoryl)vinyl)-3-methyltetrahydrofuran-2-
yl)acetate (3.328) 
To a well-stirred suspension of (3S,5S)-5-((E)-2-(dimethoxyphosphoryl)vinyl)-3-methyl-
tetrahydrofuran-2-yl)acetate 3.329 (0.148 g, 0.53 mmol) and zinc dust (3.6 eq, 0.125 g, 
1.92 mmol) in 2.5 mL of dry CH2Cl2, was added ethylbromoacetate (2.4 eq, 0.14 mL, 
1.28 mmol) and stirred for a few minutes at room temperature. TiCl4 (1.0 M solution in 
CH2Cl2) (0.1 eq, 0.05 mL, 53.3 "mol) was added and then stirred at 40
o
C in an oil bath. 
After 1 h, the reaction was then filtered and the residue was washed with EtOAc. The 
organic layer was washed with aq. HCl (10 %) to dissolve a turbid suspension, water, 
brine and dried over Na2SO4. Solvent removal and column chromatography (SiO2, 80 % 
EtOAc in hexane) of the residue afforded pure compound. (0.130 g, 80 %). IR (neat, 
NaCl) 1733, 1030 cm
-1
; 
1
H NMR (CDCl3) (diastereomer pairs) ! 6.81 (1H, m), 5.93 (1H, 
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m), 4.67 (0.25H, m) + 4.60 (0.75H, m), 4.45 & 3.92 (1H, m), 4.17 (1H, q, JHH = 7.2 Hz), 
3.73 (3H, d, JHP = 11.1 Hz), 3.71 (3H, d, JHP = 11.1 Hz), 2.45 (1H, m), 2.43 (2H, d, JHH = 
5.7 Hz), 2.02 & 1.91 & 1.40 (2H, m each), 1.278 (0.75H, t, JHH = 7.1 Hz) + 1.276 (2.25H, 
t, JHH = 7.1 Hz), 1.04 (0.75H, t, JHH = 6.5 Hz) + 0.94 (2.25H, t, JHH = 7.0 Hz); 
13
C NMR 
(CDCl3) (did not assign; too complicated spectrum due to diastereomers); 
31
P NMR 
(CDCl3) ! 22.44; HRMS (FAB, MH
+
) calcd for C13H24O6P: 307.1311, found 307.1299. 
 
Dimethyl (E)-2-((2S,4S)-4-methyltetrahydrofuran-2-yl)vinylphosphonate (3.336) 
Triethylsilane (3 eq, 0.16 mL, 0.99 mmol) was added to a solution of (3S,5S)-5-((E)-2-
(dimethoxyphosphoryl)vinyl)-3-methyltetrahydrofuran-2-yl)acetate 3.329 (0.091 g, 0.33 
mmol) in CH2Cl2 (0.3 mL) at room temperature and the reaction mixture was stirred at 
room temperature for 15 min before cooled down to 0
o
C, followed by the addition of 
trimethylsilyl trifluoromethanesulfonate (2 eq, 0.12 mL, 0.66 mmol). After stirring for 3 
h at 0
o
C, the mixture was diluted with sat. NaHCO3 solution and extracted with EtOAc. 
The organic layer was successively washed with water and brine, dried over Na2SO4 and 
evaporated in vacuo. The residue was purified by chromatography to yield the product as 
a light yellow oil (0.048 g, 67 %). IR (neat, NaCl) 1030 cm
-1
; 
1
H NMR (CDCl3) 
(diastereomer pairs) ! 6.84 (0.75H, ddd, JHH = 4.3 Hz, JHH = 17.2 Hz, JHP = 21.7 Hz) + 
6.79 (0.25H, ddd, JHH = 3.2 Hz, JHH = 16.9 Hz, JHP = 21.2 Hz), 5.92 (0.75H, ddd, JHH = 
1.6 Hz, JHH = 17.1 Hz, JHP = 21.1 Hz) + 5.89 (0.25H, ddd, JHH = 1.6 Hz, JHH = 16.9 Hz, 
JHP = 21.2 Hz), 4.62 (0.25H, m) + 4.51 (0.75H, m), 4.02 (1H, m), 3.733 (1.5H, d, JHP = 
11.1 Hz) + 3.730 (4.5H, d, JHP = 11.1 Hz), 3.37 (1H, m), 2.36 & 1.83 & 1.29 (3H, m 
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each), 1.06 (3H, d, JHH = 6.4 Hz); 
13
C NMR (CDCl3) (diastereomer pairs) ! 154.6 (d, JCP 
= 5.2 Hz) + 154.2 (d, JCP = 5.2 Hz), 114.0 (d, JCP = 188.6 Hz) + 113.6 (d, JCP = 188.9 
Hz), 79.3 (d, JCP = 22.1 Hz) + 78.2 (d, JCP = 21.6 Hz), 75.6 + 75.3, 52.6 (d, JCP = 5.6 Hz), 
40.7 (d, JCP = 1.5 Hz) + 39.5 (d, JCP = 1.8 Hz) , 34.9 + 32.9, 17.3 + 17.2; 
31
P NMR 
(CDCl3) ! 22.42, 22.37; HRMS (EI, M
+
) calcd for C9H17O4P: 220.0864, found 220.0858. 
 
Dimethyl (E)-2-((2S,4S)-4-methyl-5-oxotetrahydrofuran-2-yl)vinylphosphonate 
(3.336b) 
A vigorously stirred mixture of compound 3.329 (0.077 g, 0.28 mmol) and Dowex 50-X8 
(5 mL) in THF-water (2/1 v/v, total 4.5 mL) was maintained at 45
o
C for overnight (15 h). 
After separation of the resin, the filtrate was extracted with CH2Cl2. The organic extract 
was dried and evaporated in vacuo to obtain the crude product as a light yellow oil (0.052 
g). A solution of crude hemiacetal in CH2Cl2 (4 mL) was added dried, powdered 4 A
o 
molecular sieves (55 mg), and 4-methylmorpholine N-oxide (1.5 eq, 0.039 g, 0.33 mmol). 
After 10 min stirring at room temperature, Pr4NRuO4 (TPAP) (10 mol%, 7.7 mg, 22 
"mol) was added and the reaction mixture was stirred for overnight (14 h). The mixture 
was diluted with CH2Cl2 and was washed with 5 % sodium sulfite and brine, followed by 
filtration through celite and concentration in vacuo to give the product after 
chromatography (SiO2, 80 % EtOAc in hexane) (0.043 g, only step 2--84 % yield, 67 % 
yield over 2 steps). IR (neat, NaCl) 1777 cm
-1
; 
1
H NMR (CDCl3) (diastereomer pairs) ! 
6.79 (0.67H, ddd, JHH = 4.2 Hz, JHH = 17.2 Hz, JHP = 21.9 Hz) + 6.78 (0.33H, ddd, JHH = 
3.7 Hz, JHH = 17.7 Hz, JHP = 22.3 Hz), 5.99 (1H, m), 5.10 (0.33H, m) + 4.94 (0.67H, m), 
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3.74 (4.02H, d, JHP = 11.1 Hz) + 3.73 (1.98H, d, JHP = 11.1 Hz), 2.69 & 2.24 & 1.70 (3H, 
m each), 1.29 (3H, d, JHH = 7.0 Hz); 
13
C NMR (CDCl3) (diastereomer pairs) ! 179.1 + 
178.4, 149.4 (d, JCP = 6.0 Hz) + 148.7 (d, JCP = 5.9 Hz), 117.0 (d, JCP = 189.0 Hz), 76.6 
(d, JCP = 23.0 Hz) + 76.0 (d, JCP = 22.1 Hz), 52.8 (d, JCP = 5.6 Hz) + 52.7 (d, JCP = 4.5 
Hz), 37.0 (d, JCP = 1.6 Hz) + 35.2 (d, JCP = 1.7 Hz) , 35.7 + 32.9, 15.34 + 15.30; 
31
P 
NMR (CDCl3) ! 20.23, 20.15; HRMS (FAB, MH
+
) calcd for C9H16O5P: 235.0735, found 
235.0740. 
 
3-Methyl-1-phenyl-4-pentenol (3.339a) 
The preparation procedure and the characterization data was described according to the 
literature.
127b 
 
Methyl 2-((2S,3R,5S)-3-methyl-5-phenyltetrahydrofuran-2-yl)acetate (3.340a) 
Into a flask containing palladium(II) chloride diacetonitrile; PdCl2(CNMe)2 (10 mol%, 
4.1 mg, 16 "mol)  and CuCl2  (2.2 eq, 47 mg, 0.35 mmol), purged with CO (a bolloon) a 
few times, was added 0.5 mL dry MeOH and stirred for a while. The solution of 3-
methyl-1-phenyl-4-pentenol 3.339a in 0.5 mL dry MeOH was injected, followed by 0.3 
mL of trimethylorthoformate (18 eq, 2.86 mmol) and stirred for 5 h at room temperature 
under CO (bolloon). The mixture were concentrated in vacuo and purified by column 
chromatography to give the light yellow liquid (24 mg, 69 %). IR (neat, NaCl) 1740 cm
-1
; 
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1
H NMR (CDCl3) ! 7.30 (5H, m), 5.00 (1H, dd, JHH = 6.0 Hz, JHH = 9.8 Hz), 4.10 (1H, 
m), 3.70 (3H, s), 2.61 (2H, m), 2.49 (1H, m), 2.14 (1H, m), 1.59 (1H, m), 1.06 (3H, d, 
JHH = 6.5 Hz); 
13
C NMR (CDCl3) ! 172.1, 143.7, 128.5, 127.4, 125.7, 82.5, 80.2, 51.9, 
44.8, 40.7, 39.5, 16.5; HRMS (FAB, MNa
+
) calcd for C14H18O3Na: 257.1154, found 
257.1159. 
 
(4S,6S,E)-1-(Benzyloxy)-6-methylocta-2,7-dien-4-ol (3.344a) 
To a solution of nickel(II) acetylacetonate; Ni(acac)2 (10 mol%, 0.117, 0.45 mmol) in 10 
mL dry THF, was added isoprene (4 eq, 1.9 mL, 18.0 mmol) and stirred for a min. After 
the addition of the solution of (E)-4-(benzyloxy)but-2-enal 3.343a (1 eq, 0.800 g, 4.5 
mmol) in 5 mL dry THF, 10.9 mL of Et3B (1.0 M solution in hexane) (2.4 eq, 10.8 mmol) 
was added. The mixture was stirred for 50 h at room temperature. After dilution with 
EtOAc, the mixture was washed with 2 M HCl, saturated NaHCO3 and then with brine. 
The organic phase was dried over Na2SO4 and concentrated in vacuo. The residue was 
purified by column chromatography over silica gel (hexane/EtOAc 2/1 v/v) to provide the 
colorless liquid (0.220 g, 61 %). IR (neat, NaCl) 3400, 1453 cm
-1
; 
1
H NMR (CDCl3) ! 
7.32 (5H, m), 5.77 (3H, m),  4.95 (2H, m), 4.51 (2H, s), 4.18 (1H, m), 4.01 (2H, d, JHH = 
4.4 Hz), 2.28 (1H, m), 1.60 (1H, m), 1.43 (1H, m), 1.01 (3H, d, JHH = 6.7 Hz); 
13
C NMR 
(CDCl3) ! 144.7, 138.4, 136.1, 128.6, 127.9, 127.8, 127.5, 113.3, 72.5, 70.9, 70.3, 44.1, 
35.1, 20.6; HRMS (FAB, MNa
+
) calcd for C16H22O2Na: 269.1517, found 269.1512. 
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